colonic neoplasm: A benign or malignant neoplasm that affects the colon. Representative examples of benign neoplasms include lipoma and leiomyoma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma. Colonic adenomas always exhibit epithelial dysplasia and are considered premalignant neoplasms.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2876 |
4. Check minimum number of eventsNone |
2876 |
5. Include endpointsNone |
2876 |
6. Filter based on genotype QC (FinnGen only) |
2774 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D12
- Name in latin
- Neoplasma benignum coli descendentis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Descending colon
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Colon
- Benign neoplasm of colon, rectum, anus and anal canal
- Benign neoplasms
- Neoplasms
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 11433 | 5068 | 6323 |
| Only index persons | 10736 | 4845 | 5891 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.15 | 0.18 |
| Only index persons | 0.20 | 0.18 | 0.22 |
| Median age at first event (years) | |||
| Whole population | 67.11 | 67.05 | 67.17 |
| Only index persons | 66.90 | 66.85 | 66.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2774 | 1262 | 1512 |
| Unadjusted period prevalence (%) | 0.58 | 0.45 | 0.69 |
| Median age at first event (years) | 67.06 | 65.86 | 68.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2876
- Matched controls
- 28760
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UJF32
NOMESCO Finland
Coloscopy
12.6
307.7
2187
5771
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
13.1
307.7
428
379
UJF30
NOMESCO Finland
Ileoscopy through colon
5.4
307.7
795
1897
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
18.5
307.7
719
509
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
17.2
307.7
873
712
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
14.1
307.7
311
246
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
175473.9
307.7
2858
26
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
21.3
307.7
1318
1097
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
26.0
307.7
727
370
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
11.2
307.7
601
665
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
6.4
280.7
529
983
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
4.0
274.6
1151
4090
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.0
181.1
1359
6574
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.2
174.5
539
1493
JFA42
NOMESCO Finland
Endoscopic injection in colon
27.4
136.3
93
35
D12.7
ICD-10 Finland
Benign neoplasm: Rectosigmoid junction
9.6
101.5
121
131
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
82.3
1185
7076
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
14.7
65.7
59
41
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
65.4
822
4579
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
64.0
941
5547
JFA52
NOMESCO Finland
Other endoscopic haemostatic procedure in colon
11.6
63.0
65
57
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
62.4
360
1421
K63.5
ICD-10 Finland
Polyp of colon
4.5
61.7
155
359
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
5.6
61.1
118
218
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.8
59.8
322
1224
D64.9
ICD-10 Finland
Anaemia, unspecified
2.3
56.1
475
2241
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
56.1
483
2296
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
6.1
54.6
96
162
B01AB05
ATC
enoxaparin; parenteral
1.9
53.5
1095
7119
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
5.2
49.6
103
203
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
4.5
49.5
124
286
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
49.4
1632
12163
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
4.2
49.3
136
338
A02BC02
ATC
pantoprazole; systemic
1.9
46.6
2118
17210
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.8
45.5
244
922
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
44.4
327
1442
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
42.0
369
1755
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
2.7
42.0
247
978
K92.1
ICD-10 Finland
Melaena
2.7
41.3
236
921
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
41.1
504
2726
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
4.8
40.3
92
197
N02BE01
ATC
paracetamol; systemic, rectal
2.4
37.6
2635
23605
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
37.4
620
3700
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
37.3
463
2509
JFA45
NOMESCO Finland
Endoscopic contact coagulation in colon
8.1
37.1
50
63
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
7.5
36.5
52
70
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
8.9
36.3
45
51
JFA55
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in colon
9.3
35.7
43
47
JN4AD
NOMESCO Finland
Body CT examination
2.0
35.1
454
2491
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
7.5
33.5
48
65
UJF34
NOMESCO Finland
Left colonoscopy
7.1
33.5
50
71
P01AB01
ATC
metronidazole; oral, rectal
1.6
33.5
1128
8152
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
33.1
846
5692
N02AX02
ATC
tramadol; systemic, rectal
1.6
32.3
1329
10054
SPAT1104
SPAT
Monitoring of emergency patient
2.4
32.2
243
1079
UJH02
NOMESCO Finland
Anoscopy
2.9
32.1
159
574
Z12.1
ICD-10 Finland
Special screening examination for neoplasm of intestinal tract
4.4
32.1
80
184
L01BC06
ATC
capecitabine; oral
2.8
31.2
168
634
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
31.1
843
5742
C03CA01
ATC
furosemide; systemic
1.6
31.1
1024
7324
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
31.1
270
1273
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
4.4
30.7
78
182
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
4.6
30.6
72
158
J01DB01
ATC
cefalexin; oral
1.8
30.2
2349
20578
K64.0
ICD-10 Finland
First degree haemorrhoids
3.5
30.1
103
298
N03AX16
ATC
[U] pregabalin
1.7
29.9
712
4681
S18
ICPC
Laceration/cut
1.6
29.8
1472
11538
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
6.2
29.7
51
84
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
11.2
29.3
31
28
JFB43
NOMESCO Finland
Left hemicolectomy
7.0
28.8
44
64
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
4.8
28.5
65
139
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
7.0
28.4
43
62
C07AB07
ATC
bisoprolol; oral
1.5
28.2
1572
12591
JN4BD
NOMESCO Finland
Extensive body CT
1.9
28.2
373
2054
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.8
27.9
139
504
UJF92
NOMESCO Finland
Capsular endoscopy
3.7
27.7
89
247
A10BA02
ATC
metformin; oral
1.6
27.6
937
6706
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
27.1
886
6280
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
26.8
163
654
WX002
NOMESCO Finland
Sedation and analgesia
1.7
26.4
611
3970
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
26.3
592
3816
T90
ICPC
Diabetes non-insulin dependent
1.6
26.3
832
5844
D01
ICPC
Abdominal pain/cramps general
1.9
24.7
348
1952
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.1
24.7
250
1249
JFB30
NOMESCO Finland
Right hemicolectomy
4.0
24.6
69
174
C10AA05
ATC
atorvastatin; oral
1.5
24.3
1391
11064
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
6.3
24.0
40
64
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
23.3
879
6394
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
23.0
754
5311
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
22.8
331
1874
N06AX11
ATC
mirtazapine; oral
1.5
22.6
949
7052
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
3.2
22.5
89
283
R03AC02
ATC
salbutamol; inhalant
1.5
22.4
1469
11934
H02AB06
ATC
prednisolone; systemic
1.5
22.3
1372
11000
R02
ICPC
Shortness of breath/dyspnoea
1.7
22.3
436
2695
SPAT1263
SPAT
Sampling
1.5
22.3
1131
8731
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
21.6
1124
8704
Z3231
NOMESCO Finland
Registered nurse
1.5
21.5
784
5642
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.2
21.4
84
266
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
21.2
299
1674
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
21.2
674
4702
A02BC05
ATC
esomeprazole; systemic
1.5
21.0
1151
8988
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
21.0
1934
16681
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.5
20.8
73
215
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
20.8
1938
16739
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
20.8
507
3319
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
20.5
1204
9515
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
20.5
623
4298
M54.5
ICD-10 Finland
Low back pain
1.5
20.4
983
7477
AA1AD
NOMESCO Finland
CT of head and brain
1.5
20.4
928
6979
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
20.3
362
2176
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
20.1
1053
8136
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
20.0
813
5968
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
20.9
19.9
29
14
Z2221
NOMESCO Finland
Medical doctor
1.5
19.6
729
5252
D11
ICPC
Diarrhoea
1.8
19.5
299
1718
K62.1
ICD-10 Finland
Rectal polyp
4.1
19.4
53
131
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.6
19.3
482
3169
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
19.2
1030
7974
XKD00
NOMESCO Finland
Uroflowmetry
1.6
19.2
550
3736
C05AA08
ATC
fluocortolone; rectal, topical
1.7
19.1
401
2519
R06.0
ICD-10 Finland
Dyspnoea
1.5
18.7
817
6070
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
18.7
543
3696
E0000UV, ,
ATC
1.4
18.6
1110
8750
K64.9
ICD-10 Finland
Haemorrhoids, unspecified
2.4
18.6
126
533
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.3
18.4
138
610
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
6.4
18.4
30
47
C08CA01
ATC
amlodipine; oral
1.4
18.4
1220
9802
130
Kela drug reimbursment
Malignant tumour
1.8
18.3
313
1858
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
4.4
18.2
45
103
SPAT1097
SPAT
Recording of ECG
1.6
18.2
448
2931
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
18.1
1220
9817
J01MA02
ATC
ciprofloxacin; systemic
1.4
18.1
1129
8962
ZX120
NOMESCO Finland
Intravenous
1.8
18.0
288
1675
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
18.0
732
5358
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
6.5
17.9
29
45
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.1
17.7
181
906
A10AE04
ATC
insulin glargine; parenteral
1.8
17.7
308
1837
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
17.6
222
1198
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.5
17.5
114
473
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
7.1
17.4
26
37
A02BC03
ATC
lansoprazole; oral
1.5
17.4
817
6144
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
17.2
411
2668
D16
ICPC
Rectal bleeding
2.7
17.1
91
342
A10BH01
ATC
sitagliptin; oral
1.7
17.1
321
1956
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
16.9
989
7733
J01CA04
ATC
amoxicillin; systemic
1.5
16.9
2173
19491
A10BH05
ATC
linagliptin; oral
2.0
16.9
186
958
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
2.7
16.8
92
351
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
16.8
213
1151
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
16.8
618
4423
SPAT1254
SPAT
Administration of medicine
1.6
16.7
417
2732
G47.3
ICD-10 Finland
Sleep apnoea
1.5
16.7
678
4947
A08
ICPC
Swelling
2.0
16.7
198
1046
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
16.6
208
1119
R53
ICD-10 Finland
Malaise and fatigue
1.5
16.6
665
4840
K55.2
ICD-10 Finland
Angiodysplasia of colon
5.1
16.5
34
67
-, ,
ICD-10 Finland
2.9
16.4
78
276
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
16.4
407
2662
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
16.4
317
1945
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
16.4
311
1899
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
6.3
16.3
27
43
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
16.2
693
5106
A98
ICPC
Health maint/preventive medicine
2.0
16.2
2721
25807
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
16.1
451
3035
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.1
16.1
150
726
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
16.1
355
2256
JFB46
NOMESCO Finland
Resection of sigmoid colon
3.6
16.0
53
151
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
3.3
15.9
59
181
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
15.8
407
2686
A06AD11
ATC
lactulose; oral
1.6
15.7
442
2979
SPAT1153
SPAT
Removal of sutures
1.4
15.6
921
7194
UJF02
NOMESCO Finland
Peroral enteroscopy
5.6
15.5
29
52
C10AA01
ATC
simvastatin; oral
1.4
15.4
1310
10865
D06
ICPC
Abdominal pain localized other
1.8
15.4
240
1384
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
15.3
180
949
C189, 8211, 2
ICD-O-3
28.8
15.2
20
7
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
5.3
15.1
30
57
A02BC01
ATC
omeprazole; systemic
1.4
14.9
741
5601
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
14.9
522
3685
N05CF01
ATC
zopiclone; oral
1.4
14.9
885
6907
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
14.7
574
4144
A04
ICPC
Weakness/tiredness general
1.6
14.6
422
2857
KMAK, ,
NOMESCO Finland
1.4
14.6
1237
10227
J01MA12
ATC
levofloxacin; systemic
1.5
14.6
544
3891
R03BA02
ATC
budesonide; inhalant
1.5
14.5
458
3161
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
14.5
1339
11212
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
14.5
174
923
-60
ICPC
Result test/procedure
2.0
14.5
164
853
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
14.5
426
2897
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
14.4
796
6126
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.1
14.4
144
716
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.1
14.4
144
716
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
12.6
14.4
25
20
B80
ICPC
Iron deficiency anaemia
2.6
14.3
81
315
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
14.3
167
878
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.0
14.3
165
864
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
4.7
14.2
32
68
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.6
14.1
82
323
D18
ICPC
Change in faeces/bowel movements
2.5
14.1
90
371
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.1
14.1
139
688
A46
ICD-10 Finland
Erysipelas
1.5
14.1
452
3132
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
14.1
454
3149
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
14.0
286
1778
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.2
14.0
113
516
A07EC02
ATC
mesalazine; oral, rectal
2.0
14.0
144
724
A07EA06
ATC
budesonide; oral, local oral
2.3
13.9
104
460
K29.7
ICD-10 Finland
Gastritis, unspecified
2.2
13.9
113
518
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
13.9
552
3994
JG1CG
NOMESCO Finland
Extensive MRI of rectum
4.7
13.8
31
66
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
6.3
13.7
23
37
M79.6
ICD-10 Finland
Pain in limb
1.4
13.7
1173
9679
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
13.7
886
6995
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.5
13.6
84
341
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
13.6
476
3356
21135
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Coli descendentis
+∞
13.5
13
*
N06AX21
ATC
duloxetine; oral
1.6
13.5
306
1954
A10BB12
ATC
glimepiride; oral
1.8
13.5
219
1278
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
13.5
288
1813
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
13.5
1830
16184
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
13.4
189
1056
SPAT1301
SPAT
No procedures
1.4
13.4
838
6571
R03BB04
ATC
tiotropium bromide; inhalant
1.6
13.4
316
2039
M04AA01
ATC
allopurinol; systemic
1.5
13.4
418
2877
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.8
13.3
195
1103
R03DC03
ATC
montelukast; oral
1.5
13.3
398
2713
A10BK03
ATC
empagliflozin; oral
1.6
13.3
336
2205
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
13.3
360
2401
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
3.8
13.2
40
107
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
13.2
1146
9459
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
3.9
13.2
38
98
K30
ICD-10 Finland
Functional dyspepsia
1.6
13.2
294
1869
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.1
13.2
125
609
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.1
13.2
119
569
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.1
13.2
118
563
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.4
13.1
92
396
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.9
13.1
176
969
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
13.1
774
6011
UKC02
NOMESCO Finland
Cystoscopy
1.5
12.9
503
3623
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
12.8
720
5538
J01DA01
ATC
[U] cefalexin
1.3
12.8
1608
13997
S04
ICPC
Lump/swelling localized
1.6
12.8
290
1852
205
Kela drug reimbursment
Chronic hypertension
1.4
12.7
810
6365
Z3226
NOMESCO Finland
Physiotherapist
1.5
12.7
487
3495
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
12.7
497
3581
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.2
12.7
109
512
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.5
12.6
482
3455
R4110
NOMESCO Finland
Physiotherapy
1.4
12.5
767
5982
Z71.8
ICD-10 Finland
Other specified counselling
1.4
12.5
855
6787
R42
ICD-10 Finland
Dizziness and giddiness
1.4
12.5
641
4854
L05
ICPC
Flank/axilla symptom/complaint
1.8
12.5
195
1126
E66.8
ICD-10 Finland
Other obesity
2.0
12.4
134
685
SPAT1255
SPAT
Intravenous administration of medicine
1.8
12.4
203
1187
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
12.3
417
2915
Z93.3
ICD-10 Finland
Colostomy status
3.6
12.3
39
108
U07
ICPC
Urine symptom/complaint other
1.7
12.2
256
1602
K64.1
ICD-10 Finland
Second degree haemorrhoids
2.6
12.2
71
281
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
12.1
378
2598
R60.0
ICD-10 Finland
Localized oedema
1.5
12.1
376
2582
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
12.1
175
987
C03DA01
ATC
spironolactone; oral
1.5
12.0
371
2544
L17
ICPC
Foot/toe symptom/complaint
1.4
12.0
829
6588
R96
ICPC
Asthma
1.6
11.9
278
1787
SPAT1216
SPAT
Assessment of functional ability
1.5
11.9
446
3181
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
11.9
122
613
207
Kela drug reimbursment
Chronic arrhythmias
1.4
11.9
507
3708
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.2
11.9
102
479
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.1
11.8
111
540
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.3
11.8
88
390
M03BX02
ATC
tizanidine; oral
1.3
11.8
1583
13842
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
11.7
350
2381
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
11.7
306
2020
L03
ICPC
Low back symptom/complaint
1.4
11.7
743
5818
A07AA02
ATC
nystatin; oral
1.8
11.7
166
930
EBA00
NOMESCO Finland
Extraction of tooth
1.3
11.7
934
7580
R51.80
ICD-10 Finland
Headache
1.5
11.7
353
2408
A10BJ06
ATC
semaglutide; parenteral
1.8
11.6
159
882
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
11.6
254
1608
JAH01
NOMESCO Finland
Laparoscopy
2.1
11.6
112
551
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
3.7
11.5
36
99
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
13.7
11.4
19
14
R31
ICD-10 Finland
Unspecified haematuria
1.5
11.4
326
2199
B82
ICPC
Anaemia other/unspecified
2.2
11.4
99
468
N05BA04
ATC
oxazepam; oral
1.4
11.3
665
5138
X58
ICD-10 Finland
Exposure to other specified factors
1.5
11.3
362
2499
ZXD05
NOMESCO Finland
Urgent procedure
1.4
11.3
754
5947
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
4.2
11.3
29
69
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.4
11.3
74
310
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
11.1
299
1987
B01AA03
ATC
warfarin; systemic
1.4
11.1
566
4269
I48.1
ICD-10 Finland
Persistent atrial fibrillation
1.9
11.1
149
821
J01MA14
ATC
moxifloxacin; systemic
1.6
11.1
254
1625
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
11.1
1387
11965
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
11.1
981
8068
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.6
11.1
35
97
A02BA02
ATC
ranitidine; systemic
1.4
11.1
524
3903
J02AC01
ATC
fluconazole; systemic
1.3
11.0
869
7024
Z98.8
ICD-10 Finland
Other specified postsurgical states
3.1
11.0
44
142
R01AD09
ATC
mometasone; nasal
1.3
10.9
1075
8967
K96
ICPC
Haemorrhoids
2.3
10.9
81
358
R50.9
ICD-10 Finland
Fever, unspecified
1.5
10.9
395
2797
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
10.9
449
3259
WX722
NOMESCO Finland
PEEP
1.9
10.9
141
769
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
10.8
357
2479
SPAT1325
SPAT
Vaccination
1.3
10.8
892
7255
N06AX16
ATC
venlafaxine; oral
1.5
10.8
322
2190
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
10.7
489
3617
M48.0
ICD-10 Finland
Spinal stenosis
1.5
10.7
377
2655
A10BK01
ATC
dapagliflozin; oral
1.6
10.7
238
1513
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.0
10.6
109
548
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
12.9
10.6
18
14
R05
ICPC
Cough
1.4
10.6
636
4925
C10AC01
ATC
colestyramine; oral
2.3
10.6
78
344
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
10.6
271
1781
D02
ICPC
Abdominal pain epigastric
1.8
10.5
160
916
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
10.5
194
1174
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
10.5
335
2310
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.2
10.5
87
403
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
10.5
484
3584
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
10.5
370
2605
XF404
NOMESCO Finland
Ambulatory ECG
1.6
10.5
256
1665
B01AC04
ATC
clopidogrel; oral
1.4
10.4
515
3859
K60.2
ICD-10 Finland
Anal fissure, unspecified
3.0
10.4
45
152
ZXA00
NOMESCO Finland
Right side
1.4
10.4
721
5710
A02BC04
ATC
rabeprazole; oral
1.6
10.3
221
1390
WX892
NOMESCO Finland
Monitored bed care
1.6
10.3
222
1398
N03AX12
ATC
[U] gabapentin; oral
1.4
10.3
433
3151
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
10.3
208
1289
G04CA02
ATC
tamsulosin; oral
1.3
10.3
763
6100
-62
ICPC
Administrative procedure
2.3
10.3
79
355
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
10.3
520
3913
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
3.4
10.3
36
107
SPAT1262
SPAT
Handing over of treatment supplies
1.4
10.3
491
3659
JFA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in colon
8.8
10.3
21
24
D12
ICPC
Constipation
1.9
10.2
120
633
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.6
10.2
24
53
JN4CD
NOMESCO Finland
Very extensive body CT
2.0
10.2
117
612
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.4
10.2
69
293
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
10.2
100
495
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
10.1
268
1774
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
5.3
10.1
20
38
A01AB09
ATC
miconazole; local oral
1.6
10.1
215
1351
J45.8
ICD-10 Finland
Mixed asthma
2.2
10.1
85
397
M10.9
ICD-10 Finland
Gout, unspecified
1.6
10.1
227
1447
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
10.0
958
7937
N06AB04
ATC
citalopram; systemic
1.4
10.0
503
3780
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.2
10.0
80
366
GD1AD
NOMESCO Finland
Thorax CT examination
1.7
10.0
198
1223
N07BA03
ATC
varenicline; oral
1.9
9.9
115
604
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
3.8
9.9
29
76
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
9.9
359
2539
P03
ICPC
Feeling depressed
1.7
9.9
175
1047
J45
ICD-10 Finland
Asthma
1.6
9.9
246
1606
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
3.2
9.9
37
115
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.7
9.8
192
1180
Z01.2
ICD-10 Finland
Dental examination
1.3
9.8
1110
9397
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
9.8
288
1952
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
4.9
9.8
21
43
WVA20
NOMESCO Finland
Medicine administration
2.1
9.8
85
402
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
9.8
312
2152
J01FA09
ATC
clarithromycin; systemic
1.3
9.7
731
5851
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.8
9.7
154
894
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.8
9.7
135
754
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
2.9
9.6
45
159
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
9.6
145
829
WZC30
NOMESCO Finland
Teaching
1.4
9.6
474
3548
J01AA02
ATC
doxycycline; systemic
1.3
9.6
2115
19487
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
2.5
9.6
57
228
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
9.6
734
5886
C09CA06
ATC
candesartan; oral
1.4
9.6
636
4996
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
9.6
103
528
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
9.5
261
1742
JFB51
NOMESCO Finland
Other laparoscopic resection of colon
15.1
9.5
15
10
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
9.5
144
825
A01
ICPC
Pain general/multiple sites
1.5
9.5
274
1850
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.9
9.5
112
593
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
9.5
756
6099
D02AE01
ATC
carbamide; topical
1.7
9.5
160
946
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.5
9.4
59
242
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
9.4
497
3761
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
3.7
9.4
29
79
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
9.4
975
8149
C186, 8148, 2
ICD-O-3
100.4
9.4
10
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
9.4
197
1233
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.9
9.4
116
624
R06AE07
ATC
cetirizine; oral
1.3
9.3
1024
8622
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
9.3
188
1166
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
9.3
277
1882
E66.00
ICD-10 Finland
Metabolic syndrome
1.7
9.3
153
898
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
9.3
1147
9803
N05AH04
ATC
quetiapine; oral
1.4
9.3
398
2907
R01AD08
ATC
fluticasone; nasal
1.3
9.2
660
5238
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
9.1
365
2630
R07.3
ICD-10 Finland
Other chest pain
1.5
9.1
279
1906
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
1.9
9.1
106
558
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
9.1
402
2950
XF402
NOMESCO Finland
ECG with work load test
1.5
9.1
303
2109
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.4
9.1
58
241
K02.1
ICD-10 Finland
Caries of dentine
1.3
9.0
1420
12488
N06AX12
ATC
bupropion; oral
1.8
9.0
122
676
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.8
9.0
133
757
A11
ICPC
Chest pain NOS
1.5
9.0
249
1667
C07AA05
ATC
propranolol; systemic
1.4
8.9
448
3360
Z31.5
ICD-10 Finland
Genetic counselling
1.9
8.9
103
541
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.7
8.9
147
864
J01FF01
ATC
clindamycin; systemic
1.3
8.9
694
5576
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.6
8.8
49
190
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
8.8
1603
14325
K55.8
ICD-10 Finland
Other vascular disorders of intestine
4.7
8.8
20
43
R4120
NOMESCO Finland
Occupational therapy
1.7
8.8
175
1081
A91
ICPC
Abnormal result investigation NOS
1.7
8.8
158
950
H25.8
ICD-10 Finland
Other senile cataract
1.5
8.8
327
2325
WZA90
NOMESCO Finland
Other medical or dental certificate
1.4
8.7
553
4305
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
2.7
8.7
46
174
R03AC03
ATC
terbutaline; inhalant
1.5
8.7
321
2279
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
2.6
8.7
49
192
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
8.6
327
2334
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.5
8.6
241
1617
C18.62
ICD-10 Finland
Malignant tumor of the descending colon carcinoma of the adenoma
16.3
8.5
13
8
I50
ICD-10 Finland
Heart failure
2.0
8.5
90
459
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
8.5
490
3760
JHB00
NOMESCO Finland
Hemorrhoidectomy
2.0
8.5
88
446
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.6
8.4
46
177
A10BJ02
ATC
liraglutide; parenteral
2.1
8.4
79
386
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
8.4
145
864
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.1
8.4
79
387
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.8
8.3
130
752
S29
ICPC
Skin symptom/complaint other
1.3
8.3
540
4218
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
8.3
299
2112
SPAT1101
SPAT
Orthostatic test
1.8
8.3
123
701
-31
ICPC
Medical examin/health eval partial
1.6
8.3
168
1044
SPAT1310
SPAT
Counselling related to known health issue
1.3
8.3
787
6483
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.8
8.3
122
694
R19.4
ICD-10 Finland
Change in bowel habit
2.0
8.3
81
402
UJG02
NOMESCO Finland
Proctoscopy
2.2
8.3
65
296
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
8.3
201
1306
D12
ICD-10 Finland
Benign neoplasm of colon, rectum, anus and anal canal
3.8
8.2
24
63
A03CA02
ATC
clidinium and psycholeptics; oral
1.7
8.2
151
914
I50.0
ICD-10 Finland
Congestive heart failure
1.6
8.2
215
1421
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
8.2
84
424
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.3
8.2
61
272
SPAT1210
SPAT
Application of cast or individual aid
1.9
8.1
105
573
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.8
8.1
114
640
WX402
NOMESCO Finland
General anaesthesia
1.3
8.1
562
4433
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.7
8.1
142
850
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
3.8
8.1
24
64
R52.9
ICD-10 Finland
Pain, unspecified
1.5
8.0
259
1789
J01FA06
ATC
roxithromycin; oral
1.3
8.0
987
8389
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
8.0
734
6012
-50
ICPC
Medication/prescr/renewal
1.8
8.0
110
613
S10
ICPC
Boil/carbuncle
1.7
8.0
150
914
D75
ICPC
Malignant neoplasm colon/rectum
3.1
8.0
32
104
ZXA05
NOMESCO Finland
Left side
1.3
8.0
649
5234
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
8.0
636
5115
G44.2
ICD-10 Finland
Tension-type headache
1.5
7.9
299
2130
K62.0
ICD-10 Finland
Anal polyp
3.2
7.9
30
94
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
3.4
7.9
28
84
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
3.0
7.9
34
115
-42
ICPC
Electrical tracing
2.6
7.9
45
177
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
7.9
1662
15015
TJF80
NOMESCO Finland
Ostomy education
2.8
7.9
38
137
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
7.9
666
5395
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
7.9
246
1688
C01DA14
ATC
isosorbide mononitrate; oral
1.4
7.9
445
3400
PD5AD
NOMESCO Finland
CT of aorta
2.0
7.9
79
396
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.6
7.9
162
1011
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
7.9
157
972
WYA10
NOMESCO Finland
Emergency care or similar visit
1.6
7.8
158
981
D07AC01
ATC
betamethasone; topical
1.3
7.8
936
7925
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.4
7.8
52
221
N02BF02
ATC
pregabalin; oral
1.6
7.8
174
1109
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
7.8
657
5323
L86
ICPC
Back syndrome with radiating pain
1.6
7.8
160
999
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.4
7.8
50
209
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
3.7
7.7
24
66
SFA10
NOMESCO Finland
One-surface restoration
1.2
7.7
1333
11767
K59.0
ICD-10 Finland
Constipation
1.7
7.7
148
907
R33
ICD-10 Finland
Retention of urine
1.5
7.7
241
1655
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
7.7
714
5854
127
Kela drug reimbursment
Transplant complication
2.6
7.7
42
162
UJF30, ,
SPAT
3.0
7.7
33
112
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.6
895
7553
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
4.5
7.6
18
40
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.0
7.6
77
387
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.6
7.6
169
1075
C10AA07
ATC
rosuvastatin; oral
1.3
7.6
946
8041
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
7.6
121
705
3AC01, ,
NOMESCO Finland
3.1
7.6
31
102
C18.52
ICD-10 Finland
Malignant tumor of flexura lienalis carcinoma of adenoma
25.1
7.6
10
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.0
7.6
73
361
H02AB07
ATC
prednisone; oral
1.4
7.6
335
2458
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
7.6
254
1770
N05CF02
ATC
zolpidem; oral
1.4
7.6
410
3112
A07EA02
ATC
hydrocortisone; rectal
2.3
7.5
55
243
R35
ICD-10 Finland
Polyuria
1.5
7.5
200
1326
TJX90
NOMESCO Finland
Other minor procedure in gastroenterological surgery
8.9
7.5
15
17
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
7.5
546
4329
B01AF02
ATC
apixaban; oral
1.4
7.5
407
3089
J46
ICD-10 Finland
Status asthmaticus
2.1
7.5
70
342
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.7
7.5
134
807
PD4AD
NOMESCO Finland
CT of lower extremity arteries
3.0
7.5
31
103
C01AA05
ATC
digoxin; systemic
1.5
7.4
215
1452
K29.6
ICD-10 Finland
Other gastritis
2.6
7.4
41
159
K25.4
ICD-10 Finland
Gastric ulcer, Chronic or unspecified with haemorrhage
3.2
7.4
28
88
IGY02, ,
SPAT
3.0
7.4
32
109
UJK02
NOMESCO Finland
ERCP
2.0
7.4
78
399
R01AD58
ATC
fluticasone, combinations; nasal
1.3
7.4
502
3944
-48
ICPC
Clarification/discussion RFE/demand
2.4
7.4
48
202
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
3.0
7.3
31
104
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.3
7.3
51
221
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
7.3
232
1598
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
7.3
155
975
A06AC51
ATC
ispaghula, combinations; oral
1.7
7.3
119
698
H26.4
ICD-10 Finland
After-cataract
1.4
7.3
284
2037
L13
ICPC
Hip symptom/complaint
1.3
7.3
523
4141
L04AA06
ATC
mycophenolic acid; systemic
2.3
7.2
51
222
JF1AD
NOMESCO Finland
Small bowel CT
3.2
7.2
27
84
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.1
7.2
65
313
C09CA01
ATC
losartan; oral
1.3
7.2
727
6016
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.9
7.2
82
430
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.8
7.2
106
604
WF001
NOMESCO Finland
Preoperative radiotherapy
2.9
7.2
32
111
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
2.1
7.2
63
301
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.6
7.1
183
1204
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.2
7.1
59
275
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.6
7.1
144
895
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.1
584
4705
A10AB05
ATC
insulin aspart; parenteral
1.5
7.1
198
1327
N02BF01
ATC
gabapentin; oral
1.4
7.1
265
1885
H03AA01
ATC
levothyroxine sodium; systemic
1.3
7.1
537
4282
H02AB04
ATC
methylprednisolone; systemic
1.4
7.0
353
2644
C08CA02
ATC
felodipine; oral
1.4
7.0
264
1879
JGA85
NOMESCO Finland
Endoscopic mucosal or submucosal resection in rectum
8.8
7.0
14
16
N06AB10
ATC
escitalopram; oral
1.4
7.0
408
3128
SDA03
NOMESCO Finland
Periodontal treatment
1.3
7.0
946
8098
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
10.0
7.0
13
13
L01
ICPC
Neck symptom/complaint
1.4
7.0
372
2812
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.0
7.0
70
351
K92.0
ICD-10 Finland
Haematemesis
2.0
7.0
67
331
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.0
7.0
75
386
K92.9
ICD-10 Finland
Disease of digestive system, unspecified
3.9
7.0
20
52
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
7.0
292
2122
SPAT1312
SPAT
General health counselling
1.3
6.9
733
6097
SPAT1211
SPAT
Application of soft bandage
1.5
6.9
211
1441
JAH00
NOMESCO Finland
Laparotomy
2.0
6.9
75
387
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
6.9
151
957
R03AK08
ATC
formoterol and beclometasone; inhalant
1.7
6.9
109
634
R5110, ,
SPAT
1.5
6.9
243
1709
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
6.9
199
1344
R4190
NOMESCO Finland
Nutritional therapy
1.8
6.9
93
516
I78.8
ICD-10 Finland
Other diseases of capillaries
7.5
6.9
15
20
L04AD02
ATC
tacrolimus; systemic
3.1
6.9
28
92
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
6.9
190
1272
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
6.9
301
2204
D01AC02
ATC
miconazole; topical
1.5
6.9
195
1313
K78
ICPC
Atrial fibrillation/flutter
1.5
6.8
232
1621
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
6.8
203
1381
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
3.8
6.8
20
53
N05AN01
ATC
lithium; oral
2.2
6.8
52
235
R03DA04
ATC
theophylline; systemic, rectal
1.7
6.8
128
782
SFA00
NOMESCO Finland
Small restoration
1.4
6.8
334
2494
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
6.7
417
3227
K03.66
ICD-10 Finland
Tooth plaque
1.5
6.7
186
1245
M02AA07
ATC
piroxicam; topical
1.2
6.7
925
7929
A01AB04
ATC
amphotericin B; local oral
1.7
6.7
114
677
WW500
NOMESCO Finland
Blood transfusion
1.8
6.7
104
602
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.3
6.7
502
3993
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
6.7
175
1157
J01EA01
ATC
trimethoprim; systemic
1.3
6.7
581
4713
K22.1
ICD-10 Finland
Ulcer of oesophagus
2.2
6.7
53
243
N32.0
ICD-10 Finland
Bladder-neck obstruction
3.0
6.6
28
94
WX290
NOMESCO Finland
Other blockage of nerve
1.2
6.6
1035
8990
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.5
6.6
228
1596
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.6
463
3646
J01CA02
ATC
pivampicillin; oral
2.0
6.6
65
324
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.6
698
5801
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
1.8
6.6
92
516
8263/2-C20.9
ICD-O-3
Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS
7.8
6.6
14
18
A02BD07
ATC
lansoprazole, amoxicillin and clarithromycin; systemic
1.7
6.6
127
781
N06AB06
ATC
sertraline; oral
1.5
6.6
228
1599
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.7
6.6
34
128
R10.0
ICD-10 Finland
Acute abdomen
1.9
6.6
78
416
G04BD08
ATC
solifenacin; oral
1.5
6.6
178
1187
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
6.6
700
5825
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
1.9
6.6
83
452
I84
ICD-10 Finland
Hemorrhoids
2.0
6.5
69
354
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
2.7
6.5
33
123
N30.0
ICD-10 Finland
Acute cystitis
1.3
6.5
390
3006
A07AA09
ATC
vancomycin; oral
2.4
6.5
43
183
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
6.5
486
3867
WX882
NOMESCO Finland
High dependency care
1.9
6.5
75
397
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
6.2
6.5
16
26
KH1AD
NOMESCO Finland
CT of urinary organs
1.8
6.5
95
542
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
6.4
577
4698
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
6.4
542
4378
A04.8
ICD-10 Finland
Other specified bacterial intestinal infections
2.3
6.4
48
215
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
6.4
111
663
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
6.4
394
3045
N06AX26
ATC
vortioxetine; oral
1.6
6.4
139
880
R03BA08
ATC
ciclesonide; inhalant
1.5
6.4
198
1357
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.8
6.4
30
107
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.4
698
5820
K64.2
ICD-10 Finland
Third degree haemorrhoids
2.3
6.4
44
190
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
14.3
6.4
10
7
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.0
6.4
27
91
XG410
NOMESCO Finland
Flow-volume spirometry
1.7
6.4
102
597
K07
ICPC
Swollen ankles/oedema
1.6
6.4
135
851
Z01.7
ICD-10 Finland
Laboratory examination
1.3
6.3
400
3104
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
6.3
207
1436
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.2
6.3
49
223
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.7
6.3
104
613
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
5.2
6.3
18
35
N06AB03
ATC
fluoxetine; oral
1.4
6.3
275
2012
D19
ICPC
Teeth/gum symptom/complaint
1.3
6.3
689
5747
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.6
6.3
34
131
JFB40
NOMESCO Finland
Resection of transverse colon
9.3
6.3
12
13
R13
ICD-10 Finland
Dysphagia
1.5
6.3
193
1322
Z53.8
ICD-10 Finland
Procedure not carried out for other reasons
3.8
6.3
18
47
K573, D124,
ICD-10 Finland
+∞
6.3
6
*
S22.3
ICD-10 Finland
Fracture of rib
1.5
6.2
198
1365
K22.7
ICD-10 Finland
Barrett oesophagus
2.3
6.2
46
205
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
6.2
213
1490
SPAT1260
SPAT
Consultation of another employee
1.3
6.2
424
3327
R03BA05
ATC
fluticasone; inhalant
1.3
6.2
401
3122
Z43.3
ICD-10 Finland
Attention to colostomy
7.0
6.2
14
20
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
6.2
234
1668
XG466
NOMESCO Finland
Sleep oxymetry
1.8
6.2
82
453
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.0
6.2
60
298
N05CD07
ATC
temazepam; oral
1.4
6.2
295
2191
C09AA05
ATC
ramipril; oral
1.3
6.2
711
5963
-59
ICPC
Other therap proced/minor surg NEC
1.9
6.2
68
354
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
6.2
333
2524
L12
ICPC
Hand/finger symptom/complaint
1.3
6.2
400
3117
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.2
911
7856
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
6.1
1066
9344
R11
ICD-10 Finland
Nausea and vomiting
1.5
6.1
200
1386
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
1.9
6.1
68
355
A10BD07
ATC
metformin and sitagliptin; systemic
1.6
6.1
119
734
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.1
6.1
52
246
I20.09
ICD-10 Finland
Unstable angina
1.5
6.1
159
1052
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.7
6.1
109
658
G04BD12
ATC
mirabegron; oral
1.4
6.1
343
2617
J20
ICD-10 Finland
Acute bronchitis
1.4
6.1
232
1658
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
6.1
156
1029
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.1
6.1
52
247
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
6.0
174
1176
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.2
6.0
47
215
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Benign neoplasm: Transverse colon
D12.3 [45581282]
D12.3 [45581282]
2.4e+00
2.6e+00
3.7e+00
1.0e+50
5.0e+00
4.0e+00
3.5e+00
cases:2.65%
controls:0.24%
cases:1.50%
controls:0.11%
cases:0.73%
controls:0.02%
cases:15.64%
controls:0.00%
cases:3.39%
controls:0.02%
cases:4.84%
controls:0.09%
cases:7.17%
controls:0.22%
76
70
2794
28619
43
32
2827
28657
21
5
2849
28684
449
0
2421
28689
97
7
2763
28591
133
26
2613
27389
151
47
1955
20999
Gastroenterology
10 [38004455]
10 [38004455]
1.2e+00
1.6e+00
2.4e+00
7.9e+00
3.1e+00
2.0e+00
1.5e+00
cases:18.99%
controls:6.85%
cases:13.59%
controls:3.04%
cases:5.57%
controls:0.52%
cases:48.01%
controls:0.03%
cases:9.83%
controls:0.51%
cases:17.84%
controls:2.74%
cases:27.21%
controls:7.69%
545
1965
2325
26724
390
873
2480
27816
160
149
2710
28540
1378
10
1492
28679
281
145
2579
28453
490
752
2256
26663
573
1619
1533
19427
Benign neoplasm: Ascending colon
D12.2 [45600580]
D12.2 [45600580]
2.3e+00
2.7e+00
3.7e+00
1.0e+50
4.6e+00
3.4e+00
2.8e+00
cases:3.59%
controls:0.37%
cases:2.16%
controls:0.15%
cases:0.80%
controls:0.02%
cases:13.90%
controls:0.00%
cases:3.01%
controls:0.03%
cases:5.13%
controls:0.18%
cases:7.79%
controls:0.49%
103
105
2767
28584
62
42
2808
28647
23
6
2847
28683
399
0
2471
28689
86
9
2774
28589
141
48
2605
27367
164
103
1942
20943
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
8.2e-01
1.5e+00
2.5e+00
7.8e+00
3.1e+00
2.0e+00
1.5e+00
cases:23.48%
controls:11.90%
cases:17.56%
controls:4.76%
cases:7.91%
controls:0.70%
cases:29.27%
controls:0.02%
cases:14.02%
controls:0.72%
cases:25.97%
controls:4.60%
cases:37.99%
controls:12.48%
674
3414
2196
25275
504
1365
2366
27324
227
202
2643
28487
840
5
2030
28684
401
205
2459
28393
713
1260
2033
26155
800
2627
1306
18419
Benign neoplasm: Rectum
D12.8 [45595734]
D12.8 [45595734]
1.9e+00
1.8e+00
3.0e+00
—
4.4e+00
3.1e+00
2.2e+00
cases:3.17%
controls:0.49%
cases:1.39%
controls:0.23%
cases:0.66%
controls:0.03%
—
—
cases:2.52%
controls:0.03%
cases:4.15%
controls:0.19%
cases:5.18%
controls:0.60%
91
141
2779
28548
40
65
2830
28624
19
10
2851
28679
—
72
9
2788
28589
114
53
2632
27362
109
127
1997
20919
Endoscopic polypectomy in colon
JFA15 [2001304850]
JFA15 [2001304850]
2.0e+00
2.2e+00
3.4e+00
1.0e+50
3.1e+00
2.7e+00
2.0e+00
cases:5.82%
controls:0.81%
cases:2.58%
controls:0.29%
cases:0.94%
controls:0.03%
cases:31.01%
controls:0.00%
cases:0.70%
controls:0.03%
cases:3.82%
controls:0.27%
cases:8.21%
controls:1.15%
167
231
2703
28458
74
84
2796
28605
27
9
2843
28680
890
0
1980
28689
20
9
2840
28589
105
75
2641
27340
173
243
1933
20803
Benign neoplasm: Sigmoid colon
D12.5 [45552326]
D12.5 [45552326]
2.1e+00
2.6e+00
3.8e+00
1.0e+50
—
3.8e+00
2.7e+00
cases:4.39%
controls:0.58%
cases:2.54%
controls:0.20%
cases:1.08%
controls:0.02%
cases:15.92%
controls:0.00%
—
—
cases:6.23%
controls:0.15%
cases:7.93%
controls:0.59%
126
166
2744
28523
73
57
2797
28632
31
7
2839
28682
457
0
2413
28689
—
171
41
2575
27374
167
124
1939
20922
Benign neoplasm: Caecum
D12.0 [45586086]
D12.0 [45586086]
2.1e+00
2.2e+00
—
1.0e+50
4.4e+00
3.5e+00
2.6e+00
cases:1.99%
controls:0.24%
cases:0.94%
controls:0.10%
—
—
cases:8.43%
controls:0.00%
cases:1.89%
controls:0.02%
cases:3.20%
controls:0.10%
cases:4.61%
controls:0.36%
57
69
2813
28620
27
29
2843
28660
—
242
0
2628
28689
54
7
2806
28591
88
27
2658
27388
97
76
2009
20970
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
D12.6 [45576377]
1.8e+00
2.1e+00
2.4e+00
1.0e+50
2.9e+00
2.4e+00
1.9e+00
cases:4.84%
controls:0.83%
cases:2.30%
controls:0.29%
cases:0.66%
controls:0.06%
cases:1.05%
controls:0.00%
cases:1.43%
controls:0.08%
cases:3.10%
controls:0.28%
cases:6.55%
controls:1.03%
139
238
2731
28451
66
84
2804
28605
19
17
2851
28672
30
0
2840
28689
41
22
2819
28576
85
78
2661
27337
138
216
1968
20830
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
UJF45 [2001305031]
1.5e+00
2.0e+00
2.7e+00
1.0e+50
2.5e+00
2.7e+00
1.5e+00
cases:4.43%
controls:0.98%
cases:2.40%
controls:0.34%
cases:0.31%
controls:0.02%
cases:2.23%
controls:0.00%
cases:0.38%
controls:0.03%
cases:3.53%
controls:0.24%
cases:3.80%
controls:0.86%
127
282
2743
28407
69
97
2801
28592
9
6
2861
28683
64
0
2806
28689
11
9
2849
28589
97
67
2649
27348
80
180
2026
20866
Malignant tumor of the sigmoid invasive carcinoma
C18.71 [2000500563]
C18.71 [2000500563]
2.0e+00
2.0e+00
1.8e+00
—
2.4e+00
2.2e+00
2.2e+00
cases:1.46%
controls:0.20%
cases:1.32%
controls:0.19%
cases:0.38%
controls:0.06%
—
—
cases:0.70%
controls:0.06%
cases:1.75%
controls:0.19%
cases:2.14%
controls:0.25%
42
57
2828
28632
38
54
2832
28635
11
18
2859
28671
—
20
18
2840
28580
48
53
2698
27362
45
52
2061
20994
Malignant tumor of the rectum invasive carcinoma
C20.91 [2000500574]
C20.91 [2000500574]
1.6e+00
1.7e+00
1.8e+00
—
2.4e+00
2.2e+00
2.0e+00
cases:2.06%
controls:0.44%
cases:1.85%
controls:0.33%
cases:0.77%
controls:0.12%
—
—
cases:1.40%
controls:0.13%
cases:3.17%
controls:0.35%
cases:3.18%
controls:0.44%
59
127
2811
28562
53
96
2817
28593
22
35
2848
28654
—
40
36
2820
28562
87
96
2659
27319
67
92
2039
20954
Malignant tumor of sigmoid carcinoma of adenoma
C18.72 [2000500564]
C18.72 [2000500564]
2.5e+00
2.3e+00
—
1.0e+50
—
3.6e+00
3.2e+00
cases:0.49%
controls:0.04%
cases:0.21%
controls:0.02%
—
—
cases:0.21%
controls:0.00%
—
—
cases:0.69%
controls:0.02%
cases:0.81%
controls:0.03%
14
11
2856
28678
6
6
2864
28683
—
6
0
2864
28689
—
19
5
2727
27410
17
7
2089
21039
Coloscopy
UJF32 [2001305029]
UJF32 [2001305029]
1.2e+00
1.4e+00
3.2e+00
—
1.9e+00
1.9e+00
2.0e+00
cases:15.51%
controls:5.37%
cases:6.10%
controls:1.60%
cases:3.03%
controls:0.12%
—
—
cases:1.01%
controls:0.15%
cases:8.63%
controls:1.35%
cases:29.34%
controls:5.24%
445
1542
2425
27147
175
458
2695
28231
87
35
2783
28654
—
29
43
2831
28555
237
371
2509
27044
618
1102
1488
19944
Polyp of colon
K63.5 [45601184]
K63.5 [45601184]
1.1e+00
1.7e+00
3.1e+00
1.0e+50
2.1e+00
1.8e+00
1.5e+00
cases:0.52%
controls:0.17%
cases:0.84%
controls:0.15%
cases:0.52%
controls:0.02%
cases:0.35%
controls:0.00%
cases:0.31%
controls:0.04%
cases:0.76%
controls:0.13%
cases:2.04%
controls:0.45%
15
48
2855
28641
24
42
2846
28647
15
7
2855
28682
10
0
2860
28689
9
11
2851
28587
21
36
2725
27379
43
95
2063
20951
General Surgery
2 [38004447]
2 [38004447]
4.9e-01
8.6e-01
1.4e+00
5.3e+00
1.7e+00
8.8e-01
6.4e-01
cases:25.85%
controls:17.54%
cases:11.25%
controls:5.11%
cases:3.00%
controls:0.73%
cases:7.04%
controls:0.04%
cases:3.57%
controls:0.66%
cases:10.71%
controls:4.72%
cases:22.41%
controls:13.20%
742
5032
2128
23657
323
1465
2547
27224
86
208
2784
28481
202
11
2668
28678
102
189
2758
28409
294
1295
2452
26120
472
2779
1634
18267
Colonoscopy Study observation
28023-0 [3022145]
28023-0 [3022145]
9.3e-01
1.3e+00
3.2e+00
—
2.9e+00
1.5e+00
1.2e+00
cases:6.66%
controls:2.73%
cases:3.87%
controls:1.05%
cases:1.85%
controls:0.07%
—
—
cases:1.54%
controls:0.08%
cases:3.82%
controls:0.87%
cases:10.35%
controls:3.46%
191
783
2679
27906
111
301
2759
28388
53
21
2817
28668
—
44
24
2816
28574
105
239
2641
27176
218
729
1888
20317
Internal Medicine
11 [38004456]
11 [38004456]
5.1e-01
8.4e-01
1.3e+00
5.6e+00
1.3e+00
7.9e-01
7.0e-01
cases:35.12%
controls:24.46%
cases:19.20%
controls:9.34%
cases:5.71%
controls:1.57%
cases:13.31%
controls:0.06%
cases:5.45%
controls:1.61%
cases:17.84%
controls:8.94%
cases:36.85%
controls:22.47%
1008
7017
1862
21672
551
2680
2319
26009
164
450
2706
28239
382
16
2488
28673
156
461
2704
28137
490
2451
2256
24964
776
4728
1330
16318
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
8.9e-01
1.5e+00
2.8e+00
—
2.5e+00
1.8e+00
1.4e+00
cases:6.24%
controls:2.66%
cases:6.62%
controls:1.60%
cases:4.77%
controls:0.29%
—
—
cases:3.53%
controls:0.31%
cases:9.50%
controls:1.70%
cases:13.49%
controls:3.70%
179
762
2691
27927
190
458
2680
28231
137
83
2733
28606
—
101
90
2759
28508
261
465
2485
26950
284
778
1822
20268
Other transluminal endoscopic local operation on intestine
JFA98 [2001304883]
JFA98 [2001304883]
2.0e+00
2.9e+00
—
1.0e+50
—
3.3e+00
2.7e+00
cases:1.46%
controls:0.20%
cases:1.15%
controls:0.06%
—
—
cases:5.61%
controls:0.00%
—
—
cases:1.60%
controls:0.06%
cases:1.99%
controls:0.14%
42
58
2828
28631
33
18
2837
28671
—
161
0
2709
28689
—
44
17
2702
27398
42
30
2064
21016
Oesophageal varices without bleeding
I85.9 [45581834]
I85.9 [45581834]
1.6e+00
2.5e+00
2.6e+00
1.0e+50
—
2.4e+00
1.6e+00
cases:0.38%
controls:0.08%
cases:0.49%
controls:0.04%
cases:0.24%
controls:0.02%
cases:0.21%
controls:0.00%
—
—
cases:0.51%
controls:0.05%
cases:0.52%
controls:0.10%
11
22
2859
28667
14
12
2856
28677
7
5
2863
28684
6
0
2864
28689
—
14
13
2732
27402
11
22
2095
21024
Outpatient Visit
OP [9202]
OP [9202]
7.7e-01
7.2e-01
7.1e-01
5.3e+00
1.1e+00
8.5e-01
1.1e+00
cases:90.03%
controls:80.77%
cases:75.85%
controls:60.38%
cases:21.64%
controls:11.95%
cases:51.92%
controls:0.52%
cases:28.81%
controls:11.76%
cases:76.95%
controls:58.71%
cases:94.87%
controls:85.67%
2584
23173
286
5516
2177
17323
693
11366
621
3427
2249
25262
1490
148
1380
28541
824
3362
2036
25236
2113
16094
633
11321
1998
18031
108
3015
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
3.4e-01
4.3e-01
9.4e-01
6.2e+00
1.4e+00
7.2e-01
5.7e-01
cases:15.23%
controls:11.31%
cases:6.31%
controls:4.19%
cases:1.01%
controls:0.40%
cases:8.26%
controls:0.02%
cases:1.50%
controls:0.39%
cases:7.06%
controls:3.55%
cases:18.71%
controls:11.51%
437
3244
2433
25445
181
1203
2689
27486
29
114
2841
28575
237
5
2633
28684
43
112
2817
28486
194
974
2552
26441
394
2422
1712
18624
Melaena
K92.1 [45533624]
K92.1 [45533624]
7.7e-01
2.1e+00
4.1e+00
—
2.6e+00
8.2e-01
8.3e-01
cases:1.36%
controls:0.63%
cases:1.53%
controls:0.18%
cases:1.22%
controls:0.02%
—
—
cases:0.49%
controls:0.03%
cases:0.44%
controls:0.19%
cases:1.66%
controls:0.73%
39
181
2831
28508
44
52
2826
28637
35
6
2835
28683
—
14
10
2846
28588
12
53
2734
27362
35
154
2071
20892
Internal hemorrhoids without complication
I84.2 [45596267]
I84.2 [45596267]
5.6e-01
1.6e+00
2.2e+00
—
2.6e+00
2.2e+00
1.3e+00
cases:1.67%
controls:0.97%
cases:1.11%
controls:0.23%
cases:0.24%
controls:0.03%
—
—
cases:0.28%
controls:0.02%
cases:1.46%
controls:0.17%
cases:2.23%
controls:0.59%
48
277
2822
28412
32
66
2838
28623
7
8
2863
28681
—
8
6
2852
28592
40
47
2706
27368
47
124
2059
20922
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
6.7e-01
1.0e+00
2.3e+00
—
3.0e+00
1.9e+00
1.2e+00
cases:7.28%
controls:3.87%
cases:4.01%
controls:1.45%
cases:1.95%
controls:0.20%
—
—
cases:4.72%
controls:0.23%
cases:7.83%
controls:1.26%
cases:14.10%
controls:4.51%
209
1110
2661
27579
115
416
2755
28273
56
56
2814
28633
—
135
67
2725
28531
215
345
2531
27070
297
949
1809
20097
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
4.8e-01
6.4e-01
9.8e-01
4.9e+00
1.7e+00
7.1e-01
7.8e-01
cases:13.73%
controls:8.97%
cases:4.43%
controls:2.37%
cases:0.80%
controls:0.30%
cases:2.61%
controls:0.02%
cases:1.85%
controls:0.33%
cases:4.41%
controls:2.21%
cases:12.30%
controls:6.05%
394
2574
2476
26115
127
681
2743
28008
23
87
2847
28602
75
6
2795
28683
53
95
2807
28503
121
606
2625
26809
259
1273
1847
19773
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
9.9e-01
1.3e+00
2.7e+00
—
2.5e+00
1.3e+00
1.5e+00
cases:4.18%
controls:1.59%
cases:1.60%
controls:0.45%
cases:0.59%
controls:0.04%
—
—
cases:0.52%
controls:0.05%
cases:1.27%
controls:0.36%
cases:7.41%
controls:1.78%
120
456
2750
28233
46
129
2824
28560
17
12
2853
28677
—
15
13
2845
28585
35
100
2711
27315
156
374
1950
20672
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
8.2e-01
1.6e+00
2.6e+00
—
2.5e+00
1.5e+00
9.8e-01
cases:11.64%
controls:5.47%
cases:8.22%
controls:1.71%
cases:2.72%
controls:0.20%
—
—
cases:1.71%
controls:0.14%
cases:5.94%
controls:1.42%
cases:13.15%
controls:5.38%
334
1569
2536
27120
236
492
2634
28197
78
57
2792
28632
—
49
40
2811
28558
163
389
2583
27026
277
1133
1829
19913
Outpatient Hospital
22 [8756]
22 [8756]
5.1e-01
7.6e-01
1.0e+00
4.4e+00
1.6e+00
9.5e-01
6.7e-01
cases:37.11%
controls:26.16%
cases:13.80%
controls:6.99%
cases:2.47%
controls:0.90%
cases:3.66%
controls:0.05%
cases:3.64%
controls:0.78%
cases:13.95%
controls:5.88%
cases:28.25%
controls:16.81%
1065
7504
1805
21185
396
2004
2474
26685
71
258
2799
28431
105
13
2765
28676
104
224
2756
28374
383
1611
2363
25804
595
3537
1511
17509
Malignant tumor of the ascending colon invasive carcinoma
C18.21 [2000500543]
C18.21 [2000500543]
1.6e+00
1.5e+00
—
—
2.7e+00
2.2e+00
1.8e+00
cases:0.56%
controls:0.12%
cases:0.31%
controls:0.07%
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.66%
controls:0.07%
cases:0.85%
controls:0.14%
16
34
2854
28655
9
20
2861
28669
—
—
9
6
2851
28592
18
20
2728
27395
18
30
2088
21016
Benign neoplasm: Rectosigmoid junction
D12.7 [45595733]
D12.7 [45595733]
2.0e+00
2.6e+00
—
1.0e+50
1.0e+50
3.2e+00
2.0e+00
cases:0.59%
controls:0.08%
cases:0.63%
controls:0.05%
—
—
cases:1.57%
controls:0.00%
cases:0.49%
controls:0.00%
cases:0.91%
controls:0.04%
cases:0.76%
controls:0.10%
17
24
2853
28665
18
14
2852
28675
—
45
0
2825
28689
14
0
2846
28598
25
10
2721
27405
16
22
2090
21024
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
K44.9 [45533596]
8.0e-01
1.5e+00
2.2e+00
—
2.4e+00
1.7e+00
1.0e+00
cases:2.40%
controls:1.09%
cases:1.74%
controls:0.39%
cases:0.59%
controls:0.07%
—
—
cases:0.59%
controls:0.05%
cases:1.71%
controls:0.31%
cases:3.13%
controls:1.15%
69
314
2801
28375
50
112
2820
28577
17
19
2853
28670
—
17
15
2843
28583
47
84
2699
27331
66
242
2040
20804
Iron deficiency anaemia, unspecified
D50.9 [45605373]
D50.9 [45605373]
1.0e+00
1.9e+00
2.2e+00
1.0e+50
1.9e+00
1.5e+00
1.1e+00
cases:2.33%
controls:0.87%
cases:3.34%
controls:0.54%
cases:1.25%
controls:0.15%
cases:0.98%
controls:0.00%
cases:0.87%
controls:0.13%
cases:2.15%
controls:0.47%
cases:4.18%
controls:1.43%
67
250
2803
28439
96
154
2774
28535
36
42
2834
28647
28
0
2842
28689
25
38
2835
28560
59
130
2687
27285
88
302
2018
20744
Inpatient Visit
IP [9201]
IP [9201]
3.3e-01
4.9e-01
1.3e+00
4.3e+00
1.4e+00
9.2e-01
5.0e-01
cases:10.70%
controls:7.90%
cases:5.92%
controls:3.72%
cases:1.60%
controls:0.42%
cases:1.22%
controls:0.02%
cases:1.85%
controls:0.45%
cases:8.70%
controls:3.67%
cases:18.57%
controls:12.11%
307
2265
2563
26424
170
1068
2700
27621
46
121
2824
28568
35
5
2835
28684
53
129
2807
28469
239
1005
2507
26410
391
2549
1715
18497
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
6.9e-01
1.7e+00
2.5e+00
—
2.0e+00
1.3e+00
8.8e-01
cases:3.00%
controls:1.52%
cases:4.01%
controls:0.72%
cases:1.43%
controls:0.12%
—
—
cases:0.91%
controls:0.12%
cases:2.69%
controls:0.73%
cases:5.22%
controls:2.23%
86
436
2784
28253
115
207
2755
28482
41
33
2829
28656
—
26
34
2834
28564
74
199
2672
27216
110
469
1996
20577
Intestinal bypass and anastomosis status
Z98.0 [45561677]
Z98.0 [45561677]
2.5e+00
2.9e+00
—
1.0e+50
—
—
3.7e+00
cases:0.77%
controls:0.06%
cases:0.31%
controls:0.02%
—
—
cases:0.91%
controls:0.00%
—
—
—
—
cases:1.57%
controls:0.04%
22
18
2848
28671
9
5
2861
28684
—
26
0
2844
28689
—
—
33
8
2073
21038
Haemorrhage of anus and rectum
K62.5 [45596339]
K62.5 [45596339]
6.5e-01
2.2e+00
3.4e+00
—
2.8e+00
9.2e-01
5.1e-01
cases:1.22%
controls:0.64%
cases:2.09%
controls:0.23%
cases:0.84%
controls:0.03%
—
—
cases:0.38%
controls:0.02%
cases:0.44%
controls:0.18%
cases:1.19%
controls:0.71%
35
183
2835
28506
60
65
2810
28624
24
8
2846
28681
—
11
7
2849
28591
12
48
2734
27367
25
150
2081
20896
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
6.9e-01
8.2e-01
1.5e+00
2.8e+00
1.4e+00
8.3e-01
1.0e+00
cases:1.81%
controls:0.92%
cases:1.57%
controls:0.70%
cases:0.77%
controls:0.17%
cases:0.35%
controls:0.02%
cases:0.84%
controls:0.21%
cases:1.75%
controls:0.77%
cases:4.23%
controls:1.56%
52
263
2818
28426
45
200
2825
28489
22
50
2848
28639
10
6
2860
28683
24
60
2836
28538
48
211
2698
27204
89
328
2017
20718
Inpatient Hospital
21 [8717]
21 [8717]
3.7e-01
6.6e-01
1.5e+00
4.1e+00
1.2e+00
7.4e-01
5.4e-01
cases:39.37%
controls:30.96%
cases:16.93%
controls:9.52%
cases:5.47%
controls:1.33%
cases:3.87%
controls:0.07%
cases:4.06%
controls:1.25%
cases:16.39%
controls:8.56%
cases:32.00%
controls:21.50%
1130
8881
1740
19808
486
2731
2384
25958
157
382
2713
28307
111
20
2759
28669
116
357
2744
28241
450
2346
2296
25069
674
4524
1432
16522
Nitrate [Presence] in Urine
32030-9 [3006462]
32030-9 [3006462]
1.6e+00
2.7e+00
—
—
—
2.6e+00
2.1e+00
cases:0.59%
controls:0.12%
cases:0.52%
controls:0.03%
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.00%
controls:0.12%
17
33
2853
28656
15
10
2855
28679
—
—
—
9
7
2737
27408
21
26
2085
21020
Extensive abdominal CT
JN3BD [2001305556]
JN3BD [2001305556]
6.0e-01
1.5e+00
2.3e+00
—
2.2e+00
1.2e+00
1.2e+00
cases:3.03%
controls:1.69%
cases:1.53%
controls:0.34%
cases:0.31%
controls:0.03%
—
—
cases:0.21%
controls:0.02%
cases:0.91%
controls:0.26%
cases:3.09%
controls:1.00%
87
485
2783
28204
44
97
2826
28592
9
9
2861
28680
—
6
7
2854
28591
25
72
2721
27343
65
210
2041
20836
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
4.0e-01
7.5e-01
1.4e+00
2.6e+00
1.8e+00
1.2e+00
7.3e-01
cases:12.16%
controls:8.47%
cases:6.90%
controls:3.37%
cases:1.60%
controls:0.38%
cases:0.28%
controls:0.02%
cases:2.34%
controls:0.38%
cases:8.92%
controls:3.00%
cases:18.09%
controls:9.59%
349
2431
2521
26258
198
966
2672
27723
46
110
2824
28579
8
6
2862
28683
67
109
2793
28489
245
822
2501
26593
381
2019
1725
19027
Urine protein measurement
57378007 [4211845]
57378007 [4211845]
1.6e+00
2.7e+00
—
—
—
2.6e+00
2.0e+00
cases:0.59%
controls:0.12%
cases:0.52%
controls:0.03%
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:1.00%
controls:0.14%
17
35
2853
28654
15
10
2855
28679
—
—
—
9
7
2737
27408
21
30
2085
21016
Malignant tumor of the rectum without histology
C20.90 [2000500573]
C20.90 [2000500573]
1.9e+00
2.7e+00
—
1.0e+50
—
2.2e+00
1.8e+00
cases:1.18%
controls:0.17%
cases:0.84%
controls:0.06%
—
—
cases:0.70%
controls:0.00%
—
—
cases:0.66%
controls:0.07%
cases:0.71%
controls:0.12%
34
49
2836
28640
24
17
2846
28672
—
20
0
2850
28689
—
18
20
2728
27395
15
25
2091
21021
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
3.5e-01
5.6e-01
1.5e+00
2.8e+00
1.8e+00
1.0e+00
5.2e-01
cases:16.48%
controls:12.22%
cases:8.61%
controls:5.12%
cases:2.44%
controls:0.57%
cases:0.42%
controls:0.02%
cases:3.11%
controls:0.54%
cases:11.73%
controls:4.46%
cases:21.94%
controls:14.30%
473
3505
2397
25184
247
1468
2623
27221
70
163
2800
28526
12
7
2858
28682
89
153
2771
28445
322
1222
2424
26193
462
3010
1644
18036
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
6.2e-01
1.1e+00
2.1e+00
—
2.3e+00
1.5e+00
8.7e-01
cases:3.31%
controls:1.81%
cases:1.95%
controls:0.63%
cases:0.49%
controls:0.06%
—
—
cases:0.70%
controls:0.07%
cases:2.51%
controls:0.59%
cases:4.51%
controls:1.95%
95
520
2775
28169
56
180
2814
28509
14
17
2856
28672
—
20
20
2840
28578
69
161
2677
27254
95
410
2011
20636
Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
19176-7 [3015916]
19176-7 [3015916]
6.9e-01
1.6e+00
3.4e+00
—
—
2.1e+00
1.4e+00
cases:0.66%
controls:0.33%
cases:0.66%
controls:0.13%
cases:0.52%
controls:0.02%
—
—
—
—
cases:0.87%
controls:0.11%
cases:1.33%
controls:0.33%
19
96
2851
28593
19
38
2851
28651
15
5
2855
28684
—
—
24
31
2722
27384
28
70
2078
20976
Neoplasm of uncertain or unknown behaviour: Colon
D37.4 [45552347]
D37.4 [45552347]
1.7e+00
2.9e+00
—
1.0e+50
—
2.0e+00
1.8e+00
cases:0.91%
controls:0.17%
cases:0.77%
controls:0.04%
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.36%
controls:0.05%
cases:0.95%
controls:0.16%
26
49
2844
28640
22
12
2848
28677
—
12
0
2858
28689
—
10
13
2736
27402
20
33
2086
21013
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
24108-3 [3022914]
6.1e-01
1.3e+00
2.4e+00
—
1.9e+00
1.5e+00
7.0e-01
cases:1.46%
controls:0.80%
cases:1.36%
controls:0.39%
cases:0.70%
controls:0.07%
—
—
cases:0.52%
controls:0.08%
cases:1.97%
controls:0.44%
cases:2.28%
controls:1.14%
42
229
2828
28460
39
111
2831
28578
20
19
2850
28670
—
15
22
2845
28576
54
121
2692
27294
48
240
2058
20806
Malignant tumor of the sigmoid or other unspecified histology
C18.79 [2000500565]
C18.79 [2000500565]
3.0e+00
—
—
—
—
2.8e+00
2.6e+00
cases:0.35%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.02%
cases:0.38%
controls:0.03%
10
5
2860
28684
—
—
—
—
8
5
2738
27410
8
6
2098
21040
Malignant tumor of the transverse colon invasive carcinoma
C18.41 [2000500551]
C18.41 [2000500551]
2.8e+00
—
—
—
—
2.6e+00
2.9e+00
cases:0.38%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.03%
cases:0.43%
controls:0.02%
11
7
2859
28682
—
—
—
—
9
7
2737
27408
9
5
2097
21041
Body temperature
8310-5 [3020891]
8310-5 [3020891]
1.0e+00
1.0e+00
2.5e+00
—
1.9e+00
1.0e+00
6.2e-01
cases:2.47%
controls:0.90%
cases:1.29%
controls:0.47%
cases:0.45%
controls:0.04%
—
—
cases:0.35%
controls:0.05%
cases:1.38%
controls:0.50%
cases:3.32%
controls:1.82%
71
259
2799
28430
37
134
2833
28555
13
11
2857
28678
—
10
15
2850
28583
38
137
2708
27278
70
382
2036
20664
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
6.5e-01
1.6e+00
3.0e+00
—
1.6e+00
5.5e-01
5.3e-01
cases:5.44%
controls:2.90%
cases:6.27%
controls:1.32%
cases:2.58%
controls:0.13%
—
—
cases:0.63%
controls:0.13%
cases:2.22%
controls:1.30%
cases:6.22%
controls:3.76%
156
832
2714
27857
180
378
2690
28311
74
37
2796
28652
—
18
38
2842
28560
61
356
2685
27059
131
791
1975
20255
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
5.4e-01
7.6e-01
7.7e-01
2.8e+00
1.4e+00
9.7e-01
6.6e-01
cases:8.61%
controls:5.19%
cases:6.62%
controls:3.20%
cases:1.36%
controls:0.63%
cases:0.38%
controls:0.02%
cases:2.27%
controls:0.56%
cases:8.08%
controls:3.23%
cases:12.35%
controls:6.76%
247
1490
2623
27199
190
917
2680
27772
39
181
2831
28508
11
7
2859
28682
65
160
2795
28438
222
885
2524
26530
260
1423
1846
19623
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
4.5e-01
1.2e+00
2.2e+00
1.0e+50
2.4e+00
1.0e+00
6.2e-01
cases:5.09%
controls:3.31%
cases:3.87%
controls:1.18%
cases:1.15%
controls:0.13%
cases:1.53%
controls:0.00%
cases:0.70%
controls:0.07%
cases:2.48%
controls:0.88%
cases:6.70%
controls:3.70%
146
951
2724
27738
111
339
2759
28350
33
37
2837
28652
44
0
2826
28689
20
19
2840
28579
68
242
2678
27173
141
779
1965
20267
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
2.5e-01
5.9e-01
1.7e+00
2.0e+00
1.7e+00
9.2e-01
6.6e-01
cases:9.16%
controls:7.28%
cases:5.78%
controls:3.29%
cases:2.61%
controls:0.50%
cases:0.21%
controls:0.03%
cases:2.38%
controls:0.46%
cases:7.72%
controls:3.22%
cases:14.77%
controls:8.23%
263
2089
2607
26600
166
943
2704
27746
75
143
2795
28546
6
8
2864
28681
68
131
2792
28467
212
882
2534
26533
311
1733
1795
19313
Family history of malignant neoplasm of digestive organs
Z80.0 [45542462]
Z80.0 [45542462]
1.4e+00
2.0e+00
—
1.0e+50
—
2.1e+00
2.2e+00
cases:0.38%
controls:0.09%
cases:0.28%
controls:0.04%
—
—
cases:0.35%
controls:0.00%
—
—
cases:0.33%
controls:0.04%
cases:0.66%
controls:0.08%
11
26
2859
28663
8
11
2862
28678
—
10
0
2860
28689
—
9
11
2737
27404
14
16
2092
21030
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
4.9e-01
5.6e-01
8.9e-01
3.7e+00
9.5e-01
5.7e-01
5.1e-01
cases:12.54%
controls:8.09%
cases:7.70%
controls:4.53%
cases:1.99%
controls:0.83%
cases:1.88%
controls:0.05%
cases:2.06%
controls:0.81%
cases:8.16%
controls:4.78%
cases:16.38%
controls:10.55%
360
2322
2510
26367
221
1299
2649
27390
57
237
2813
28452
54
14
2816
28675
59
232
2801
28366
224
1310
2522
26105
345
2221
1761
18825
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
D50.0 [45566697]
8.3e-01
1.8e+00
—
—
2.3e+00
1.9e+00
8.2e-01
cases:0.73%
controls:0.32%
cases:0.66%
controls:0.12%
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.80%
controls:0.12%
cases:1.04%
controls:0.46%
21
92
2849
28597
19
33
2851
28656
—
—
6
6
2854
28592
22
33
2724
27382
22
97
2084
20949
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
7.3e-01
1.3e+00
2.1e+00
1.0e+50
2.5e+00
9.1e-01
4.3e-01
cases:2.51%
controls:1.22%
cases:1.60%
controls:0.44%
cases:0.70%
controls:0.09%
cases:0.77%
controls:0.00%
cases:0.49%
controls:0.04%
cases:1.09%
controls:0.44%
cases:2.23%
controls:1.46%
72
351
2798
28338
46
126
2824
28563
20
25
2850
28664
22
0
2848
28689
14
11
2846
28587
30
121
2716
27294
47
307
2059
20739
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
5.3e-01
1.3e+00
2.4e+00
—
1.6e+00
9.8e-01
7.9e-01
cases:9.44%
controls:5.77%
cases:7.07%
controls:1.95%
cases:2.30%
controls:0.22%
—
—
cases:0.94%
controls:0.20%
cases:4.33%
controls:1.67%
cases:12.35%
controls:6.03%
271
1654
2599
27035
203
560
2667
28129
66
64
2804
28625
—
27
56
2833
28542
119
457
2627
26958
260
1269
1846
19777
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
5.6e-01
8.5e-01
1.8e+00
—
2.2e+00
1.3e+00
8.1e-01
cases:3.80%
controls:2.20%
cases:2.26%
controls:0.98%
cases:0.73%
controls:0.12%
—
—
cases:1.01%
controls:0.11%
cases:3.42%
controls:0.93%
cases:5.84%
controls:2.69%
109
632
2761
28057
65
281
2805
28408
21
35
2849
28654
—
29
32
2831
28566
94
254
2652
27161
123
566
1983
20480
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
6.1e-01
1.4e+00
2.1e+00
—
1.8e+00
9.8e-01
7.0e-01
cases:10.31%
controls:5.90%
cases:10.94%
controls:2.95%
cases:3.03%
controls:0.39%
—
—
cases:1.78%
controls:0.30%
cases:8.05%
controls:3.17%
cases:17.90%
controls:9.77%
296
1694
2574
26995
314
845
2556
27844
87
112
2783
28577
—
51
86
2809
28512
221
870
2525
26545
377
2057
1729
18989
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-2.7e-01
-2.3e-01
2.0e-01
—
2.5e+00
2.5e+00
2.7e+00
cases:22.16%
controls:27.18%
cases:6.27%
controls:7.76%
cases:0.98%
controls:0.80%
—
—
cases:1.40%
controls:0.11%
cases:8.05%
controls:0.73%
cases:21.27%
controls:1.71%
636
7799
2234
20890
180
2225
2690
26464
28
229
2842
28460
—
40
32
2820
28566
221
201
2525
27214
448
360
1658
20686
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
6.0e-01
7.6e-01
1.1e+00
2.4e+00
1.0e+00
8.9e-01
6.8e-01
cases:9.30%
controls:5.35%
cases:4.98%
controls:2.39%
cases:0.94%
controls:0.31%
cases:0.31%
controls:0.03%
cases:1.01%
controls:0.37%
cases:4.88%
controls:2.06%
cases:9.02%
controls:4.77%
267
1535
2603
27154
143
685
2727
28004
27
90
2843
28599
9
8
2861
28681
29
106
2831
28492
134
566
2612
26849
190
1004
1916
20042
Malignant neoplasm of rectosigmoid junction
C19 [45561791]
C19 [45561791]
1.7e+00
1.6e+00
—
1.0e+50
2.4e+00
1.7e+00
1.3e+00
cases:0.42%
controls:0.08%
cases:0.28%
controls:0.06%
—
—
cases:0.21%
controls:0.00%
cases:0.28%
controls:0.02%
cases:0.33%
controls:0.06%
cases:0.24%
controls:0.07%
12
22
2858
28667
8
16
2862
28673
—
6
0
2864
28689
8
7
2852
28591
9
17
2737
27398
5
14
2101
21032
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
31017-7 [3019050]
4.0e-01
1.4e+00
2.7e+00
—
2.0e+00
5.3e-01
3.0e-01
cases:6.90%
controls:4.72%
cases:6.38%
controls:1.59%
cases:1.85%
controls:0.12%
—
—
cases:0.70%
controls:0.10%
cases:2.33%
controls:1.39%
cases:7.50%
controls:5.68%
198
1355
2672
27334
183
456
2687
28233
53
35
2817
28654
—
20
28
2840
28570
64
380
2682
27035
158
1196
1948
19850
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
5.4e-01
1.5e+00
1.8e+00
—
1.8e+00
9.9e-01
6.6e-01
cases:2.40%
controls:1.42%
cases:2.20%
controls:0.52%
cases:0.38%
controls:0.06%
—
—
cases:0.38%
controls:0.06%
cases:1.57%
controls:0.59%
cases:4.23%
controls:2.24%
69
408
2801
28281
63
150
2807
28539
11
18
2859
28671
—
11
18
2849
28580
43
161
2703
27254
89
471
2017
20575
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 [3024889]
2617-9 [3024889]
7.9e-01
1.0e+00
2.0e+00
—
1.9e+00
8.4e-01
6.8e-01
cases:2.16%
controls:0.99%
cases:1.39%
controls:0.51%
cases:0.42%
controls:0.06%
—
—
cases:0.35%
controls:0.05%
cases:1.46%
controls:0.63%
cases:4.51%
controls:2.34%
62
284
2808
28405
40
147
2830
28542
12
17
2858
28672
—
10
15
2850
28583
40
174
2706
27241
95
492
2011
20554
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 [3010517]
2032-1 [3010517]
7.8e-01
9.9e-01
2.0e+00
—
1.8e+00
8.9e-01
7.0e-01
cases:2.16%
controls:1.00%
cases:1.39%
controls:0.52%
cases:0.42%
controls:0.06%
—
—
cases:0.35%
controls:0.06%
cases:1.53%
controls:0.63%
cases:4.65%
controls:2.36%
62
288
2808
28401
40
150
2830
28539
12
17
2858
28672
—
10
16
2850
28582
42
173
2704
27242
98
497
2008
20549
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
5.4e-01
1.2e+00
2.0e+00
—
1.6e+00
1.1e+00
6.0e-01
cases:5.05%
controls:3.02%
cases:5.92%
controls:1.81%
cases:2.16%
controls:0.29%
—
—
cases:1.36%
controls:0.27%
cases:5.43%
controls:1.83%
cases:9.26%
controls:5.30%
145
866
2725
27823
170
518
2700
28171
62
83
2808
28606
—
39
77
2821
28521
149
501
2597
26914
195
1116
1911
19930
Abdominal CT examination
JN3AD [2001305554]
JN3AD [2001305554]
5.4e-01
1.1e+00
2.1e+00
1.0e+50
1.4e+00
1.1e+00
8.0e-01
cases:2.30%
controls:1.36%
cases:1.85%
controls:0.61%
cases:0.42%
controls:0.05%
cases:0.35%
controls:0.00%
cases:0.45%
controls:0.11%
cases:2.33%
controls:0.76%
cases:5.89%
controls:2.75%
66
390
2804
28299
53
174
2817
28515
12
15
2858
28674
10
0
2860
28689
13
31
2847
28567
64
209
2682
27206
124
578
1982
20468
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
5.2e-01
8.4e-01
2.4e+00
1.0e+50
1.5e+00
9.8e-01
7.7e-01
cases:5.85%
controls:3.56%
cases:2.54%
controls:1.12%
cases:1.08%
controls:0.10%
cases:0.49%
controls:0.00%
cases:0.49%
controls:0.10%
cases:2.77%
controls:1.06%
cases:8.26%
controls:4.02%
168
1020
2702
27669
73
320
2797
28369
31
28
2839
28661
14
0
2856
28689
14
30
2846
28568
76
291
2670
27124
174
845
1932
20201
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
5.4e-01
1.2e+00
2.0e+00
—
1.6e+00
1.1e+00
6.0e-01
cases:5.40%
controls:3.22%
cases:6.24%
controls:1.93%
cases:2.20%
controls:0.30%
—
—
cases:1.40%
controls:0.28%
cases:5.54%
controls:1.98%
cases:10.02%
controls:5.74%
155
923
2715
27766
179
555
2691
28134
63
86
2807
28603
—
40
80
2820
28518
152
544
2594
26871
211
1209
1895
19837
Adenocarcinoma, NOS, of sigmoid colon
8140/3-C18.7 [44504380]
8140/3-C18.7 [44504380]
2.1e+00
2.7e+00
—
1.0e+50
—
2.2e+00
—
cases:1.05%
controls:0.13%
cases:0.49%
controls:0.03%
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.25%
controls:0.03%
—
—
30
36
2840
28653
14
9
2856
28680
—
11
0
2859
28689
—
7
8
2739
27407
—
Malignant tumour
130 [2001600128]
130 [2001600128]
9.2e-01
8.4e-01
—
—
2.5e+00
1.8e+00
9.6e-01
cases:2.06%
controls:0.83%
cases:0.91%
controls:0.39%
—
—
—
—
cases:0.45%
controls:0.04%
cases:1.97%
controls:0.32%
cases:2.42%
controls:0.95%
59
239
2811
28450
26
113
2844
28576
—
—
13
11
2847
28587
54
87
2692
27328
51
199
2055
20847
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
5.4e-01
1.2e+00
2.0e+00
—
1.6e+00
1.1e+00
5.8e-01
cases:5.92%
controls:3.56%
cases:6.52%
controls:2.03%
cases:2.26%
controls:0.32%
—
—
cases:1.43%
controls:0.29%
cases:5.83%
controls:2.09%
cases:10.54%
controls:6.20%
170
1020
2700
27669
187
582
2683
28107
65
91
2805
28598
—
41
82
2819
28516
160
574
2586
26841
222
1304
1884
19742
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
10863-9 [3020961]
5.1e-01
1.6e+00
2.8e+00
—
2.5e+00
2.5e-01
9.6e-02
cases:1.60%
controls:0.97%
cases:1.43%
controls:0.29%
cases:0.35%
controls:0.02%
—
—
cases:0.21%
controls:0.02%
cases:0.33%
controls:0.26%
cases:1.04%
controls:0.95%
46
278
2824
28411
41
83
2829
28606
10
6
2860
28683
—
6
5
2854
28593
9
70
2737
27345
22
200
2084
20846
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
5.1e-01
1.1e+00
1.6e+00
—
1.5e+00
1.2e+00
1.0e+00
cases:8.26%
controls:5.14%
cases:3.83%
controls:1.37%
cases:1.11%
controls:0.23%
—
—
cases:0.87%
controls:0.19%
cases:3.75%
controls:1.17%
cases:8.12%
controls:3.02%
237
1474
2633
27215
110
392
2760
28297
32
67
2838
28622
—
25
55
2835
28543
103
320
2643
27095
171
636
1935
20410
Other and unspecified cirrhosis of liver
K74.6 [45538546]
K74.6 [45538546]
1.1e+00
1.9e+00
2.0e+00
1.0e+50
—
1.7e+00
1.3e+00
cases:0.35%
controls:0.11%
cases:0.59%
controls:0.09%
cases:0.28%
controls:0.04%
cases:0.24%
controls:0.00%
—
—
cases:0.66%
controls:0.12%
cases:0.81%
controls:0.22%
10
32
2860
28657
17
25
2853
28664
8
11
2862
28678
7
0
2863
28689
—
18
34
2728
27381
17
47
2089
20999
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
4.9e-01
7.8e-01
1.5e+00
—
2.0e+00
1.4e+00
6.3e-01
cases:10.80%
controls:6.92%
cases:4.46%
controls:2.09%
cases:1.25%
controls:0.27%
—
—
cases:2.17%
controls:0.29%
cases:6.88%
controls:1.82%
cases:11.02%
controls:6.16%
310
1985
2560
26704
128
600
2742
28089
36
78
2834
28611
—
62
83
2798
28515
189
500
2557
26915
232
1297
1874
19749
Left sided colitis
K51.5 [45533604]
K51.5 [45533604]
1.1e+00
1.1e+00
9.7e-01
—
1.8e+00
1.4e+00
1.4e+00
cases:1.25%
controls:0.40%
cases:0.84%
controls:0.29%
cases:0.17%
controls:0.07%
—
—
cases:0.38%
controls:0.07%
cases:1.02%
controls:0.25%
cases:1.66%
controls:0.41%
36
115
2834
28574
24
82
2846
28607
5
19
2865
28670
—
11
19
2849
28579
28
69
2718
27346
35
86
2071
20960
Malignant tumor of flexura hiealis invasive carcinoma
C18.51 [2000500555]
C18.51 [2000500555]
2.1e+00
—
—
—
—
2.2e+00
2.5e+00
cases:0.21%
controls:0.02%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.04%
cases:0.33%
controls:0.03%
6
7
2864
28682
—
—
—
—
9
10
2737
27405
7
6
2099
21040
Emergency Room Visit
ER [9203]
ER [9203]
4.1e-01
7.1e-01
1.0e+00
2.7e+00
7.9e-01
6.3e-01
5.5e-01
cases:45.23%
controls:35.37%
cases:21.60%
controls:11.90%
cases:4.15%
controls:1.51%
cases:1.05%
controls:0.07%
cases:3.43%
controls:1.59%
cases:19.05%
controls:11.15%
cases:43.07%
controls:30.30%
1298
10147
1572
18542
620
3414
2250
25275
119
432
2751
28257
30
21
2840
28668
98
455
2762
28143
523
3058
2223
24357
907
6377
1199
14669
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.3e-01
3.9e-01
9.5e-01
3.9e+00
7.7e-01
4.1e-01
1.8e-01
cases:58.50%
controls:55.25%
cases:61.11%
controls:51.63%
cases:34.15%
controls:16.70%
cases:32.72%
controls:1.00%
cases:30.03%
controls:16.56%
cases:63.26%
controls:53.28%
cases:75.26%
controls:71.82%
1679
15850
1191
12839
1754
14813
1116
13876
980
4791
1890
23898
939
287
1931
28402
859
4736
2001
23862
1737
14606
1009
12809
1585
15116
521
5930
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
3.6e-01
1.4e+00
2.2e+00
—
1.7e+00
6.8e-01
4.1e-01
cases:5.89%
controls:4.20%
cases:5.44%
controls:1.45%
cases:1.36%
controls:0.16%
—
—
cases:0.63%
controls:0.12%
cases:2.55%
controls:1.30%
cases:7.26%
controls:4.96%
169
1205
2701
27484
156
417
2714
28272
39
45
2831
28644
—
18
33
2842
28565
70
357
2676
27058
153
1044
1953
20002
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
6.0e-01
8.5e-01
1.6e+00
—
2.2e+00
8.8e-01
5.5e-01
cases:13.38%
controls:7.81%
cases:4.98%
controls:2.19%
cases:1.08%
controls:0.22%
—
—
cases:1.43%
controls:0.16%
cases:4.33%
controls:1.85%
cases:11.30%
controls:6.87%
384
2242
2486
26447
143
627
2727
28062
31
62
2839
28627
—
41
47
2819
28551
119
506
2627
26909
238
1445
1868
19601
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
30350-3 [3004119]
7.5e-01
1.0e+00
1.8e+00
—
1.9e+00
7.8e-01
4.5e-01
cases:2.68%
controls:1.28%
cases:1.81%
controls:0.67%
cases:0.49%
controls:0.08%
—
—
cases:0.49%
controls:0.08%
cases:1.68%
controls:0.77%
cases:4.75%
controls:3.08%
77
368
2793
28321
52
193
2818
28496
14
24
2856
28665
—
14
22
2846
28576
46
212
2700
27203
100
648
2006
20398
octreotide; parenteral
H01CB02 [21602716]
H01CB02 [21602716]
2.3e+00
2.1e+00
—
—
—
2.1e+00
2.1e+00
cases:0.21%
controls:0.02%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.22%
controls:0.03%
cases:0.24%
controls:0.03%
6
6
2864
28683
6
7
2864
28682
—
—
—
6
7
2740
27408
5
6
2101
21040
Person encountering health services in unspecified circumstances
Z76.9 [45609967]
Z76.9 [45609967]
5.6e-01
5.3e-01
3.4e+00
1.0e+50
1.8e+00
8.8e-01
5.2e-01
cases:1.46%
controls:0.84%
cases:0.66%
controls:0.39%
cases:0.91%
controls:0.03%
cases:0.49%
controls:0.00%
cases:0.31%
controls:0.05%
cases:1.02%
controls:0.43%
cases:2.47%
controls:1.48%
42
241
2828
28448
19
112
2851
28577
26
9
2844
28680
14
0
2856
28689
9
15
2851
28583
28
117
2718
27298
52
312
2054
20734
Benign neoplasm: Descending colon
D12.4 [45571597]
D12.4 [45571597]
2.3e+00
—
1.0e+50
1.0e+50
—
—
6.5e+00
cases:0.17%
controls:0.02%
—
—
cases:0.84%
controls:0.00%
cases:99.13%
controls:0.00%
—
—
—
—
cases:18.14%
controls:0.03%
5
5
2865
28684
—
24
0
2846
28689
2845
0
25
28689
—
—
382
7
1724
21039
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
1.3e-01
5.2e-01
9.3e-01
3.1e+00
9.1e-01
5.9e-01
3.8e-01
cases:7.70%
controls:6.80%
cases:6.27%
controls:3.82%
cases:1.43%
controls:0.57%
cases:0.59%
controls:0.03%
cases:1.33%
controls:0.54%
cases:7.43%
controls:4.24%
cases:18.99%
controls:13.76%
221
1951
2649
26738
180
1096
2690
27593
41
163
2829
28526
17
8
2853
28681
38
154
2822
28444
204
1163
2542
26252
400
2896
1706
18150
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
9.0e-01
9.7e-01
1.9e+00
—
1.6e+00
6.1e-01
4.0e-01
cases:2.26%
controls:0.93%
cases:1.57%
controls:0.60%
cases:0.49%
controls:0.08%
—
—
cases:0.38%
controls:0.08%
cases:1.35%
controls:0.73%
cases:4.04%
controls:2.75%
65
267
2805
28422
45
173
2825
28516
14
22
2856
28667
—
11
22
2849
28576
37
201
2709
27214
85
578
2021
20468
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
4.4e-01
8.0e-01
1.4e+00
—
1.7e+00
1.2e+00
7.2e-01
cases:9.20%
controls:6.12%
cases:5.37%
controls:2.49%
cases:1.15%
controls:0.30%
—
—
cases:1.61%
controls:0.30%
cases:7.39%
controls:2.27%
cases:13.53%
controls:7.10%
264
1757
2606
26932
154
713
2716
27976
33
85
2837
28604
—
46
85
2814
28513
203
623
2543
26792
285
1494
1821
19552
Colostomy status
Z93.3 [45590775]
Z93.3 [45590775]
1.1e+00
1.9e+00
—
—
—
3.6e+00
2.6e+00
cases:0.31%
controls:0.10%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
cases:0.66%
controls:0.02%
cases:0.66%
controls:0.05%
9
29
2861
28660
6
9
2864
28680
—
—
—
18
5
2728
27410
14
10
2092
21036
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
2.4e-01
4.3e-01
5.7e-01
3.6e+00
7.5e-01
3.7e-01
2.8e-01
cases:31.01%
controls:26.18%
cases:19.65%
controls:13.72%
cases:4.18%
controls:2.40%
cases:4.67%
controls:0.14%
cases:4.93%
controls:2.39%
cases:19.74%
controls:14.55%
cases:40.69%
controls:34.05%
890
7512
1980
21177
564
3937
2306
24752
120
689
2750
28000
134
39
2736
28650
141
684
2719
27914
542
3988
2204
23427
857
7167
1249
13879
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
5.0e-01
1.0e+00
1.8e+00
1.6e+00
1.4e+00
8.9e-01
5.6e-01
cases:14.98%
controls:9.69%
cases:14.67%
controls:5.72%
cases:4.84%
controls:0.82%
cases:0.21%
controls:0.04%
cases:3.04%
controls:0.76%
cases:13.66%
controls:6.11%
cases:25.31%
controls:16.25%
430
2781
2440
25908
421
1641
2449
27048
139
235
2731
28454
6
12
2864
28677
87
217
2773
28381
375
1675
2371
25740
533
3419
1573
17627
General Practice
1 [38004446]
1 [38004446]
1.9e-01
4.1e-01
1.5e+00
2.8e+00
6.2e-01
3.7e-01
2.8e-01
cases:17.56%
controls:14.98%
cases:8.92%
controls:6.12%
cases:4.04%
controls:0.90%
cases:0.84%
controls:0.05%
cases:1.75%
controls:0.95%
cases:9.43%
controls:6.73%
cases:24.60%
controls:19.70%
504
4299
2366
24390
256
1756
2614
26933
116
259
2754
28430
24
15
2846
28674
50
271
2810
28327
259
1846
2487
25569
518
4147
1588
16899
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
3.5e-01
7.5e-01
7.3e-01
—
2.6e+00
1.4e+00
1.0e+00
cases:6.76%
controls:4.87%
cases:2.26%
controls:1.09%
cases:0.17%
controls:0.08%
—
—
cases:0.77%
controls:0.06%
cases:2.91%
controls:0.70%
cases:6.13%
controls:2.32%
194
1397
2676
27292
65
312
2805
28377
5
24
2865
28665
—
22
17
2838
28581
80
193
2666
27222
129
489
1977
20557
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
6.7e-01
7.5e-01
5.7e-01
1.0e+50
2.2e+00
1.2e+00
1.3e+00
cases:3.94%
controls:2.05%
cases:1.57%
controls:0.75%
cases:0.21%
controls:0.12%
cases:0.28%
controls:0.00%
cases:0.73%
controls:0.08%
cases:1.75%
controls:0.53%
cases:3.66%
controls:1.07%
113
589
2757
28100
45
215
2825
28474
6
34
2864
28655
8
0
2862
28689
21
23
2839
28575
48
145
2698
27270
77
225
2029
20821
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
6.1e-01
9.6e-01
1.3e+00
-1.0e+50
1.1e+00
1.1e+00
8.6e-01
cases:4.11%
controls:2.28%
cases:3.17%
controls:1.24%
cases:1.05%
controls:0.28%
cases:0.00%
controls:0.02%
cases:1.01%
controls:0.34%
cases:3.97%
controls:1.30%
cases:7.41%
controls:3.28%
118
655
2752
28034
91
356
2779
28333
30
79
2840
28610
0
7
2870
28682
29
96
2831
28502
109
356
2637
27059
156
690
1950
20356
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
7.3e-01
9.0e-01
1.7e+00
—
1.5e+00
7.0e-01
4.8e-01
cases:3.31%
controls:1.62%
cases:2.13%
controls:0.88%
cases:0.59%
controls:0.11%
—
—
cases:0.49%
controls:0.11%
cases:2.11%
controls:1.06%
cases:6.22%
controls:3.92%
95
466
2775
28223
61
252
2809
28437
17
32
2853
28657
—
14
31
2846
28567
58
291
2688
27124
131
826
1975
20220
Other specified counselling
Z71.8 [45581061]
Z71.8 [45581061]
2.5e-01
4.6e-01
1.1e+00
3.4e+00
7.7e-01
3.4e-01
2.5e-01
cases:6.10%
controls:4.83%
cases:4.11%
controls:2.63%
cases:1.22%
controls:0.42%
cases:0.63%
controls:0.02%
cases:0.87%
controls:0.41%
cases:4.15%
controls:2.99%
cases:11.02%
controls:8.80%
175
1385
2695
27304
118
754
2752
27935
35
121
2835
28568
18
6
2852
28683
25
116
2835
28482
114
821
2632
26594
232
1853
1874
19193
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
7.8e-01
9.3e-01
1.8e+00
—
1.7e+00
7.0e-01
3.8e-01
cases:2.37%
controls:1.10%
cases:1.53%
controls:0.61%
cases:0.52%
controls:0.09%
—
—
cases:0.42%
controls:0.07%
cases:1.31%
controls:0.65%
cases:3.51%
controls:2.42%
68
317
2802
28372
44
176
2826
28513
15
25
2855
28664
—
12
21
2848
28577
36
179
2710
27236
74
510
2032
20536
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
6.1e-01
8.4e-01
1.5e+00
—
1.5e+00
1.0e+00
5.1e-01
cases:4.95%
controls:2.76%
cases:3.45%
controls:1.51%
cases:0.80%
controls:0.18%
—
—
cases:0.80%
controls:0.19%
cases:4.26%
controls:1.55%
cases:8.97%
controls:5.57%
142
792
2728
27897
99
434
2771
28255
23
53
2847
28636
—
23
54
2837
28544
117
426
2629
26989
189
1173
1917
19873
capecitabine
L01BC06 [21601440]
L01BC06 [21601440]
1.3e+00
9.7e-01
—
—
—
2.3e+00
1.3e+00
cases:1.78%
controls:0.47%
cases:0.66%
controls:0.25%
—
—
—
—
—
—
cases:1.93%
controls:0.20%
cases:1.42%
controls:0.39%
51
135
2819
28554
19
72
2851
28617
—
—
—
53
54
2693
27361
30
83
2076
20963
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
3.3e-01
5.6e-01
8.7e-01
2.3e+00
6.9e-01
7.5e-01
4.4e-01
cases:20.21%
controls:15.43%
cases:14.25%
controls:8.70%
cases:6.41%
controls:2.78%
cases:1.64%
controls:0.17%
cases:5.59%
controls:2.88%
cases:16.50%
controls:8.57%
cases:28.02%
controls:20.10%
580
4427
2290
24262
409
2495
2461
26194
184
797
2686
27892
47
49
2823
28640
160
823
2700
27775
453
2349
2293
25066
590
4231
1516
16815
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
4.2e-01
6.1e-01
9.0e-01
1.8e+00
8.8e-01
8.0e-01
5.2e-01
cases:10.21%
controls:6.96%
cases:6.79%
controls:3.83%
cases:1.99%
controls:0.82%
cases:0.24%
controls:0.04%
cases:1.75%
controls:0.73%
cases:7.94%
controls:3.74%
cases:15.15%
controls:9.57%
293
1996
2577
26693
195
1098
2675
27591
57
234
2813
28455
7
12
2863
28677
50
209
2810
28389
218
1025
2528
26390
319
2014
1787
19032
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
6.0e-01
8.2e-01
1.6e+00
—
1.5e+00
7.8e-01
5.1e-01
cases:3.69%
controls:2.05%
cases:2.68%
controls:1.20%
cases:0.87%
controls:0.18%
—
—
cases:0.73%
controls:0.16%
cases:2.91%
controls:1.36%
cases:7.12%
controls:4.40%
106
589
2764
28100
77
345
2793
28344
25
52
2845
28637
—
21
45
2839
28553
80
372
2666
27043
150
927
1956
20119
Sleep apnoea
G47.3 [45562094]
G47.3 [45562094]
4.7e-01
4.9e-01
5.0e-01
3.0e+00
7.8e-01
4.8e-01
5.6e-01
cases:10.63%
controls:6.90%
cases:6.83%
controls:4.29%
cases:1.39%
controls:0.85%
cases:1.08%
controls:0.05%
cases:1.78%
controls:0.82%
cases:6.99%
controls:4.45%
cases:13.39%
controls:8.08%
305
1980
2565
26709
196
1231
2674
27458
40
245
2830
28444
31
15
2839
28674
51
235
2809
28363
192
1219
2554
26196
282
1700
1824
19346
Nephrology
39 [38004479]
39 [38004479]
7.9e-01
9.9e-01
1.0e+00
1.2e+00
1.0e+00
9.4e-01
1.1e+00
cases:2.89%
controls:1.33%
cases:2.68%
controls:1.02%
cases:1.15%
controls:0.42%
cases:0.21%
controls:0.07%
cases:1.12%
controls:0.42%
cases:2.62%
controls:1.04%
cases:4.27%
controls:1.49%
83
381
2787
28308
77
292
2793
28397
33
121
2837
28568
6
19
2864
28670
32
119
2828
28479
72
284
2674
27131
90
314
2016
20732
Capsular endoscopy
UJF92 [2001305032]
UJF92 [2001305032]
1.4e+00
1.5e+00
—
—
—
3.0e+00
1.4e+00
cases:0.77%
controls:0.20%
cases:0.21%
controls:0.05%
—
—
—
—
—
—
cases:0.51%
controls:0.03%
cases:0.71%
controls:0.17%
22
57
2848
28632
6
14
2864
28675
—
—
—
14
7
2732
27408
15
36
2091
21010
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
6.3e-01
8.1e-01
1.6e+00
—
1.5e+00
7.1e-01
5.1e-01
cases:3.76%
controls:2.04%
cases:2.68%
controls:1.21%
cases:0.91%
controls:0.18%
—
—
cases:0.73%
controls:0.17%
cases:2.80%
controls:1.40%
cases:7.26%
controls:4.51%
108
585
2762
28104
77
346
2793
28343
26
51
2844
28638
—
21
48
2839
28550
77
383
2669
27032
153
950
1953
20096
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
4.5e-01
1.0e+00
1.7e+00
2.0e+00
1.3e+00
7.1e-01
4.8e-01
cases:12.58%
controls:8.37%
cases:9.02%
controls:3.39%
cases:2.37%
controls:0.44%
cases:0.17%
controls:0.02%
cases:1.40%
controls:0.37%
cases:6.74%
controls:3.41%
cases:17.38%
controls:11.50%
361
2402
2509
26287
259
972
2611
27717
68
125
2802
28564
5
7
2865
28682
40
106
2820
28492
185
936
2561
26479
366
2420
1740
18626
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.7e-01
6.0e-01
9.9e-01
1.6e+00
1.0e+00
7.0e-01
5.6e-01
cases:16.13%
controls:12.83%
cases:11.74%
controls:6.80%
cases:3.10%
controls:1.17%
cases:0.28%
controls:0.06%
cases:2.97%
controls:1.11%
cases:13.33%
controls:7.11%
cases:27.97%
controls:18.16%
463
3681
2407
25008
337
1950
2533
26739
89
336
2781
28353
8
16
2862
28673
85
318
2775
28280
366
1948
2380
25467
589
3823
1517
17223
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
3.5e-01
6.8e-01
1.2e+00
1.5e+00
8.4e-01
6.3e-01
6.0e-01
cases:34.49%
controls:27.01%
cases:27.98%
controls:16.39%
cases:9.90%
controls:3.31%
cases:0.70%
controls:0.16%
cases:7.03%
controls:3.16%
cases:27.17%
controls:16.52%
cases:49.67%
controls:35.11%
990
7750
1880
20939
803
4701
2067
23988
284
950
2586
27739
20
47
2850
28642
201
903
2659
27695
746
4528
2000
22887
1046
7390
1060
13656
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
6.2e-01
8.3e-01
1.6e+00
—
1.4e+00
7.9e-01
5.1e-01
cases:3.90%
controls:2.14%
cases:2.89%
controls:1.28%
cases:0.91%
controls:0.19%
—
—
cases:0.73%
controls:0.18%
cases:3.02%
controls:1.40%
cases:7.36%
controls:4.55%
112
614
2758
28075
83
366
2787
28323
26
54
2844
28635
—
21
52
2839
28546
83
384
2663
27031
155
957
1951
20089
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
3.6e-01
7.6e-01
1.6e+00
1.5e+00
1.4e+00
9.8e-01
6.4e-01
cases:16.69%
controls:12.23%
cases:13.21%
controls:6.66%
cases:5.71%
controls:1.16%
cases:0.28%
controls:0.06%
cases:4.41%
controls:1.17%
cases:15.88%
controls:6.64%
cases:29.15%
controls:17.88%
479
3510
2391
25179
379
1910
2491
26779
164
334
2706
28355
8
18
2862
28671
126
336
2734
28262
436
1821
2310
25594
614
3764
1492
17282
Endocrinology
46 [38004485]
46 [38004485]
4.2e-01
6.4e-01
6.3e-01
2.5e+00
9.1e-01
7.5e-01
5.1e-01
cases:5.33%
controls:3.57%
cases:3.55%
controls:1.91%
cases:0.77%
controls:0.41%
cases:0.21%
controls:0.02%
cases:0.98%
controls:0.40%
cases:3.90%
controls:1.89%
cases:6.03%
controls:3.73%
153
1024
2717
27665
102
547
2768
28142
22
117
2848
28572
6
5
2864
28684
28
113
2832
28485
107
517
2639
26898
127
784
1979
20262
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
6.6e-01
7.9e-01
1.1e+00
—
1.6e+00
1.2e+00
1.4e+00
cases:4.63%
controls:2.45%
cases:1.64%
controls:0.75%
cases:0.17%
controls:0.06%
—
—
cases:0.38%
controls:0.08%
cases:1.78%
controls:0.54%
cases:5.94%
controls:1.47%
133
702
2737
27987
47
215
2823
28474
5
17
2865
28672
—
11
22
2849
28576
49
149
2697
27266
125
309
1981
20737
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
6.6e-01
7.9e-01
1.1e+00
—
1.6e+00
1.2e+00
1.4e+00
cases:4.63%
controls:2.45%
cases:1.64%
controls:0.75%
cases:0.17%
controls:0.06%
—
—
cases:0.38%
controls:0.08%
cases:1.78%
controls:0.54%
cases:5.94%
controls:1.47%
133
702
2737
27987
47
215
2823
28474
5
17
2865
28672
—
11
22
2849
28576
49
149
2697
27266
125
309
1981
20737
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
6.6e-01
7.9e-01
1.1e+00
—
1.6e+00
1.2e+00
1.4e+00
cases:4.63%
controls:2.45%
cases:1.64%
controls:0.75%
cases:0.17%
controls:0.06%
—
—
cases:0.38%
controls:0.08%
cases:1.78%
controls:0.54%
cases:5.94%
controls:1.47%
133
702
2737
27987
47
215
2823
28474
5
17
2865
28672
—
11
22
2849
28576
49
149
2697
27266
125
309
1981
20737
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
6.6e-01
7.9e-01
1.1e+00
—
1.6e+00
1.2e+00
1.4e+00
cases:4.63%
controls:2.45%
cases:1.64%
controls:0.75%
cases:0.17%
controls:0.06%
—
—
cases:0.38%
controls:0.08%
cases:1.78%
controls:0.54%
cases:5.94%
controls:1.47%
133
702
2737
27987
47
215
2823
28474
5
17
2865
28672
—
11
22
2849
28576
49
149
2697
27266
125
309
1981
20737
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
6.6e-01
7.9e-01
1.1e+00
—
1.6e+00
1.2e+00
1.4e+00
cases:4.63%
controls:2.45%
cases:1.64%
controls:0.75%
cases:0.17%
controls:0.06%
—
—
cases:0.38%
controls:0.08%
cases:1.78%
controls:0.54%
cases:5.94%
controls:1.47%
133
702
2737
27987
47
215
2823
28474
5
17
2865
28672
—
11
22
2849
28576
49
149
2697
27266
125
309
1981
20737
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
77147-7 [46236952]
7.1e-01
6.6e-01
1.7e+00
—
1.2e+00
7.6e-01
6.8e-01
cases:4.22%
controls:2.12%
cases:1.74%
controls:0.91%
cases:0.66%
controls:0.13%
—
—
cases:0.42%
controls:0.12%
cases:2.00%
controls:0.94%
cases:5.13%
controls:2.68%
121
609
2749
28080
50
261
2820
28428
19
36
2851
28653
—
12
35
2848
28563
55
259
2691
27156
108
563
1998
20483
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.9e-01
3.3e-01
4.8e-01
3.5e+00
5.3e-01
2.9e-01
3.0e-01
cases:79.30%
controls:76.04%
cases:76.45%
controls:69.96%
cases:41.18%
controls:30.29%
cases:40.84%
controls:1.96%
cases:41.82%
controls:29.65%
cases:77.86%
controls:72.46%
cases:90.65%
controls:87.81%
2276
21814
594
6875
2194
20070
676
8619
1182
8690
1688
19999
1172
563
1698
28126
1196
8478
1664
20120
2138
19866
608
7549
1909
18480
197
2566
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
5.0e-01
7.9e-01
1.4e+00
—
1.4e+00
9.2e-01
6.0e-01
cases:2.82%
controls:1.74%
cases:1.85%
controls:0.85%
cases:0.38%
controls:0.10%
—
—
cases:0.45%
controls:0.12%
cases:2.22%
controls:0.90%
cases:5.60%
controls:3.17%
81
498
2789
28191
53
243
2817
28446
11
28
2859
28661
—
13
33
2847
28565
61
247
2685
27168
118
667
1988
20379
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
3.6e-01
8.7e-01
1.6e+00
—
1.4e+00
1.0e+00
6.4e-01
cases:2.65%
controls:1.85%
cases:2.30%
controls:0.98%
cases:0.66%
controls:0.13%
—
—
cases:0.59%
controls:0.15%
cases:2.84%
controls:1.03%
cases:5.75%
controls:3.12%
76
532
2794
28157
66
280
2804
28409
19
37
2851
28652
—
17
44
2843
28554
78
282
2668
27133
121
656
1985
20390
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
2.5e-01
5.5e-01
9.2e-01
1.8e+00
9.7e-01
6.6e-01
4.0e-01
cases:21.64%
controls:17.67%
cases:14.15%
controls:8.66%
cases:3.03%
controls:1.23%
cases:0.38%
controls:0.07%
cases:3.01%
controls:1.16%
cases:15.29%
controls:8.56%
cases:32.43%
controls:24.27%
621
5070
2249
23619
406
2484
2464
26205
87
352
2783
28337
11
19
2859
28670
86
332
2774
28266
420
2346
2326
25069
683
5108
1423
15938
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.0e-01
6.9e-01
1.1e+00
1.5e+00
8.5e-01
5.9e-01
4.4e-01
cases:46.10%
controls:38.81%
cases:39.44%
controls:24.67%
cases:14.08%
controls:4.98%
cases:1.71%
controls:0.39%
cases:11.19%
controls:5.09%
cases:37.76%
controls:25.25%
cases:61.59%
controls:50.82%
1323
11134
1547
17555
1132
7078
1738
21611
404
1429
2466
27260
49
112
2821
28577
320
1457
2540
27141
1037
6922
1709
20493
1297
10695
809
10351
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
7.0e-01
8.2e-01
8.4e-01
—
1.4e+00
1.1e+00
1.5e+00
cases:5.44%
controls:2.78%
cases:2.13%
controls:0.94%
cases:0.21%
controls:0.09%
—
—
cases:0.45%
controls:0.11%
cases:2.08%
controls:0.73%
cases:7.03%
controls:1.71%
156
797
2714
27892
61
271
2809
28418
6
26
2864
28663
—
13
31
2847
28567
57
201
2689
27214
148
360
1958
20686
FEV1
20150-9 [3024653]
20150-9 [3024653]
7.0e-01
8.2e-01
8.4e-01
—
1.4e+00
1.1e+00
1.5e+00
cases:5.44%
controls:2.78%
cases:2.13%
controls:0.94%
cases:0.21%
controls:0.09%
—
—
cases:0.45%
controls:0.11%
cases:2.08%
controls:0.73%
cases:7.03%
controls:1.71%
156
797
2714
27892
61
271
2809
28418
6
26
2864
28663
—
13
31
2847
28567
57
201
2689
27214
148
360
1958
20686
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
7.0e-01
8.2e-01
8.4e-01
—
1.4e+00
1.1e+00
1.5e+00
cases:5.44%
controls:2.78%
cases:2.13%
controls:0.94%
cases:0.21%
controls:0.09%
—
—
cases:0.45%
controls:0.11%
cases:2.08%
controls:0.73%
cases:7.03%
controls:1.71%
156
797
2714
27892
61
271
2809
28418
6
26
2864
28663
—
13
31
2847
28567
57
201
2689
27214
148
360
1958
20686
Alcoholic cirrhosis of liver
K70.3 [45596343]
K70.3 [45596343]
1.1e+00
1.7e+00
2.0e+00
1.0e+50
1.9e+00
1.7e+00
8.7e-01
cases:0.38%
controls:0.13%
cases:0.45%
controls:0.08%
cases:0.28%
controls:0.04%
cases:0.21%
controls:0.00%
cases:0.21%
controls:0.03%
cases:0.66%
controls:0.12%
cases:0.47%
controls:0.20%
11
38
2859
28651
13
23
2857
28666
8
11
2862
28678
6
0
2864
28689
6
9
2854
28589
18
32
2728
27383
10
42
2096
21004
methoxy polyethylene glycol-epoetin beta; parenteral
B03XA03 [21601135]
B03XA03 [21601135]
1.3e+00
1.7e+00
1.9e+00
—
—
2.0e+00
1.7e+00
cases:0.31%
controls:0.08%
cases:0.28%
controls:0.05%
cases:0.21%
controls:0.03%
—
—
—
—
cases:0.33%
controls:0.04%
cases:0.38%
controls:0.07%
9
24
2861
28665
8
15
2862
28674
6
9
2864
28680
—
—
9
12
2737
27403
8
14
2098
21032
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
2.2e-01
4.5e-01
1.7e+00
—
1.6e+00
1.1e+00
1.0e+00
cases:4.84%
controls:3.92%
cases:1.53%
controls:0.99%
cases:0.42%
controls:0.08%
—
—
cases:0.38%
controls:0.08%
cases:2.29%
controls:0.74%
cases:7.50%
controls:2.86%
139
1125
2731
27564
44
283
2826
28406
12
22
2858
28667
—
11
23
2849
28575
63
204
2683
27211
158
602
1948
20444
Abdominal X-ray examination without contrast
JN3AA [2001305553]
JN3AA [2001305553]
5.8e-01
1.8e+00
—
—
—
2.3e+00
1.3e+00
cases:0.94%
controls:0.53%
cases:0.73%
controls:0.13%
—
—
—
—
—
—
cases:0.80%
controls:0.08%
cases:1.33%
controls:0.35%
27
151
2843
28538
21
36
2849
28653
—
—
—
22
22
2724
27393
28
74
2078
20972
Other obesity
E66.8 [45533036]
E66.8 [45533036]
8.6e-01
8.1e-01
1.2e+00
—
1.8e+00
9.5e-01
1.0e+00
cases:1.67%
controls:0.72%
cases:0.80%
controls:0.36%
cases:0.28%
controls:0.08%
—
—
cases:0.42%
controls:0.07%
cases:0.91%
controls:0.35%
cases:1.90%
controls:0.70%
48
206
2822
28483
23
103
2847
28586
8
24
2862
28665
—
12
20
2848
28578
25
97
2721
27318
40
148
2066
20898
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
2.3e-01
5.7e-01
9.8e-01
1.6e+00
9.4e-01
6.3e-01
4.8e-01
cases:17.32%
controls:14.27%
cases:13.10%
controls:7.85%
cases:3.48%
controls:1.33%
cases:0.31%
controls:0.07%
cases:3.22%
controls:1.28%
cases:14.60%
controls:8.31%
cases:30.86%
controls:21.57%
497
4095
2373
24594
376
2251
2494
26438
100
382
2770
28307
9
19
2861
28670
92
365
2768
28233
401
2278
2345
25137
650
4540
1456
16506
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
7.6e-01
9.6e-01
1.6e+00
—
1.7e+00
1.4e+00
5.8e-01
cases:2.79%
controls:1.32%
cases:1.64%
controls:0.63%
cases:0.28%
controls:0.06%
—
—
cases:0.38%
controls:0.07%
cases:2.33%
controls:0.59%
cases:4.23%
controls:2.42%
80
379
2790
28310
47
182
2823
28507
8
17
2862
28672
—
11
21
2849
28577
64
161
2682
27254
89
509
2017
20537
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
7.4e-01
9.7e-01
1.6e+00
—
1.4e+00
1.4e+00
5.7e-01
cases:2.75%
controls:1.34%
cases:1.60%
controls:0.61%
cases:0.28%
controls:0.06%
—
—
cases:0.31%
controls:0.08%
cases:2.33%
controls:0.56%
cases:3.94%
controls:2.27%
79
383
2791
28306
46
176
2824
28513
8
16
2862
28673
—
9
22
2851
28576
64
154
2682
27261
83
478
2023
20568
Malignant tumor of the rectum carcinoma of the adenoma
C20.92 [2000500575]
C20.92 [2000500575]
1.7e+00
2.4e+00
—
1.0e+50
—
2.9e+00
1.1e+00
cases:0.21%
controls:0.04%
cases:0.28%
controls:0.02%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.51%
controls:0.03%
cases:0.24%
controls:0.08%
6
11
2864
28678
8
7
2862
28682
—
5
0
2865
28689
—
14
8
2732
27407
5
17
2101
21029
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
7.4e-01
9.8e-01
1.6e+00
—
1.6e+00
1.4e+00
5.9e-01
cases:2.79%
controls:1.35%
cases:1.64%
controls:0.62%
cases:0.28%
controls:0.06%
—
—
cases:0.38%
controls:0.08%
cases:2.26%
controls:0.59%
cases:4.18%
controls:2.37%
80
387
2790
28302
47
178
2823
28511
8
17
2862
28672
—
11
22
2849
28576
62
161
2684
27254
88
499
2018
20547
Pure hypercholesterolaemia
E78.01 [2000501514]
E78.01 [2000501514]
2.2e-01
2.8e-01
3.5e-01
4.4e+00
8.9e-01
3.0e-01
2.1e-01
cases:6.48%
controls:5.26%
cases:3.66%
controls:2.80%
cases:0.77%
controls:0.54%
cases:1.36%
controls:0.02%
cases:1.08%
controls:0.45%
cases:3.93%
controls:2.94%
cases:10.21%
controls:8.47%
186
1509
2684
27180
105
802
2765
27887
22
155
2848
28534
39
5
2831
28684
31
128
2829
28470
108
805
2638
26610
215
1783
1891
19263
Emergency Medicine
93 [38004510]
93 [38004510]
1.8e-01
4.8e-01
6.9e-01
2.5e+00
6.5e-01
4.4e-01
2.8e-01
cases:21.88%
controls:18.90%
cases:14.56%
controls:9.52%
cases:2.65%
controls:1.35%
cases:0.77%
controls:0.06%
cases:2.69%
controls:1.42%
cases:15.15%
controls:10.33%
cases:34.52%
controls:28.57%
628
5423
2242
23266
418
2730
2452
25959
76
387
2794
28302
22
18
2848
28671
77
407
2783
28191
416
2832
2330
24583
727
6012
1379
15034
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
5.6e-01
8.0e-01
9.7e-01
—
1.8e+00
1.2e+00
8.3e-01
cases:2.20%
controls:1.27%
cases:1.81%
controls:0.82%
cases:0.35%
controls:0.13%
—
—
cases:0.91%
controls:0.16%
cases:3.20%
controls:0.96%
cases:5.60%
controls:2.52%
63
364
2807
28325
52
236
2818
28453
10
38
2860
28651
—
26
45
2834
28553
88
262
2658
27153
118
530
1988
20516
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
4.7e-01
6.6e-01
1.2e+00
—
1.0e+00
9.5e-01
8.3e-01
cases:3.24%
controls:2.06%
cases:2.47%
controls:1.29%
cases:0.63%
controls:0.20%
—
—
cases:0.63%
controls:0.22%
cases:3.10%
controls:1.23%
cases:6.17%
controls:2.80%
93
590
2777
28099
71
370
2799
28319
18
56
2852
28633
—
18
64
2842
28534
85
336
2661
27079
130
589
1976
20457
Constipation, unspecified
K59.09 [2000502926]
K59.09 [2000502926]
5.3e-01
1.8e+00
2.6e+00
1.0e+50
—
6.1e-01
6.7e-01
cases:1.39%
controls:0.82%
cases:1.64%
controls:0.28%
cases:0.38%
controls:0.03%
cases:0.45%
controls:0.00%
—
—
cases:0.73%
controls:0.40%
cases:2.75%
controls:1.43%
40
236
2830
28453
47
79
2823
28610
11
8
2859
28681
13
0
2857
28689
—
20
109
2726
27306
58
302
2048
20744
Malignant neoplasm: Sigmoid colon
C18.7 [45571491]
C18.7 [45571491]
1.5e+00
—
—
—
—
1.9e+00
1.7e+00
cases:0.38%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.04%
cases:0.38%
controls:0.07%
11
25
2859
28664
—
—
—
—
7
11
2739
27404
8
14
2098
21032
mesalazine; oral, rectal
A07EC02 [21600664]
A07EC02 [21600664]
8.1e-01
8.0e-01
5.3e-01
—
1.3e+00
9.3e-01
1.2e+00
cases:2.26%
controls:1.02%
cases:1.88%
controls:0.85%
cases:0.56%
controls:0.33%
—
—
cases:1.08%
controls:0.29%
cases:2.11%
controls:0.84%
cases:3.04%
controls:0.95%
65
292
2805
28397
54
244
2816
28445
16
94
2854
28595
—
31
83
2829
28515
58
231
2688
27184
64
199
2042
20847
Repair of incisional hernia using prosthetic material
JAD30 [2001304421]
JAD30 [2001304421]
7.3e-01
—
—
—
—
2.9e+00
2.2e+00
cases:0.21%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.02%
cases:0.95%
controls:0.11%
6
29
2864
28660
—
—
—
—
9
5
2737
27410
20
23
2086
21023
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
1.3e+00
1.4e+00
—
—
—
1.2e+00
1.1e+00
cases:0.87%
controls:0.24%
cases:0.52%
controls:0.13%
—
—
—
—
—
—
cases:0.44%
controls:0.13%
cases:0.81%
controls:0.27%
25
69
2845
28620
15
36
2855
28653
—
—
—
12
36
2734
27379
17
56
2089
20990
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
3.8e-01
6.0e-01
9.8e-01
—
2.1e+00
1.1e+00
8.3e-01
cases:9.90%
controls:6.96%
cases:2.89%
controls:1.61%
cases:0.45%
controls:0.17%
—
—
cases:0.91%
controls:0.11%
cases:3.61%
controls:1.20%
cases:8.12%
controls:3.73%
284
1997
2586
26692
83
462
2787
28227
13
49
2857
28640
—
26
32
2834
28566
99
328
2647
27087
171
784
1935
20262
Malignant tumor of the caecum invasive carcinoma
C18.01 [2000500535]
C18.01 [2000500535]
1.5e+00
1.4e+00
—
—
—
1.7e+00
1.9e+00
cases:0.49%
controls:0.11%
cases:0.31%
controls:0.08%
—
—
—
—
—
—
cases:0.47%
controls:0.09%
cases:0.76%
controls:0.11%
14
32
2856
28657
9
22
2861
28667
—
—
—
13
25
2733
27390
16
24
2090
21022
Abdominal pain localized other
D06 [2002000305]
D06 [2002000305]
5.0e-01
1.6e+00
2.1e+00
—
—
8.6e-01
5.3e-01
cases:1.85%
controls:1.13%
cases:1.46%
controls:0.30%
cases:0.24%
controls:0.03%
—
—
—
—
cases:0.76%
controls:0.32%
cases:2.23%
controls:1.32%
53
323
2817
28366
42
85
2828
28604
7
9
2863
28680
—
—
21
89
2725
27326
47
278
2059
20768
Urology
34 [38004474]
34 [38004474]
3.4e-01
4.8e-01
8.0e-01
1.8e+00
5.6e-01
6.1e-01
4.7e-01
cases:14.36%
controls:10.67%
cases:8.68%
controls:5.54%
cases:2.23%
controls:1.01%
cases:0.24%
controls:0.04%
cases:1.82%
controls:1.05%
cases:9.18%
controls:5.22%
cases:16.71%
controls:11.17%
412
3060
2458
25629
249
1588
2621
27101
64
291
2806
28398
7
12
2863
28677
52
300
2808
28298
252
1431
2494
25984
352
2351
1754
18695
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
6.2e-01
1.3e+00
1.5e+00
—
1.1e+00
8.8e-01
6.9e-01
cases:3.38%
controls:1.85%
cases:3.24%
controls:0.91%
cases:0.77%
controls:0.17%
—
—
cases:0.42%
controls:0.14%
cases:2.26%
controls:0.94%
cases:6.27%
controls:3.26%
97
532
2773
28157
93
261
2777
28428
22
48
2848
28641
—
12
40
2848
28558
62
259
2684
27156
132
686
1974
20360
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.8e-01
5.1e-01
1.1e+00
1.7e+00
7.8e-01
4.6e-01
2.7e-01
cases:55.78%
controls:51.41%
cases:55.71%
controls:43.02%
cases:25.23%
controls:9.76%
cases:3.07%
controls:0.60%
cases:18.85%
controls:9.62%
cases:56.26%
controls:44.85%
cases:73.60%
controls:68.04%
1601
14749
1269
13940
1599
12341
1271
16348
724
2799
2146
25890
88
171
2782
28518
539
2750
2321
25848
1545
12295
1201
15120
1550
14320
556
6726
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
JN1CG [2001305527]
1.2e+00
1.4e+00
—
—
—
2.3e+00
1.4e+00
cases:0.91%
controls:0.26%
cases:0.24%
controls:0.06%
—
—
—
—
—
—
cases:0.51%
controls:0.05%
cases:0.90%
controls:0.21%
26
76
2844
28613
7
18
2863
28671
—
—
—
14
14
2732
27401
19
45
2087
21001
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
1.7e-01
5.1e-01
1.1e+00
1.7e+00
7.8e-01
4.6e-01
2.6e-01
cases:55.68%
controls:51.34%
cases:55.61%
controls:42.93%
cases:25.09%
controls:9.74%
cases:3.07%
controls:0.59%
cases:18.81%
controls:9.58%
cases:56.12%
controls:44.79%
cases:73.31%
controls:67.97%
1598
14728
1272
13961
1596
12315
1274
16374
720
2793
2150
25896
88
170
2782
28519
538
2739
2322
25859
1541
12278
1205
15137
1544
14304
562
6742
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
1.7e-01
5.1e-01
1.1e+00
1.7e+00
7.8e-01
4.5e-01
2.6e-01
cases:55.68%
controls:51.42%
cases:55.71%
controls:43.00%
cases:25.09%
controls:9.76%
cases:3.07%
controls:0.59%
cases:18.78%
controls:9.59%
cases:56.08%
controls:44.84%
cases:73.36%
controls:67.99%
1598
14752
1272
13937
1599
12335
1271
16354
720
2800
2150
25889
88
170
2782
28519
537
2742
2323
25856
1540
12292
1206
15123
1545
14310
561
6736
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.7e-01
5.1e-01
1.1e+00
1.7e+00
7.8e-01
4.5e-01
2.6e-01
cases:55.68%
controls:51.41%
cases:55.64%
controls:42.98%
cases:25.09%
controls:9.74%
cases:3.07%
controls:0.59%
cases:18.78%
controls:9.60%
cases:56.12%
controls:44.82%
cases:73.31%
controls:68.02%
1598
14749
1272
13940
1597
12330
1273
16359
720
2795
2150
25894
88
170
2782
28519
537
2745
2323
25853
1541
12287
1205
15128
1544
14316
562
6730
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.7e-01
5.1e-01
1.1e+00
1.7e+00
7.8e-01
4.5e-01
2.6e-01
cases:55.68%
controls:51.41%
cases:55.61%
controls:43.03%
cases:25.12%
controls:9.75%
cases:3.07%
controls:0.60%
cases:18.85%
controls:9.61%
cases:56.12%
controls:44.87%
cases:73.36%
controls:68.03%
1598
14749
1272
13940
1596
12345
1274
16344
721
2798
2149
25891
88
171
2782
28518
539
2747
2321
25851
1541
12300
1205
15115
1545
14317
561
6729
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.7e-01
5.1e-01
1.1e+00
1.7e+00
7.8e-01
4.5e-01
2.6e-01
cases:55.61%
controls:51.26%
cases:55.57%
controls:42.93%
cases:25.09%
controls:9.75%
cases:3.03%
controls:0.59%
cases:18.78%
controls:9.59%
cases:56.08%
controls:44.76%
cases:73.31%
controls:67.97%
1596
14707
1274
13982
1595
12315
1275
16374
720
2796
2150
25893
87
170
2783
28519
537
2743
2323
25855
1540
12272
1206
15143
1544
14306
562
6740
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.7e-01
5.1e-01
1.1e+00
1.7e+00
7.8e-01
4.5e-01
2.6e-01
cases:55.64%
controls:51.44%
cases:55.68%
controls:43.06%
cases:25.19%
controls:9.77%
cases:3.07%
controls:0.60%
cases:18.92%
controls:9.62%
cases:56.19%
controls:44.89%
cases:73.36%
controls:68.09%
1597
14758
1273
13931
1598
12354
1272
16335
723
2804
2147
25885
88
172
2782
28517
541
2752
2319
25846
1543
12306
1203
15109
1545
14330
561
6716
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
5.2e-01
1.6e+00
1.6e+00
—
1.2e+00
8.2e-01
9.3e-01
cases:1.67%
controls:1.00%
cases:2.13%
controls:0.44%
cases:0.35%
controls:0.07%
—
—
cases:0.17%
controls:0.05%
cases:1.02%
controls:0.45%
cases:3.80%
controls:1.53%
48
288
2822
28401
61
127
2809
28562
10
20
2860
28669
—
5
15
2855
28583
28
124
2718
27291
80
323
2026
20723
Change in bowel habit
R19.4 [45573017]
R19.4 [45573017]
5.5e-01
2.2e+00
2.8e+00
—
—
—
-5.7e-01
cases:0.45%
controls:0.26%
cases:0.91%
controls:0.10%
cases:0.28%
controls:0.02%
—
—
—
—
—
—
cases:0.24%
controls:0.42%
13
75
2857
28614
26
30
2844
28659
8
5
2862
28684
—
—
—
5
88
2101
20958
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
1.6e-01
3.9e-01
2.9e-01
3.2e+00
6.6e-01
4.3e-01
2.6e-01
cases:8.26%
controls:7.14%
cases:5.78%
controls:3.98%
cases:1.15%
controls:0.86%
cases:1.25%
controls:0.05%
cases:1.64%
controls:0.86%
cases:5.97%
controls:3.96%
cases:12.25%
controls:9.75%
237
2047
2633
26642
166
1141
2704
27548
33
247
2837
28442
36
15
2834
28674
47
246
2813
28352
164
1087
2582
26328
258
2052
1848
18994
metronidazole; oral, rectal
P01AB01 [21604857]
P01AB01 [21604857]
3.5e-01
1.1e+00
1.0e+00
—
1.3e+00
5.3e-01
6.0e-01
cases:9.93%
controls:7.18%
cases:5.30%
controls:1.79%
cases:0.59%
controls:0.21%
—
—
cases:0.70%
controls:0.19%
cases:3.17%
controls:1.89%
cases:9.78%
controls:5.64%
285
2061
2585
26628
152
514
2718
28175
17
61
2853
28628
—
20
55
2840
28543
87
519
2659
26896
206
1187
1900
19859
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
4679-7 [3027945]
5.0e-01
1.3e+00
1.6e+00
—
9.9e-01
8.9e-01
6.5e-01
cases:4.36%
controls:2.69%
cases:4.56%
controls:1.33%
cases:1.01%
controls:0.21%
—
—
cases:0.49%
controls:0.18%
cases:2.95%
controls:1.23%
cases:7.83%
controls:4.26%
125
773
2745
27916
131
381
2739
28308
29
59
2841
28630
—
14
52
2846
28546
81
338
2665
27077
165
896
1941
20150
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
13969-1 [3005785]
5.5e-01
1.0e+00
1.9e+00
—
8.9e-01
7.3e-01
6.4e-01
cases:4.18%
controls:2.45%
cases:2.40%
controls:0.86%
cases:0.31%
controls:0.05%
—
—
cases:0.28%
controls:0.12%
cases:1.78%
controls:0.87%
cases:5.41%
controls:2.92%
120
703
2750
27986
69
248
2801
28441
9
13
2861
28676
—
8
33
2852
28565
49
239
2697
27176
114
614
1992
20432
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
83084-4 [42529201]
4.7e-01
4.7e-01
2.3e+00
—
1.3e+00
1.3e+00
1.3e+00
cases:0.70%
controls:0.44%
cases:0.49%
controls:0.31%
cases:0.35%
controls:0.03%
—
—
cases:0.17%
controls:0.05%
cases:0.98%
controls:0.26%
cases:2.37%
controls:0.69%
20
125
2850
28564
14
88
2856
28601
10
10
2860
28679
—
5
13
2855
28585
27
72
2719
27343
50
145
2056
20901
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.2e-01
4.5e-01
1.1e+00
1.7e+00
7.6e-01
3.5e-01
2.7e-01
cases:48.71%
controls:43.20%
cases:38.54%
controls:28.56%
cases:14.98%
controls:5.39%
cases:1.74%
controls:0.32%
cases:10.66%
controls:5.27%
cases:36.96%
controls:29.14%
cases:59.78%
controls:53.14%
1398
12393
1472
16296
1106
8195
1764
20494
430
1546
2440
27143
50
93
2820
28596
305
1508
2555
27090
1015
7988
1731
19427
1259
11183
847
9863
Follow-up examination after other treatment for other conditions
Z09.8 [45600303]
Z09.8 [45600303]
1.1e+00
—
—
—
—
2.2e+00
1.5e+00
cases:0.56%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.05%
cases:0.71%
controls:0.16%
16
52
2854
28637
—
—
—
—
12
13
2734
27402
15
34
2091
21012
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
8.5e-01
1.1e+00
5.4e-01
2.0e-01
4.6e-01
9.9e-01
9.2e-01
cases:98.57%
controls:96.71%
cases:96.83%
controls:91.36%
cases:69.76%
controls:57.43%
cases:3.97%
controls:3.27%
cases:67.90%
controls:57.11%
cases:96.80%
controls:91.81%
cases:98.91%
controls:97.30%
2829
27745
41
944
2779
26209
91
2480
2002
16475
868
12214
114
937
2756
27752
1942
16331
918
12267
2658
25169
88
2246
2083
20478
23
568
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.1e-01
4.7e-01
9.5e-01
1.7e+00
7.4e-01
4.5e-01
2.8e-01
cases:54.46%
controls:49.33%
cases:52.72%
controls:40.97%
cases:20.00%
controls:8.83%
cases:2.54%
controls:0.48%
cases:16.57%
controls:8.63%
cases:53.93%
controls:42.83%
cases:72.22%
controls:66.29%
1563
14152
1307
14537
1513
11755
1357
16934
574
2534
2296
26155
73
138
2797
28551
474
2469
2386
26129
1481
11743
1265
15672
1521
13952
585
7094
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
T81.0 [45599741]
T81.0 [45599741]
4.1e-01
1.1e+00
—
—
2.6e+00
7.6e-01
1.1e+00
cases:0.98%
controls:0.65%
cases:0.56%
controls:0.20%
—
—
—
—
cases:0.24%
controls:0.02%
cases:0.44%
controls:0.20%
cases:1.76%
controls:0.62%
28
186
2842
28503
16
56
2854
28633
—
—
7
5
2853
28593
12
56
2734
27359
37
130
2069
20916
Laparoscopic right hemicolectomy
JFB31 [2001304892]
JFB31 [2001304892]
2.0e+00
1.4e+00
—
—
—
2.8e+00
—
cases:0.70%
controls:0.10%
cases:0.17%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.04%
—
—
20
28
2850
28661
5
12
2865
28677
—
—
—
16
10
2730
27405
—
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
F31.30 [2000501976]
1.4e+00
1.8e+00
—
—
—
1.5e+00
1.6e+00
cases:0.49%
controls:0.13%
cases:0.28%
controls:0.05%
—
—
—
—
—
—
cases:0.18%
controls:0.04%
cases:0.47%
controls:0.10%
14
36
2856
28653
8
13
2862
28676
—
—
—
5
11
2741
27404
10
21
2096
21025
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
4.3e-01
8.5e-01
9.0e-01
—
8.4e-01
8.7e-01
8.2e-01
cases:5.23%
controls:3.45%
cases:4.53%
controls:1.99%
cases:1.15%
controls:0.47%
—
—
cases:1.08%
controls:0.47%
cases:4.95%
controls:2.14%
cases:9.78%
controls:4.56%
150
989
2720
27700
130
570
2740
28119
33
135
2837
28554
—
31
134
2829
28464
136
587
2610
26828
206
960
1900
20086
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
2.3e-01
5.0e-01
8.4e-01
1.7e+00
7.2e-01
4.5e-01
3.1e-01
cases:51.78%
controls:46.04%
cases:48.19%
controls:35.97%
cases:14.70%
controls:6.96%
cases:2.13%
controls:0.41%
cases:13.18%
controls:6.90%
cases:48.83%
controls:37.72%
cases:69.66%
controls:62.71%
1486
13209
1384
15480
1383
10318
1487
18371
422
1996
2448
26693
61
118
2809
28571
377
1974
2483
26624
1341
10341
1405
17074
1467
13198
639
7848
External hemorrhoids without complication
I84.5 [45581832]
I84.5 [45581832]
8.1e-02
2.1e+00
—
1.0e+50
—
2.6e+00
1.1e+00
cases:0.31%
controls:0.29%
cases:0.21%
controls:0.02%
—
—
cases:0.77%
controls:0.00%
—
—
cases:0.33%
controls:0.03%
cases:0.57%
controls:0.19%
9
83
2861
28606
6
7
2864
28682
—
22
0
2848
28689
—
9
7
2737
27408
12
39
2094
21007
Emergency Room - Hospital
23 [8870]
23 [8870]
1.0e+00
2.0e+00
—
—
—
1.7e+00
6.8e-01
cases:1.08%
controls:0.38%
cases:0.56%
controls:0.08%
—
—
—
—
—
—
cases:0.33%
controls:0.06%
cases:0.71%
controls:0.36%
31
110
2839
28579
16
22
2854
28667
—
—
—
9
17
2737
27398
15
76
2091
20970
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
2.3e-01
5.0e-01
8.2e-01
1.7e+00
6.9e-01
4.5e-01
3.1e-01
cases:52.13%
controls:46.29%
cases:48.75%
controls:36.48%
cases:14.81%
controls:7.08%
cases:2.16%
controls:0.41%
cases:13.22%
controls:7.07%
cases:49.13%
controls:38.22%
cases:69.85%
controls:63.05%
1496
13280
1374
15409
1399
10467
1471
18222
425
2032
2445
26657
62
119
2808
28570
378
2023
2482
26575
1349
10479
1397
16936
1471
13269
635
7777
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
1.5e-01
4.2e-01
1.7e+00
—
1.8e+00
7.5e-01
2.1e-01
cases:6.93%
controls:6.01%
cases:2.82%
controls:1.88%
cases:0.94%
controls:0.17%
—
—
cases:0.70%
controls:0.12%
cases:3.20%
controls:1.54%
cases:7.50%
controls:6.20%
199
1725
2671
26964
81
538
2789
28151
27
49
2843
28640
—
20
34
2840
28564
88
422
2658
26993
158
1304
1948
19742
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.9e-01
7.2e-01
7.4e-01
—
1.1e+00
7.7e-01
7.8e-01
cases:18.33%
controls:12.14%
cases:9.16%
controls:4.66%
cases:1.32%
controls:0.64%
—
—
cases:1.68%
controls:0.55%
cases:8.81%
controls:4.27%
cases:25.07%
controls:13.30%
526
3482
2344
25207
263
1338
2607
27351
38
183
2832
28506
—
48
158
2812
28440
242
1170
2504
26245
528
2799
1578
18247
Malignant neoplasm of colon
C18 [45576305]
C18 [45576305]
2.0e+00
1.6e+00
—
—
—
2.6e+00
1.6e+00
cases:0.38%
controls:0.05%
cases:0.24%
controls:0.05%
—
—
—
—
—
—
cases:0.40%
controls:0.03%
cases:0.38%
controls:0.08%
11
15
2859
28674
7
14
2863
28675
—
—
—
11
8
2735
27407
8
17
2098
21029
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
5.6e-01
8.8e-01
1.2e+00
—
1.6e+00
1.1e+00
5.0e-01
cases:3.90%
controls:2.28%
cases:2.37%
controls:1.00%
cases:0.35%
controls:0.10%
—
—
cases:0.56%
controls:0.12%
cases:3.06%
controls:1.01%
cases:6.03%
controls:3.76%
112
653
2758
28036
68
287
2802
28402
10
30
2860
28659
—
16
34
2844
28564
84
276
2662
27139
127
792
1979
20254
Resection of sigmoid colon
JFB46 [2001304899]
JFB46 [2001304899]
1.9e+00
—
—
—
—
2.7e+00
—
cases:0.49%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.02%
—
—
14
21
2856
28668
—
—
—
—
9
6
2737
27409
—
Cells panel - Urine sediment
58434-2 [40761535]
58434-2 [40761535]
8.0e-01
9.1e-01
1.3e+00
—
9.4e-01
9.8e-01
5.9e-01
cases:5.96%
controls:2.78%
cases:2.65%
controls:1.09%
cases:0.56%
controls:0.15%
—
—
cases:0.38%
controls:0.15%
cases:2.59%
controls:0.99%
cases:4.84%
controls:2.75%
171
797
2699
27892
76
312
2794
28377
16
42
2854
28647
—
11
43
2849
28555
71
271
2675
27144
102
579
2004
20467
ferrous glycine sulfate; oral
B03AA01 [21601080]
B03AA01 [21601080]
7.4e-01
1.3e+00
1.4e+00
—
1.2e+00
1.2e+00
4.1e-01
cases:1.85%
controls:0.89%
cases:1.39%
controls:0.39%
cases:0.42%
controls:0.10%
—
—
cases:0.35%
controls:0.10%
cases:1.42%
controls:0.45%
cases:2.04%
controls:1.36%
53
256
2817
28433
40
112
2830
28577
12
29
2858
28660
—
10
30
2850
28568
39
123
2707
27292
43
286
2063
20760
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
-1.5e-01
9.4e-02
1.8e+00
—
2.6e+00
1.4e+00
6.9e-01
cases:0.73%
controls:0.85%
cases:0.35%
controls:0.32%
cases:0.21%
controls:0.03%
—
—
cases:0.31%
controls:0.02%
cases:0.87%
controls:0.23%
cases:1.42%
controls:0.72%
21
244
2849
28445
10
91
2860
28598
6
10
2864
28679
—
9
7
2851
28591
24
62
2722
27353
30
152
2076
20894
Ascites
R18 [45548949]
R18 [45548949]
1.1e+00
2.1e+00
—
—
2.5e+00
1.3e+00
1.0e+00
cases:0.28%
controls:0.09%
cases:0.31%
controls:0.04%
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.29%
controls:0.08%
cases:0.52%
controls:0.19%
8
26
2862
28663
9
11
2861
28678
—
—
6
5
2854
28593
8
22
2738
27393
11
39
2095
21007
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
10704-5 [3003327]
6.1e-01
1.7e+00
2.9e+00
—
—
5.3e-01
3.8e-01
cases:1.22%
controls:0.67%
cases:1.22%
controls:0.23%
cases:0.31%
controls:0.02%
—
—
—
—
cases:0.40%
controls:0.24%
cases:1.23%
controls:0.85%
35
192
2835
28497
35
65
2835
28624
9
5
2861
28684
—
—
11
65
2735
27350
26
179
2080
20867
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
3.4e-01
8.8e-01
1.1e+00
1.1e+00
8.9e-01
7.6e-01
5.9e-01
cases:19.90%
controls:15.08%
cases:17.46%
controls:8.03%
cases:5.05%
controls:1.72%
cases:0.28%
controls:0.09%
cases:3.81%
controls:1.61%
cases:16.02%
controls:8.23%
cases:31.58%
controls:20.36%
571
4327
2299
24362
501
2305
2369
26384
145
493
2725
28196
8
26
2862
28663
109
460
2751
28138
440
2255
2306
25160
665
4284
1441
16762
fluocortolone
C05AA08 [21601612]
C05AA08 [21601612]
5.7e-01
1.3e+00
1.9e+00
—
7.3e-01
8.7e-01
3.8e-01
cases:2.65%
controls:1.52%
cases:1.46%
controls:0.42%
cases:0.38%
controls:0.06%
—
—
cases:0.17%
controls:0.08%
cases:0.98%
controls:0.42%
cases:1.85%
controls:1.27%
76
435
2794
28254
42
121
2828
28568
11
17
2859
28672
—
5
24
2855
28574
27
114
2719
27301
39
268
2067
20778
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
3.7e-01
9.1e-01
1.6e+00
—
9.2e-01
1.1e+00
5.1e-01
cases:3.87%
controls:2.70%
cases:2.72%
controls:1.11%
cases:0.91%
controls:0.18%
—
—
cases:0.38%
controls:0.15%
cases:3.02%
controls:0.98%
cases:5.75%
controls:3.53%
111
776
2759
27913
78
318
2792
28371
26
52
2844
28637
—
11
44
2849
28554
83
269
2663
27146
121
743
1985
20303
Internal hemorrhoids with other complications
I84.1 [45562417]
I84.1 [45562417]
6.4e-01
2.2e+00
—
1.0e+50
—
2.3e+00
7.2e-01
cases:0.38%
controls:0.20%
cases:0.56%
controls:0.06%
—
—
cases:0.24%
controls:0.00%
—
—
cases:0.22%
controls:0.02%
cases:0.43%
controls:0.21%
11
58
2859
28631
16
17
2854
28672
—
7
0
2863
28689
—
6
6
2740
27409
9
44
2097
21002
Adenocarcinoma, NOS, of rectum, NOS
8140/3-C20.9 [44500130]
8140/3-C20.9 [44500130]
1.7e+00
2.8e+00
—
1.0e+50
—
9.7e-01
—
cases:1.39%
controls:0.25%
cases:0.52%
controls:0.03%
—
—
cases:0.63%
controls:0.00%
—
—
cases:0.18%
controls:0.07%
—
—
40
72
2830
28617
15
9
2855
28680
—
18
0
2852
28689
—
5
19
2741
27396
—
Laparoscopic resection of sigmoid colon
JFB47 [2001304900]
JFB47 [2001304900]
2.1e+00
2.5e+00
—
—
—
—
—
cases:0.70%
controls:0.09%
cases:0.24%
controls:0.02%
—
—
—
—
—
—
—
—
—
—
20
25
2850
28664
7
6
2863
28683
—
—
—
—
—
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
5.6e-01
8.9e-01
9.7e-01
—
1.5e+00
1.0e+00
5.1e-01
cases:4.49%
controls:2.61%
cases:2.82%
controls:1.17%
cases:0.35%
controls:0.13%
—
—
cases:0.63%
controls:0.14%
cases:3.20%
controls:1.17%
cases:6.65%
controls:4.11%
129
749
2741
27940
81
337
2789
28352
10
38
2860
28651
—
18
39
2842
28559
88
320
2658
27095
140
865
1966
20181
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
5.6e-01
8.9e-01
9.7e-01
—
1.5e+00
1.0e+00
5.1e-01
cases:4.49%
controls:2.61%
cases:2.82%
controls:1.17%
cases:0.35%
controls:0.13%
—
—
cases:0.63%
controls:0.14%
cases:3.20%
controls:1.17%
cases:6.65%
controls:4.11%
129
749
2741
27940
81
337
2789
28352
10
38
2860
28651
—
18
39
2842
28559
88
320
2658
27095
140
865
1966
20181
Follow-up examination after surgery for malignant neoplasm
Z08.0 [45556811]
Z08.0 [45556811]
1.1e+00
1.3e+00
—
1.0e+50
—
1.9e+00
1.6e+00
cases:0.77%
controls:0.26%
cases:0.31%
controls:0.08%
—
—
cases:0.38%
controls:0.00%
—
—
cases:0.51%
controls:0.08%
cases:1.14%
controls:0.24%
22
75
2848
28614
9
24
2861
28665
—
11
0
2859
28689
—
14
22
2732
27393
24
51
2082
20995
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
5.5e-01
8.7e-01
9.4e-01
—
1.5e+00
1.1e+00
5.4e-01
cases:4.46%
controls:2.62%
cases:2.79%
controls:1.18%
cases:0.35%
controls:0.14%
—
—
cases:0.63%
controls:0.15%
cases:3.24%
controls:1.16%
cases:6.79%
controls:4.09%
128
753
2742
27936
80
339
2790
28350
10
39
2860
28650
—
18
42
2842
28556
89
317
2657
27098
143
860
1963
20186
Barrett oesophagus
K22.7 [45605924]
K22.7 [45605924]
3.7e-01
1.5e+00
—
—
—
1.7e+00
1.3e+00
cases:0.31%
controls:0.22%
cases:0.35%
controls:0.08%
—
—
—
—
—
—
cases:0.40%
controls:0.07%
cases:0.81%
controls:0.22%
9
62
2861
28627
10
23
2860
28666
—
—
—
11
20
2735
27395
17
47
2089
20999
Haematemesis
K92.0 [45605964]
K92.0 [45605964]
1.1e+00
2.2e+00
—
—
—
—
1.2e+00
cases:0.45%
controls:0.15%
cases:0.42%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.17%
13
43
2857
28646
12
14
2858
28675
—
—
—
—
12
36
2094
21010
Malignant tumor of the sigmoid without histology
C18.70 [2000500562]
C18.70 [2000500562]
2.2e+00
2.3e+00
—
1.0e+50
—
1.5e+00
8.2e-01
cases:0.98%
controls:0.11%
cases:0.63%
controls:0.07%
—
—
cases:0.35%
controls:0.00%
—
—
cases:0.29%
controls:0.07%
cases:0.24%
controls:0.10%
28
31
2842
28658
18
19
2852
28670
—
10
0
2860
28689
—
8
18
2738
27397
5
22
2101
21024
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
1.8e-01
1.0e+00
—
—
1.9e+00
9.3e-01
6.7e-01
cases:0.91%
controls:0.76%
cases:0.80%
controls:0.29%
—
—
—
—
cases:0.24%
controls:0.04%
cases:0.80%
controls:0.32%
cases:2.61%
controls:1.36%
26
217
2844
28472
23
84
2847
28605
—
—
7
11
2853
28587
22
87
2724
27328
55
286
2051
20760
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
1.7e-01
4.3e-01
1.1e+00
1.6e+00
7.9e-01
3.7e-01
8.2e-02
cases:41.29%
controls:37.35%
cases:37.91%
controls:28.51%
cases:16.59%
controls:6.29%
cases:1.99%
controls:0.40%
cases:13.04%
controls:6.36%
cases:37.98%
controls:29.72%
cases:51.23%
controls:49.19%
1185
10716
1685
17973
1088
8179
1782
20510
476
1804
2394
26885
57
115
2813
28574
373
1820
2487
26778
1043
8147
1703
19268
1079
10352
1027
10694
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
5.3e-01
8.9e-01
1.1e+00
—
1.5e+00
1.1e+00
4.9e-01
cases:4.36%
controls:2.62%
cases:2.79%
controls:1.17%
cases:0.35%
controls:0.12%
—
—
cases:0.63%
controls:0.15%
cases:3.28%
controls:1.13%
cases:6.55%
controls:4.12%
125
752
2745
27937
80
335
2790
28354
10
35
2860
28654
—
18
42
2842
28556
90
309
2656
27106
138
867
1968
20179
Rubber band ligature of haemorrhoids or prolapse of mucosa
JHB30 [2001305142]
JHB30 [2001305142]
5.9e-01
1.2e+00
—
1.0e+50
—
2.1e+00
1.1e+00
cases:1.22%
controls:0.68%
cases:0.77%
controls:0.22%
—
—
cases:1.67%
controls:0.00%
—
—
cases:1.13%
controls:0.15%
cases:1.61%
controls:0.53%
35
195
2835
28494
22
64
2848
28625
—
48
0
2822
28689
—
31
40
2715
27375
34
111
2072
20935
liraglutide; parenteral
A10BJ02 [1123630]
A10BJ02 [1123630]
8.8e-01
8.8e-01
1.0e+00
—
1.1e+00
8.2e-01
7.0e-01
cases:1.67%
controls:0.70%
cases:1.32%
controls:0.55%
cases:0.42%
controls:0.15%
—
—
cases:0.56%
controls:0.18%
cases:1.09%
controls:0.49%
cases:1.85%
controls:0.93%
48
201
2822
28488
38
159
2832
28530
12
43
2858
28646
—
16
51
2844
28547
30
133
2716
27282
39
196
2067
20850
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
5.5e-01
8.8e-01
1.2e+00
—
1.3e+00
1.2e+00
4.7e-01
cases:3.48%
controls:2.03%
cases:2.23%
controls:0.93%
cases:0.31%
controls:0.09%
—
—
cases:0.42%
controls:0.12%
cases:2.88%
controls:0.90%
cases:5.41%
controls:3.45%
100
583
2770
28106
64
268
2806
28421
9
26
2861
28663
—
12
33
2848
28565
79
246
2667
27169
114
727
1992
20319
Benign neoplasm: Stomach
D13.1 [45586087]
D13.1 [45586087]
1.1e+00
1.2e+00
2.1e+00
1.0e+50
—
1.8e+00
1.4e+00
cases:0.70%
controls:0.22%
cases:0.38%
controls:0.11%
cases:0.17%
controls:0.02%
cases:0.45%
controls:0.00%
—
—
cases:0.51%
controls:0.08%
cases:1.04%
controls:0.26%
20
64
2850
28625
11
32
2859
28657
5
6
2865
28683
13
0
2857
28689
—
14
23
2732
27392
22
55
2084
20991
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
3.9e-01
8.9e-01
—
—
1.7e+00
1.1e+00
6.2e-01
cases:1.71%
controls:1.16%
cases:1.36%
controls:0.56%
—
—
—
—
cases:0.42%
controls:0.08%
cases:1.68%
controls:0.54%
cases:3.47%
controls:1.90%
49
332
2821
28357
39
162
2831
28527
—
—
12
22
2848
28576
46
149
2700
27266
73
400
2033
20646
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
6.4e-01
7.3e-01
1.1e+00
—
8.6e-01
6.4e-01
4.0e-01
cases:11.11%
controls:6.20%
cases:7.25%
controls:3.64%
cases:1.43%
controls:0.50%
—
—
cases:1.15%
controls:0.49%
cases:7.17%
controls:3.91%
cases:15.53%
controls:11.00%
319
1779
2551
26910
208
1045
2662
27644
41
144
2829
28545
—
33
141
2827
28457
197
1073
2549
26342
327
2315
1779
18731
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
4.5e-01
9.4e-02
2.4e+00
—
1.4e+00
1.0e+00
8.4e-01
cases:1.22%
controls:0.78%
cases:0.35%
controls:0.32%
cases:0.28%
controls:0.02%
—
—
cases:0.17%
controls:0.04%
cases:0.69%
controls:0.25%
cases:2.04%
controls:0.89%
35
225
2835
28464
10
91
2860
28598
8
7
2862
28682
—
5
12
2855
28586
19
69
2727
27346
43
188
2063
20858
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
6.7e-01
1.2e+00
1.3e+00
1.0e+50
1.3e+00
1.2e+00
1.2e+00
cases:3.69%
controls:1.92%
cases:1.81%
controls:0.54%
cases:0.24%
controls:0.07%
cases:0.24%
controls:0.00%
cases:0.24%
controls:0.07%
cases:1.49%
controls:0.44%
cases:5.27%
controls:1.72%
106
551
2764
28138
52
155
2818
28534
7
19
2863
28670
7
0
2863
28689
7
20
2853
28578
41
120
2705
27295
111
362
1995
20684
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
3.8e-01
9.7e-01
1.3e+00
—
8.0e-01
8.9e-01
7.2e-01
cases:4.15%
controls:2.89%
cases:2.40%
controls:0.93%
cases:0.45%
controls:0.12%
—
—
cases:0.21%
controls:0.09%
cases:1.97%
controls:0.82%
cases:5.51%
controls:2.77%
119
828
2751
27861
69
266
2801
28423
13
34
2857
28655
—
6
27
2854
28571
54
225
2692
27190
116
583
1990
20463
budesonide; oral, sublingual
A07EA06 [21600658]
A07EA06 [21600658]
5.4e-01
4.4e-01
—
—
1.9e+00
1.3e+00
1.1e+00
cases:0.94%
controls:0.55%
cases:0.45%
controls:0.29%
—
—
—
—
cases:0.31%
controls:0.05%
cases:1.06%
controls:0.30%
cases:1.80%
controls:0.63%
27
158
2843
28531
13
84
2857
28605
—
—
9
13
2851
28585
29
81
2717
27334
38
132
2068
20914
Liver transplant status
Z94.4 [45566478]
Z94.4 [45566478]
9.7e-01
1.1e+00
—
—
—
2.2e+00
2.1e+00
cases:0.17%
controls:0.07%
cases:0.17%
controls:0.06%
—
—
—
—
—
—
cases:0.44%
controls:0.05%
cases:0.47%
controls:0.06%
5
19
2865
28670
5
17
2865
28672
—
—
—
12
14
2734
27401
10
12
2096
21034
Magnesium Ionized [Moles/volume] in Serum or Plasma
2600-5 [3021197]
2600-5 [3021197]
—
1.3e+00
—
—
—
2.3e+00
2.0e+00
—
—
cases:0.21%
controls:0.06%
—
—
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.47%
controls:0.07%
—
6
16
2864
28673
—
—
—
8
8
2738
27407
10
14
2096
21032
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
2.4e-01
4.4e-01
3.4e-01
2.8e+00
2.7e-01
4.4e-01
3.2e-01
cases:10.63%
controls:8.57%
cases:7.14%
controls:4.74%
cases:1.29%
controls:0.92%
cases:0.70%
controls:0.04%
cases:1.40%
controls:1.07%
cases:7.06%
controls:4.65%
cases:13.68%
controls:10.29%
305
2459
2565
26230
205
1359
2665
27330
37
264
2833
28425
20
12
2850
28677
40
305
2820
28293
194
1276
2552
26139
288
2165
1818
18881
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
7.5e-01
9.0e-01
—
—
—
2.4e+00
1.1e+00
cases:1.36%
controls:0.64%
cases:0.42%
controls:0.17%
—
—
—
—
—
—
cases:1.57%
controls:0.15%
cases:1.38%
controls:0.45%
39
185
2831
28504
12
49
2858
28640
—
—
—
43
41
2703
27374
29
94
2077
20952
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
72160-5 [43054903]
3.9e-01
7.9e-01
1.3e+00
—
9.5e-01
4.1e-01
4.2e-01
cases:15.89%
controls:11.31%
cases:12.16%
controls:5.91%
cases:1.95%
controls:0.55%
—
—
cases:1.40%
controls:0.55%
cases:9.21%
controls:6.31%
cases:27.49%
controls:20.01%
456
3245
2414
25444
349
1696
2521
26993
56
159
2814
28530
—
40
156
2820
28442
253
1730
2493
25685
579
4212
1527
16834
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
F31.6 [45571757]
1.7e+00
2.5e+00
—
—
—
2.0e+00
1.7e+00
cases:0.45%
controls:0.08%
cases:0.21%
controls:0.02%
—
—
—
—
—
—
cases:0.18%
controls:0.03%
cases:0.28%
controls:0.05%
13
23
2857
28666
6
5
2864
28684
—
—
—
5
7
2741
27408
6
11
2100
21035
Hemoglobin.gastrointestinal [Presence] in Stool
2335-8 [3016251]
2335-8 [3016251]
2.5e-01
2.0e+00
2.2e+00
—
—
-5.0e-01
1.8e-01
cases:1.74%
controls:1.37%
cases:3.14%
controls:0.42%
cases:0.28%
controls:0.03%
—
—
—
—
cases:0.22%
controls:0.36%
cases:2.04%
controls:1.71%
50
392
2820
28297
90
121
2780
28568
8
9
2862
28680
—
—
6
99
2740
27316
43
360
2063
20686
Celiac disease serology panel - Serum
94494-2 [36660697]
94494-2 [36660697]
2.5e-01
1.4e+00
2.8e+00
—
1.7e+00
4.4e-01
3.3e-01
cases:2.06%
controls:1.60%
cases:1.99%
controls:0.49%
cases:0.56%
controls:0.03%
—
—
cases:0.17%
controls:0.03%
cases:0.73%
controls:0.47%
cases:2.75%
controls:1.99%
59
460
2811
28229
57
142
2813
28547
16
10
2854
28679
—
5
9
2855
28589
20
129
2726
27286
58
418
2048
20628
CT of urinary organs
KH1AD [2001306328]
KH1AD [2001306328]
1.1e+00
1.6e+00
—
—
—
1.5e+00
6.3e-01
cases:1.08%
controls:0.37%
cases:0.49%
controls:0.10%
—
—
—
—
—
—
cases:0.44%
controls:0.10%
cases:0.85%
controls:0.46%
31
107
2839
28582
14
28
2856
28661
—
—
—
12
27
2734
27388
18
96
2088
20950
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
4.0e-01
1.2e+00
1.9e+00
—
1.0e+00
5.3e-01
7.0e-01
cases:4.32%
controls:2.94%
cases:3.24%
controls:0.99%
cases:0.56%
controls:0.09%
—
—
cases:0.31%
controls:0.11%
cases:1.68%
controls:0.99%
cases:6.51%
controls:3.35%
124
843
2746
27846
93
283
2777
28406
16
25
2854
28664
—
9
32
2851
28566
46
272
2700
27143
137
705
1969
20341
Diarrhoea
D11 [2002000310]
D11 [2002000310]
4.8e-01
1.4e+00
2.3e+00
—
1.6e+00
7.1e-01
4.5e-01
cases:2.09%
controls:1.30%
cases:1.57%
controls:0.40%
cases:0.28%
controls:0.03%
—
—
cases:0.17%
controls:0.03%
cases:0.73%
controls:0.36%
cases:2.37%
controls:1.52%
60
374
2810
28315
45
115
2825
28574
8
8
2862
28681
—
5
10
2855
28588
20
99
2726
27316
50
320
2056
20726
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
3.9e-01
7.9e-01
1.4e+00
—
1.0e+00
9.0e-01
6.9e-01
cases:3.14%
controls:2.15%
cases:1.92%
controls:0.87%
cases:0.35%
controls:0.09%
—
—
cases:0.24%
controls:0.09%
cases:1.82%
controls:0.75%
cases:4.18%
controls:2.15%
90
618
2780
28071
55
251
2815
28438
10
25
2860
28664
—
7
25
2853
28573
50
206
2696
27209
88
452
2018
20594
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
4.4e-01
9.0e-01
1.7e+00
—
—
6.6e-01
4.9e-01
cases:4.04%
controls:2.64%
cases:1.99%
controls:0.82%
cases:0.42%
controls:0.08%
—
—
—
—
cases:1.57%
controls:0.82%
cases:4.84%
controls:3.03%
116
757
2754
27932
57
235
2813
28454
12
23
2858
28666
—
—
43
224
2703
27191
102
638
2004
20408
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 [3024403]
4533-6 [3024403]
9.7e-01
1.0e+00
1.7e+00
—
2.3e+00
1.2e+00
9.5e-01
cases:1.22%
controls:0.46%
cases:0.70%
controls:0.25%
cases:0.17%
controls:0.03%
—
—
cases:0.17%
controls:0.02%
cases:0.58%
controls:0.18%
cases:1.90%
controls:0.75%
35
133
2835
28556
20
72
2850
28617
5
9
2865
28680
—
5
5
2855
28593
16
50
2730
27365
40
157
2066
20889
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
3.3e-01
3.6e-01
—
1.0e+50
2.1e+00
1.2e+00
8.2e-01
cases:2.89%
controls:2.09%
cases:1.15%
controls:0.81%
—
—
cases:0.66%
controls:0.00%
cases:0.42%
controls:0.05%
cases:1.64%
controls:0.50%
cases:3.94%
controls:1.77%
83
599
2787
28090
33
231
2837
28458
—
19
0
2851
28689
12
15
2848
28583
45
138
2701
27277
83
372
2023
20674
Abdominal CT examination both without and with contrast
JN3CD [2001305561]
JN3CD [2001305561]
1.1e+00
1.7e+00
—
—
—
—
1.3e+00
cases:1.11%
controls:0.38%
cases:0.56%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.21%
32
109
2838
28580
16
29
2854
28660
—
—
—
—
16
44
2090
21002
Salmonella sp identified in Stool by Organism specific culture
20955-1 [3004716]
20955-1 [3004716]
4.7e-01
1.8e+00
2.3e+00
—
—
5.7e-01
4.0e-01
cases:1.57%
controls:0.98%
cases:1.29%
controls:0.22%
cases:0.35%
controls:0.03%
—
—
—
—
cases:0.29%
controls:0.16%
cases:1.23%
controls:0.83%
45
282
2825
28407
37
63
2833
28626
10
10
2860
28679
—
—
8
45
2738
27370
26
175
2080
20871
Endoscopic contact coagulation in colon
JFA45 [2001304860]
JFA45 [2001304860]
1.6e+00
—
—
1.0e+50
—
—
2.5e+00
cases:0.28%
controls:0.06%
—
—
—
—
cases:0.38%
controls:0.00%
—
—
—
—
cases:0.33%
controls:0.03%
8
16
2862
28673
—
—
11
0
2859
28689
—
—
7
6
2099
21040
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
2.8e-01
7.3e-01
—
—
2.1e+00
1.2e+00
3.7e-01
cases:2.26%
controls:1.73%
cases:1.22%
controls:0.59%
—
—
—
—
cases:0.35%
controls:0.04%
cases:1.89%
controls:0.57%
cases:2.80%
controls:1.96%
65
495
2805
28194
35
170
2835
28519
—
—
10
12
2850
28586
52
156
2694
27259
59
412
2047
20634
Malignant tumor of the rectum other or unspecified histology
C20.99 [2000500576]
C20.99 [2000500576]
2.0e+00
2.0e+00
—
—
—
—
—
cases:0.45%
controls:0.06%
cases:0.21%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
13
17
2857
28672
6
8
2864
28681
—
—
—
—
—
vilanterol and fluticasone furoate
R03AK10 [43534841]
R03AK10 [43534841]
8.7e-01
9.7e-01
9.8e-01
—
8.9e-01
6.8e-01
5.3e-01
cases:2.16%
controls:0.92%
cases:1.88%
controls:0.72%
cases:0.70%
controls:0.26%
—
—
cases:0.52%
controls:0.22%
cases:1.53%
controls:0.78%
cases:2.33%
controls:1.38%
62
263
2808
28426
54
207
2816
28482
20
75
2850
28614
—
15
62
2845
28536
42
213
2704
27202
49
290
2057
20756
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
3.1e-01
7.7e-01
8.0e-01
—
1.6e+00
8.7e-01
4.8e-01
cases:5.05%
controls:3.77%
cases:2.75%
controls:1.30%
cases:0.35%
controls:0.16%
—
—
cases:0.84%
controls:0.17%
cases:3.24%
controls:1.38%
cases:6.84%
controls:4.33%
145
1082
2725
27607
79
372
2791
28317
10
45
2860
28644
—
24
49
2836
28549
89
378
2657
27037
144
912
1962
20134
Malignant tumor of the caecum without histology
C18.00 [2000500534]
C18.00 [2000500534]
2.1e+00
—
—
1.0e+50
—
1.9e+00
1.3e+00
cases:0.38%
controls:0.05%
—
—
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.25%
controls:0.04%
cases:0.24%
controls:0.07%
11
14
2859
28675
—
—
5
0
2865
28689
—
7
10
2739
27405
5
14
2101
21032
Liver Pathology biopsy report
65752-8 [40768441]
65752-8 [40768441]
1.7e-01
2.0e+00
—
—
—
2.1e+00
8.0e-01
cases:0.17%
controls:0.15%
cases:0.42%
controls:0.06%
—
—
—
—
—
—
cases:0.25%
controls:0.03%
cases:0.38%
controls:0.17%
5
42
2865
28647
12
17
2858
28672
—
—
—
7
9
2739
27406
8
36
2098
21010
Diverticular disease of intestine, part unspecified, without perforation or abscess
K57.9 [45543325]
K57.9 [45543325]
6.5e-01
2.4e+00
—
—
—
1.6e+00
4.2e-01
cases:0.42%
controls:0.22%
cases:0.42%
controls:0.04%
—
—
—
—
—
—
cases:0.33%
controls:0.07%
cases:0.43%
controls:0.28%
12
63
2858
28626
12
11
2858
28678
—
—
—
9
18
2737
27397
9
59
2097
20987
Functional diarrhoea
K59.1 [45543327]
K59.1 [45543327]
2.3e-01
1.7e+00
—
1.0e+50
2.3e+00
9.9e-01
6.7e-01
cases:0.84%
controls:0.66%
cases:1.18%
controls:0.22%
—
—
cases:0.38%
controls:0.00%
cases:0.21%
controls:0.02%
cases:0.40%
controls:0.15%
cases:1.38%
controls:0.71%
24
190
2846
28499
34
63
2836
28626
—
11
0
2859
28689
6
6
2854
28592
11
41
2735
27374
29
150
2077
20896
Other specified bacterial intestinal infections
A04.8 [45561679]
A04.8 [45561679]
1.1e+00
1.9e+00
—
—
—
2.1e+00
1.5e+00
cases:0.31%
controls:0.11%
cases:0.24%
controls:0.03%
—
—
—
—
—
—
cases:0.25%
controls:0.03%
cases:0.33%
controls:0.07%
9
31
2861
28658
7
10
2863
28679
—
—
—
7
9
2739
27406
7
15
2099
21031
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
6.0e-01
1.1e+00
—
—
—
1.3e+00
9.8e-01
cases:2.13%
controls:1.18%
cases:0.91%
controls:0.31%
—
—
—
—
—
—
cases:1.13%
controls:0.30%
cases:2.85%
controls:1.09%
61
338
2809
28351
26
88
2844
28601
—
—
—
31
83
2715
27332
60
229
2046
20817
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
5.7e-02
3.3e-01
7.8e-01
1.5e+00
7.2e-01
3.4e-01
3.0e-01
cases:36.10%
controls:34.80%
cases:36.62%
controls:29.31%
cases:12.93%
controls:6.34%
cases:1.46%
controls:0.33%
cases:11.78%
controls:6.12%
cases:38.78%
controls:30.99%
cases:58.59%
controls:51.14%
1036
9984
1834
18705
1051
8410
1819
20279
371
1820
2499
26869
42
94
2828
28595
337
1749
2523
26849
1065
8496
1681
18919
1234
10763
872
10283
Right hemicolectomy
JFB30 [2001304891]
JFB30 [2001304891]
1.7e+00
—
—
—
—
2.3e+00
1.6e+00
cases:0.56%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.29%
controls:0.03%
cases:0.38%
controls:0.08%
16
30
2854
28659
—
—
—
—
8
8
2738
27407
8
17
2098
21029
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
3.9e-01
1.0e+00
1.3e+00
—
6.9e-01
9.8e-01
7.2e-01
cases:2.79%
controls:1.91%
cases:2.40%
controls:0.89%
cases:0.63%
controls:0.18%
—
—
cases:0.28%
controls:0.14%
cases:2.08%
controls:0.79%
cases:5.75%
controls:2.89%
80
548
2790
28141
69
256
2801
28433
18
51
2852
28638
—
8
40
2852
28558
57
216
2689
27199
121
609
1985
20437
Infiltration anesthesia
WX110 [2001310767]
WX110 [2001310767]
2.1e-01
2.9e-01
5.4e-01
2.1e+00
5.9e-01
4.5e-01
3.7e-01
cases:26.24%
controls:22.44%
cases:10.87%
controls:8.39%
cases:1.53%
controls:0.90%
cases:0.38%
controls:0.05%
cases:1.71%
controls:0.96%
cases:12.71%
controls:8.51%
cases:31.24%
controls:23.81%
753
6439
2117
22250
312
2406
2558
26283
44
258
2826
28431
11
14
2859
28675
49
275
2811
28323
349
2334
2397
25081
658
5012
1448
16034
Rectal prolapse
K62.3 [45605947]
K62.3 [45605947]
4.8e-01
1.9e+00
—
1.0e+50
—
2.0e+00
—
cases:0.17%
controls:0.11%
cases:0.24%
controls:0.03%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.22%
controls:0.03%
—
—
5
31
2865
28658
7
10
2863
28679
—
5
0
2865
28689
—
6
8
2740
27407
—
Benign neoplasm: Duodenum
D13.2 [45542682]
D13.2 [45542682]
1.7e+00
1.9e+00
—
—
—
2.1e+00
1.3e+00
cases:0.24%
controls:0.05%
cases:0.24%
controls:0.04%
—
—
—
—
—
—
cases:0.33%
controls:0.04%
cases:0.28%
controls:0.08%
7
13
2863
28676
7
11
2863
28678
—
—
—
9
11
2737
27404
6
17
2100
21029
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
2.8e-01
7.1e-01
8.6e-01
—
9.5e-01
6.7e-01
4.8e-01
cases:8.54%
controls:6.57%
cases:5.57%
controls:2.83%
cases:0.87%
controls:0.37%
—
—
cases:0.98%
controls:0.38%
cases:5.97%
controls:3.14%
cases:15.05%
controls:9.89%
245
1885
2625
26804
160
812
2710
27877
25
106
2845
28583
—
28
109
2832
28489
164
860
2582
26555
317
2081
1789
18965
Abdominal pain/cramps general
D01 [2002000300]
D01 [2002000300]
6.4e-01
1.6e+00
1.6e+00
—
1.4e+00
8.7e-01
8.2e-01
cases:2.82%
controls:1.51%
cases:2.23%
controls:0.45%
cases:0.24%
controls:0.05%
—
—
cases:0.17%
controls:0.04%
cases:1.02%
controls:0.43%
cases:3.94%
controls:1.78%
81
433
2789
28256
64
128
2806
28561
7
14
2863
28675
—
5
12
2855
28586
28
118
2718
27297
83
375
2023
20671
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
Y83 [45552036]
7.6e-01
1.1e+00
—
—
—
1.2e+00
9.2e-01
cases:1.39%
controls:0.66%
cases:0.49%
controls:0.16%
—
—
—
—
—
—
cases:0.55%
controls:0.17%
cases:1.23%
controls:0.49%
40
189
2830
28500
14
47
2856
28642
—
—
—
15
47
2731
27368
26
104
2080
20942
Rectal polyp
K62.1 [45586728]
K62.1 [45586728]
1.1e+00
—
—
1.0e+50
—
2.1e+00
1.8e+00
cases:0.28%
controls:0.09%
—
—
—
—
cases:0.21%
controls:0.00%
—
—
cases:0.22%
controls:0.03%
cases:0.62%
controls:0.10%
8
26
2862
28663
—
—
6
0
2864
28689
—
6
7
2740
27408
13
22
2093
21024
Protein electrophoresis panel - Serum or Plasma
24351-9 [3004588]
24351-9 [3004588]
3.8e-01
9.7e-01
1.4e+00
—
9.5e-01
9.0e-01
6.8e-01
cases:2.44%
controls:1.68%
cases:1.99%
controls:0.76%
cases:0.52%
controls:0.13%
—
—
cases:0.28%
controls:0.11%
cases:1.64%
controls:0.67%
cases:4.56%
controls:2.37%
70
481
2800
28208
57
219
2813
28470
15
38
2855
28651
—
8
31
2852
28567
45
185
2701
27230
96
498
2010
20548
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
5.4e-01
5.8e-01
8.8e-01
—
8.4e-01
5.2e-01
5.6e-01
cases:4.22%
controls:2.49%
cases:2.75%
controls:1.55%
cases:0.77%
controls:0.32%
—
—
cases:0.84%
controls:0.36%
cases:2.62%
controls:1.58%
cases:5.84%
controls:3.43%
121
715
2749
27974
79
446
2791
28243
22
92
2848
28597
—
24
104
2836
28494
72
433
2674
26982
123
722
1983
20324
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
2.0e-01
4.8e-01
8.1e-01
1.1e+00
5.8e-01
4.0e-01
3.2e-01
cases:51.39%
controls:46.42%
cases:46.66%
controls:35.07%
cases:13.55%
controls:6.54%
cases:0.87%
controls:0.29%
cases:10.42%
controls:6.14%
cases:46.32%
controls:36.75%
cases:69.75%
controls:62.59%
1475
13317
1395
15372
1339
10061
1531
18628
389
1877
2481
26812
25
82
2845
28607
298
1756
2562
26842
1272
10074
1474
17341
1469
13172
637
7874
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
3.0e-01
1.0e+00
1.3e+00
—
8.4e-01
7.4e-01
5.8e-01
cases:7.56%
controls:5.69%
cases:4.49%
controls:1.69%
cases:0.63%
controls:0.18%
—
—
cases:0.31%
controls:0.14%
cases:3.13%
controls:1.51%
cases:8.83%
controls:5.15%
217
1633
2653
27056
129
485
2741
28204
18
51
2852
28638
—
9
39
2851
28559
86
415
2660
27000
186
1084
1920
19962
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
32998-7 [3046870]
2.9e-01
1.5e+00
2.4e+00
—
—
2.0e-01
2.4e-01
cases:0.87%
controls:0.65%
cases:1.22%
controls:0.29%
cases:0.31%
controls:0.03%
—
—
—
—
cases:0.44%
controls:0.36%
cases:1.76%
controls:1.39%
25
187
2845
28502
35
82
2835
28607
9
8
2861
28681
—
—
12
98
2734
27317
37
292
2069
20754
montelukast; oral
R03DC03 [21603356]
R03DC03 [21603356]
4.3e-01
6.0e-01
7.7e-01
—
7.4e-01
6.6e-01
6.6e-01
cases:5.02%
controls:3.33%
cases:3.73%
controls:2.08%
cases:1.15%
controls:0.53%
—
—
cases:1.08%
controls:0.52%
cases:4.04%
controls:2.12%
cases:6.17%
controls:3.27%
144
954
2726
27735
107
597
2763
28092
33
153
2837
28536
—
31
148
2829
28450
111
582
2635
26833
130
689
1976
20357
Anoscopy
UJH02 [2001305182]
UJH02 [2001305182]
5.5e-01
2.0e+00
—
1.0e+50
—
1.9e+00
8.3e-01
cases:0.73%
controls:0.43%
cases:0.52%
controls:0.07%
—
—
cases:0.56%
controls:0.00%
—
—
cases:0.62%
controls:0.09%
cases:0.62%
controls:0.27%
21
122
2849
28567
15
21
2855
28668
—
16
0
2854
28689
—
17
26
2729
27389
13
57
2093
20989
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
3.4e-01
5.7e-01
9.5e-01
9.4e-01
7.1e-01
7.1e-01
5.8e-01
cases:22.58%
controls:17.19%
cases:17.32%
controls:10.56%
cases:6.24%
controls:2.51%
cases:0.38%
controls:0.15%
cases:4.69%
controls:2.37%
cases:18.83%
controls:10.27%
cases:34.05%
controls:22.47%
648
4933
2222
23756
497
3030
2373
25659
179
721
2691
27968
11
43
2859
28646
134
678
2726
27920
517
2816
2229
24599
717
4728
1389
16318
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.0e-01
5.8e-01
1.1e+00
8.4e-01
7.2e-01
6.3e-01
5.1e-01
cases:18.47%
controls:14.34%
cases:14.29%
controls:8.52%
cases:4.84%
controls:1.68%
cases:0.21%
controls:0.09%
cases:3.15%
controls:1.55%
cases:14.75%
controls:8.42%
cases:29.44%
controls:20.00%
530
4114
2340
24575
410
2443
2460
26246
139
482
2731
28207
6
26
2864
28663
90
444
2770
28154
405
2307
2341
25108
620
4209
1486
16837
Malignant tumor of the ascending colon without histology
C18.20 [2000500542]
C18.20 [2000500542]
1.7e+00
—
—
1.0e+50
—
2.2e+00
—
cases:0.38%
controls:0.07%
—
—
—
—
cases:0.42%
controls:0.00%
—
—
cases:0.25%
controls:0.03%
—
—
11
21
2859
28668
—
—
12
0
2858
28689
—
7
8
2739
27407
—
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
2.9e-01
5.8e-01
1.1e+00
8.4e-01
7.3e-01
6.2e-01
5.1e-01
cases:18.26%
controls:14.28%
cases:14.22%
controls:8.51%
cases:4.84%
controls:1.67%
cases:0.21%
controls:0.09%
cases:3.15%
controls:1.55%
cases:14.53%
controls:8.38%
cases:29.25%
controls:19.89%
524
4097
2346
24592
408
2442
2462
26247
139
480
2731
28209
6
26
2864
28663
90
442
2770
28156
399
2297
2347
25118
616
4185
1490
16861
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
2518-9 [3018405]
8.9e-01
9.9e-01
1.8e+00
—
—
1.4e+00
5.7e-01
cases:1.92%
controls:0.80%
cases:0.87%
controls:0.32%
cases:0.17%
controls:0.03%
—
—
—
—
cases:1.09%
controls:0.28%
cases:2.14%
controls:1.22%
55
229
2815
28460
25
93
2845
28596
5
8
2865
28681
—
—
30
77
2716
27338
45
256
2061
20790
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
3.0e-01
7.4e-01
1.1e+00
—
6.0e-01
6.6e-01
4.2e-01
cases:13.62%
controls:10.43%
cases:9.48%
controls:4.78%
cases:2.06%
controls:0.70%
—
—
cases:1.33%
controls:0.73%
cases:9.18%
controls:4.98%
cases:20.09%
controls:14.14%
391
2991
2479
25698
272
1371
2598
27318
59
200
2811
28489
—
38
209
2822
28389
252
1364
2494
26051
423
2976
1683
18070
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
3.0e-01
5.8e-01
1.1e+00
8.4e-01
7.3e-01
6.2e-01
5.2e-01
cases:19.23%
controls:14.96%
cases:14.77%
controls:8.86%
cases:5.02%
controls:1.80%
cases:0.21%
controls:0.09%
cases:3.29%
controls:1.61%
cases:15.08%
controls:8.74%
cases:30.48%
controls:20.63%
552
4291
2318
24398
424
2543
2446
26146
144
515
2726
28174
6
26
2864
28663
94
459
2766
28139
414
2396
2332
25019
642
4342
1464
16704
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
2.8e-01
3.3e-01
6.5e-01
2.3e+00
7.9e-01
6.2e-01
6.1e-01
cases:9.02%
controls:6.94%
cases:3.76%
controls:2.74%
cases:0.66%
controls:0.35%
cases:0.21%
controls:0.02%
cases:0.70%
controls:0.32%
cases:4.73%
controls:2.61%
cases:13.53%
controls:7.84%
259
1992
2611
26697
108
785
2762
27904
19
99
2851
28590
6
6
2864
28683
20
91
2840
28507
130
716
2616
26699
285
1651
1821
19395
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
3.1e-01
4.4e-01
2.8e-01
3.3e+00
3.4e-01
3.3e-01
4.8e-01
cases:2.89%
controls:2.14%
cases:1.99%
controls:1.29%
cases:0.49%
controls:0.37%
cases:0.49%
controls:0.02%
cases:0.49%
controls:0.35%
cases:1.97%
controls:1.42%
cases:4.46%
controls:2.82%
83
615
2787
28074
57
370
2813
28319
14
106
2856
28583
14
5
2856
28684
14
100
2846
28498
54
389
2692
27026
94
594
2012
20452
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
5.6e-01
5.7e-01
6.2e-01
-1.0e+50
7.2e-01
6.5e-01
6.6e-01
cases:4.95%
controls:2.88%
cases:3.76%
controls:2.16%
cases:1.36%
controls:0.73%
cases:0.00%
controls:0.03%
cases:1.47%
controls:0.72%
cases:4.01%
controls:2.13%
cases:6.32%
controls:3.38%
142
825
2728
27864
108
621
2762
28068
39
210
2831
28479
0
10
2870
28679
42
206
2818
28392
110
584
2636
26831
133
712
1973
20334
Other specified symptoms and signs involving the digestive system and abdomen
R19.8 [45558460]
R19.8 [45558460]
—
2.1e+00
1.0e+50
—
—
—
1.7e+00
—
—
cases:0.24%
controls:0.03%
cases:0.17%
controls:0.00%
—
—
—
—
—
—
cases:0.66%
controls:0.12%
—
7
9
2863
28680
5
0
2865
28689
—
—
—
14
25
2092
21021
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
2.7e-01
5.6e-01
1.1e+00
8.0e-01
7.2e-01
6.2e-01
5.0e-01
cases:18.85%
controls:15.01%
cases:14.56%
controls:8.86%
cases:4.91%
controls:1.74%
cases:0.21%
controls:0.09%
cases:3.22%
controls:1.59%
cases:14.97%
controls:8.64%
cases:29.72%
controls:20.43%
541
4307
2329
24382
418
2542
2452
26147
141
498
2729
28191
6
27
2864
28662
92
455
2768
28143
411
2370
2335
25045
626
4300
1480
16746
Preoperative radiotherapy
WF001 [2001310700]
WF001 [2001310700]
1.6e+00
—
—
—
—
2.2e+00
-1.0e+50
cases:0.45%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.03%
cases:0.00%
controls:0.07%
13
27
2857
28662
—
—
—
—
7
8
2739
27407
0
14
2106
21032
Malignant neoplasm of rectum
C20 [45542587]
C20 [45542587]
1.8e+00
—
—
—
—
1.9e+00
1.5e+00
cases:0.31%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.25%
controls:0.04%
cases:0.38%
controls:0.09%
9
15
2861
28674
—
—
—
—
7
10
2739
27405
8
18
2098
21028
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
2.5e-01
8.7e-01
1.3e+00
—
5.4e-01
9.6e-01
6.3e-01
cases:2.79%
controls:2.18%
cases:1.92%
controls:0.81%
cases:0.56%
controls:0.16%
—
—
cases:0.21%
controls:0.12%
cases:2.37%
controls:0.92%
cases:4.94%
controls:2.69%
80
626
2790
28063
55
232
2815
28457
16
45
2854
28644
—
6
35
2854
28563
65
252
2681
27163
104
566
2002
20480
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
5.4e-02
2.8e-01
9.6e-01
1.6e+00
6.8e-01
2.4e-01
3.2e-02
cases:33.14%
controls:31.96%
cases:31.88%
controls:26.09%
cases:14.39%
controls:6.07%
cases:1.85%
controls:0.39%
cases:11.19%
controls:5.99%
cases:32.67%
controls:27.59%
cases:45.73%
controls:44.94%
951
9168
1919
19521
915
7486
1955
21203
413
1742
2457
26947
53
112
2817
28577
320
1712
2540
26886
897
7563
1849
19852
963
9458
1143
11588
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
8.2e-01
8.3e-01
—
—
1.2e+00
9.5e-01
1.1e+00
cases:0.91%
controls:0.40%
cases:0.80%
controls:0.35%
—
—
—
—
cases:0.28%
controls:0.08%
cases:0.87%
controls:0.34%
cases:1.33%
controls:0.44%
26
115
2844
28574
23
101
2847
28588
—
—
8
23
2852
28575
24
93
2722
27322
28
92
2078
20954
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
1825-9 [3026285]
1825-9 [3026285]
3.9e-01
1.4e+00
—
—
—
2.3e+00
6.7e-01
cases:0.45%
controls:0.31%
cases:0.35%
controls:0.09%
—
—
—
—
—
—
cases:0.51%
controls:0.05%
cases:0.62%
controls:0.32%
13
88
2857
28601
10
25
2860
28664
—
—
—
14
14
2732
27401
13
67
2093
20979
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.3e-01
7.5e-01
1.1e+00
—
5.9e-01
4.3e-01
4.6e-01
cases:31.99%
controls:25.22%
cases:23.34%
controls:12.57%
cases:5.16%
controls:1.75%
—
—
cases:3.18%
controls:1.80%
cases:18.39%
controls:12.80%
cases:42.78%
controls:31.97%
918
7234
1952
21455
670
3607
2200
25082
148
502
2722
28187
—
91
514
2769
28084
505
3509
2241
23906
901
6729
1205
14317
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
2.9e-01
7.1e-01
1.4e+00
—
6.6e-01
9.1e-01
6.4e-01
cases:3.10%
controls:2.33%
cases:1.85%
controls:0.91%
cases:0.38%
controls:0.09%
—
—
cases:0.21%
controls:0.11%
cases:2.04%
controls:0.83%
cases:4.56%
controls:2.46%
89
668
2781
28021
53
262
2817
28427
11
27
2859
28662
—
6
31
2854
28567
56
227
2690
27188
96
518
2010
20528
Cardiology
6 [38004451]
6 [38004451]
2.4e-01
4.5e-01
2.4e-01
2.2e+00
3.4e-01
4.1e-01
3.7e-01
cases:19.34%
controls:15.81%
cases:11.50%
controls:7.63%
cases:1.60%
controls:1.26%
cases:0.52%
controls:0.06%
cases:1.57%
controls:1.13%
cases:10.31%
controls:7.11%
cases:23.74%
controls:17.69%
555
4535
2315
24154
330
2190
2540
26499
46
362
2824
28327
15
17
2855
28672
45
323
2815
28275
283
1950
2463
25465
500
3723
1606
17323
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
R03DA04 [21603332]
7.6e-01
1.0e+00
7.5e-01
—
5.1e-01
9.2e-01
9.5e-01
cases:1.53%
controls:0.72%
cases:1.18%
controls:0.43%
cases:0.28%
controls:0.13%
—
—
cases:0.24%
controls:0.15%
cases:1.13%
controls:0.45%
cases:1.38%
controls:0.54%
44
207
2826
28482
34
124
2836
28565
8
38
2862
28651
—
7
42
2853
28556
31
124
2715
27291
29
113
2077
20933
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
5.4e-01
9.5e-01
9.2e-01
—
1.3e+00
1.2e+00
9.3e-01
cases:2.37%
controls:1.40%
cases:1.29%
controls:0.50%
cases:0.31%
controls:0.13%
—
—
cases:0.35%
controls:0.09%
cases:1.46%
controls:0.43%
cases:2.99%
controls:1.20%
68
401
2802
28288
37
144
2833
28545
9
36
2861
28653
—
10
27
2850
28571
40
118
2706
27297
63
253
2043
20793
Malignant tumor of the colon descending invasive carcinoma
C18.61 [2000500559]
C18.61 [2000500559]
1.9e+00
—
—
—
—
3.6e+00
—
cases:0.21%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.02%
—
—
6
9
2864
28680
—
—
—
—
19
5
2727
27410
—
Malignant neoplasm colon/rectum
D75 [2002000373]
D75 [2002000373]
1.2e+00
1.4e+00
—
—
—
1.7e+00
1.9e+00
cases:0.21%
controls:0.06%
cases:0.21%
controls:0.05%
—
—
—
—
—
—
cases:0.29%
controls:0.05%
cases:0.38%
controls:0.06%
6
18
2864
28671
6
15
2864
28674
—
—
—
8
14
2738
27401
8
12
2098
21034
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
1.7e-01
8.6e-01
1.6e+00
—
1.0e+00
7.6e-01
4.6e-01
cases:2.09%
controls:1.76%
cases:1.46%
controls:0.62%
cases:0.31%
controls:0.07%
—
—
cases:0.24%
controls:0.09%
cases:1.46%
controls:0.69%
cases:3.61%
controls:2.32%
60
506
2810
28183
42
179
2828
28510
9
19
2861
28670
—
7
25
2853
28573
40
188
2706
27227
76
488
2030
20558
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
4.1e-01
6.9e-01
9.3e-01
—
6.5e-01
6.1e-01
3.3e-01
cases:15.82%
controls:11.09%
cases:10.73%
controls:5.68%
cases:1.95%
controls:0.78%
—
—
cases:1.54%
controls:0.81%
cases:10.34%
controls:5.91%
cases:22.89%
controls:17.53%
454
3182
2416
25507
308
1630
2562
27059
56
224
2814
28465
—
44
231
2816
28367
284
1621
2462
25794
482
3690
1624
17356
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
7.1e-01
1.1e+00
1.1e+00
—
1.1e+00
1.3e+00
1.3e+00
cases:0.66%
controls:0.33%
cases:0.49%
controls:0.17%
cases:0.31%
controls:0.11%
—
—
cases:0.35%
controls:0.12%
cases:0.58%
controls:0.16%
cases:0.71%
controls:0.20%
19
94
2851
28595
14
48
2856
28641
9
31
2861
28658
—
10
33
2850
28565
16
44
2730
27371
15
43
2091
21003
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
4.4e-01
6.8e-01
6.0e-01
4.3e-01
6.9e-01
6.6e-01
5.6e-01
cases:31.29%
controls:22.75%
cases:23.62%
controls:13.60%
cases:5.51%
controls:3.10%
cases:0.21%
controls:0.14%
cases:5.80%
controls:3.01%
cases:23.45%
controls:13.73%
cases:37.80%
controls:25.75%
898
6528
1972
22161
678
3901
2192
24788
158
888
2712
27801
6
39
2864
28650
166
860
2694
27738
644
3763
2102
23652
796
5420
1310
15626
Potassium [Moles/volume] in Arterial blood
32713-0 [3043409]
32713-0 [3043409]
9.9e-01
1.1e+00
2.1e+00
—
—
1.6e+00
5.7e-01
cases:1.88%
controls:0.70%
cases:0.84%
controls:0.29%
cases:0.17%
controls:0.02%
—
—
—
—
cases:1.09%
controls:0.23%
cases:1.85%
controls:1.05%
54
202
2816
28487
24
83
2846
28606
5
6
2865
28683
—
—
30
64
2716
27351
39
222
2067
20824
dexrabeprazole
A02BC07 [45893509]
A02BC07 [45893509]
7.7e-01
9.9e-01
1.3e+00
—
1.0e+00
9.3e-01
9.2e-01
cases:2.65%
controls:1.24%
cases:1.39%
controls:0.52%
cases:0.35%
controls:0.10%
—
—
cases:0.31%
controls:0.11%
cases:1.20%
controls:0.48%
cases:2.47%
controls:1.00%
76
356
2794
28333
40
150
2830
28539
10
28
2860
28661
—
9
32
2851
28566
33
131
2713
27284
52
210
2054
20836
rabeprazole; oral
A02BC04 [21600099]
A02BC04 [21600099]
7.7e-01
9.9e-01
1.3e+00
—
1.0e+00
9.3e-01
9.2e-01
cases:2.65%
controls:1.24%
cases:1.39%
controls:0.52%
cases:0.35%
controls:0.10%
—
—
cases:0.31%
controls:0.11%
cases:1.20%
controls:0.48%
cases:2.47%
controls:1.00%
76
356
2794
28333
40
150
2830
28539
10
28
2860
28661
—
9
32
2851
28566
33
131
2713
27284
52
210
2054
20836
Protein [Mass/volume] in Urine
2888-6 [3037121]
2888-6 [3037121]
6.4e-01
9.7e-01
1.0e+00
—
—
1.3e+00
6.8e-01
cases:1.57%
controls:0.83%
cases:1.25%
controls:0.48%
cases:0.17%
controls:0.06%
—
—
—
—
cases:1.27%
controls:0.35%
cases:2.33%
controls:1.19%
45
239
2825
28450
36
138
2834
28551
5
18
2865
28671
—
—
35
95
2711
27320
49
250
2057
20796
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
3.9e-01
5.9e-01
1.6e+00
—
1.1e+00
8.2e-01
7.9e-01
cases:3.31%
controls:2.27%
cases:1.08%
controls:0.60%
cases:0.28%
controls:0.06%
—
—
cases:0.17%
controls:0.06%
cases:1.09%
controls:0.49%
cases:3.47%
controls:1.61%
95
652
2775
28037
31
172
2839
28517
8
16
2862
28673
—
5
17
2855
28581
30
133
2716
27282
73
339
2033
20707
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
754
3272
2.77
113.74
5.7
4.3
4.96
24.11
ug/l
4.93
646
2707
1270
7504
2.24
93.68
3.0
2.4
3.23
2.86
mg/l
6.12
1164
6457
1848
12834
2.23
89.21
6.6
5.4
35.15
35.14
g/l
0.02
1778
12048
2017
14699
2.25
83.67
8.2
7.0
11.43
12.04
umol/l
1.28
1955
14065
889
5025
2.11
68.61
3.7
2.8
11.64
12.65
umol/l
4.32
851
4697
1341
8814
1.98
67.70
3.5
2.7
60.07
70.07
u/l
0.54
1276
8164
2490
20537
2.58
67.14
11.5
8.8
81.21
80.80
u/l
0.15
2419
19550
1634
11530
1.97
66.55
4.3
3.1
128.01
150.11
ug/l
4.02
1567
10667
841
4718
2.11
65.74
3.6
2.7
2.36
2.27
g/l
4.24
807
4374
597
2929
2.31
65.20
2.4
2.3
139.39
151.80
ug/g
0.44
493
2371
2009
15298
2.04
64.80
10.8
9.8
4.33
4.22
e9/l
1.21
1785
13212
796
4406
2.12
64.24
3.6
2.8
19.88
22.57
%
7.50
763
4112
1109
6931
1.98
63.80
2.9
2.5
—
—
—
0
0
2092
16360
2.02
59.89
7.1
5.4
7.00
6.82
mmol/l
3.05
2019
15676
1892
14444
1.91
56.23
10.2
7.8
1.21
1.21
mmol/l
2.40
1777
12489
2346
19299
2.17
56.16
5.6
4.5
14.43
13.19
mm/h
3.25
2232
17999
1717
12745
1.86
55.32
2.6
2.2
95.45
94.91
pmol/l
0.17
1055
6788
1745
13034
1.86
54.94
9.1
7.0
1.20
1.21
mmol/l
1.01
1672
12059
1809
13707
1.86
53.92
21.9
17.2
1.34
1.30
inr
2.00
1543
11478
1799
13608
1.86
53.92
7.5
6.3
0.04
0.04
e9/l
0.68
1579
11547
1788
13563
1.84
52.37
7.5
6.3
0.62
0.61
e9/l
1.06
1571
11506
2148
17278
1.96
52.29
6.2
5.0
319.33
1540.65
e6/l
—
6
270
1830
13994
1.85
52.06
7.7
6.5
0.20
0.20
e9/l
0.20
1624
12067
1811
13820
1.84
51.69
7.6
6.4
1.91
1.89
e9/l
0.12
1616
12023
1692
12675
1.81
51.05
3.4
2.9
—
—
estimate
—
0
0
867
5316
1.90
50.22
1.3
1.3
2.68
1.41
u/ml
0.73
227
1386
1001
6585
1.80
45.28
5.3
3.8
0.50
0.10
0.91
16
79
2723
24509
3.09
43.48
26.7
18.5
25.70
26.25
mg/l
0.41
2448
20560
1464
10909
1.70
41.24
5.1
4.2
40.90
103.76
ng/l
0.96
1157
8362
798
5060
1.80
39.87
1.8
1.8
1108.95
1178.33
nmol/l
1.09
650
3830
1306
9535
1.68
38.97
3.7
3.3
1634.64
1469.93
ng/l
0.56
1179
8312
758
4766
1.80
38.79
1.5
1.5
2.60
2.62
g/l
0.07
444
2870
1192
8542
1.68
37.86
1.9
1.7
20.14
20.19
nmol/l
0.05
1075
7166
544
3102
1.93
37.84
5.2
3.7
1.63
1.88
mmol/l
0.87
485
2696
551
3188
1.90
36.55
5.2
3.7
5.78
5.82
kpa
0.38
544
3101
519
2956
1.92
36.07
9.9
7.5
10.78
10.46
mmol/l
0.43
507
2837
618
3735
1.83
35.62
8.2
7.8
5.04
5.09
kpa
0.59
597
3598
618
3736
1.83
35.59
8.2
7.8
11.94
12.12
kpa
0.41
595
3601
1058
7461
1.66
35.01
3.3
3.0
362.73
352.45
umol/l
2.27
953
6515
1013
7075
1.67
34.74
5.7
4.4
85.99
86.76
%
0.41
987
6938
424
2282
2.01
34.65
5.0
4.0
104.55
94.25
ng/l
1.29
393
1978
333
1638
2.17
34.61
3.5
2.7
0.63
0.61
%
0.37
333
1627
472
2638
1.94
34.58
4.2
3.0
4.44
4.51
kpa
0.34
464
2561
611
3712
1.82
34.50
8.4
7.7
0.77
0.92
mmol/l
0.37
488
3073
565
3372
1.84
33.72
8.6
8.0
95.35
95.52
%
0.25
553
3253
903
6165
1.68
33.54
5.7
4.2
1.02
1.26
kg/l
0.50
634
4154
1762
14184
1.63
33.50
5.5
4.1
0.04
0.12
estimate
0.31
247
2851
654
4101
1.77
33.01
8.2
6.2
1.05
1.03
mmol/l
0.51
629
3833
1745
14074
1.61
32.37
5.4
4.1
3.97
2.64
estimate
0.13
272
3069
773
5117
1.70
31.98
3.6
3.2
1.04
1.14
e6/l
0.32
449
2792
1946
16180
1.63
31.25
4.7
3.4
61.50
54.61
u/l
1.88
1847
15053
496
2912
1.85
30.96
2.6
2.6
72.04
69.45
e9/l
0.96
386
2156
1331
10142
1.58
30.87
4.2
3.5
7.43
7.44
mmol/l
0.03
1186
8498
1251
9403
1.58
30.73
4.3
3.6
55.94
86.87
e6/l
0.58
989
7267
1358
10419
1.57
30.41
5.1
4.2
105.75
103.46
e6/l
0.02
998
7525
391
2140
1.96
30.20
9.6
9.7
93.66
93.89
%
0.34
391
2131
1305
9932
1.57
30.20
4.2
3.5
58.93
49.34
mg/l
0.82
944
6464
1513
11959
1.56
29.29
2.9
2.4
78.74
78.61
nmol/l
0.06
1405
10682
1319
10123
1.56
29.02
4.9
4.2
9.99
9.04
mg/mmol
0.32
944
6392
1711
13919
1.57
29.02
5.4
4.0
0.00
0.00
estimate
0.80
265
2985
490
2925
1.81
28.80
3.0
2.2
0.21
0.21
g/l
1.79
471
2719
1567
12513
1.55
28.76
7.8
6.5
58.90
57.94
%
2.35
1501
11925
2204
19088
1.66
28.23
5.2
4.3
15.13
14.95
pmol/l
2.78
2068
17369
2752
25603
2.74
28.13
33.1
22.3
139.73
139.68
mmol/l
0.41
2746
25136
385
2154
1.91
27.72
1.8
1.7
—
—
—
0
0
2753
25645
2.72
27.53
33.2
22.5
3.99
4.00
mmol/l
0.61
2746
25138
512
3138
1.77
27.42
9.3
8.5
119.34
121.30
g/l
1.40
503
3064
1275
9802
1.54
27.26
3.9
3.7
2.35
2.35
mmol/l
0.09
1179
8891
518
3200
1.75
26.94
3.0
2.9
8.16
8.86
umol/l
0.35
462
2853
295
1535
2.03
26.15
1.7
1.7
1.55
1.56
g/l
0.05
263
1328
1575
12750
1.52
25.97
8.0
6.6
25.96
26.72
%
1.85
1507
12057
2621
24012
2.03
25.91
24.8
18.3
74.84
76.52
ml/min/173m2
3.92
2517
22474
1084
8108
1.54
25.88
4.2
3.5
0.48
0.45
e6/l
0.17
820
6030
2526
22889
1.85
25.44
6.7
5.4
2.01
1.97
mu/l
0.22
2403
20946
438
2632
1.78
24.91
3.0
2.4
6.60
7.53
ug/l
0.35
391
2342
2633
24224
2.03
24.74
7.0
5.6
6.25
6.06
mmol/l
10.79
2506
22079
2554
23265
1.87
24.68
5.4
4.6
1.41
1.30
mmol/l
10.70
2419
21167
2777
26140
2.81
24.17
35.7
24.6
86.73
81.59
umol/l
6.73
2768
25833
1180
9082
1.51
24.16
2.4
2.3
212.12
218.97
u/l
0.09
1134
8590
462
2860
1.73
23.59
8.5
7.8
1.40
1.36
mmol/l
0.23
451
2815
2601
23898
1.92
23.50
9.3
7.1
41.05
40.06
mmol/mol
6.46
2494
22203
521
3339
1.68
23.41
11.3
7.3
—
—
—
0
0
2752
25856
2.49
22.92
18.1
13.3
26.41
26.17
u/l
0.29
2719
25076
436
2687
1.73
22.55
2.9
2.5
33.47
40.10
u/l
1.71
373
2270
558
3685
1.64
22.20
4.1
4.5
233.02
247.25
u/l
1.71
531
3499
802
5770
1.54
22.11
2.0
1.8
1.28
1.43
mg/l
0.59
656
4561
2670
24847
2.04
21.78
7.5
6.4
2.49
2.61
mmol/l
9.98
2552
22922
388
2346
1.76
21.40
2.9
2.8
60.94
62.51
ml/min/173m2
0.32
181
1014
673
4696
1.57
21.13
3.9
3.3
2.37
1.96
e6/l
0.41
353
2356
888
6583
1.50
21.07
3.2
2.8
4.39
5.04
e6/l
0.65
797
6023
155
680
2.35
21.05
1.3
1.2
—
—
—
0
0
716
5071
1.55
21.02
3.8
3.4
0.81
0.82
mmol/l
0.97
681
4787
154
685
2.32
20.26
1.3
1.2
—
—
—
0
0
800
5843
1.51
20.23
3.7
3.2
2.47
2.46
mmol/l
1.09
717
5271
2778
26365
2.58
19.86
42.1
27.9
245.74
244.13
e9/l
0.66
2760
25808
2778
26368
2.57
19.80
42.0
27.8
91.79
91.68
fl
0.59
2771
26061
185
896
2.14
19.78
1.5
1.5
246.18
268.60
ug/g
0.86
118
545
2778
26369
2.57
19.78
43.1
28.5
39.55
40.16
%
6.78
2769
26049
2778
26370
2.57
19.76
42.1
27.9
4.39
4.45
e12/l
7.33
2755
25719
2778
26370
2.57
19.76
42.1
27.9
7.05
6.80
e9/l
7.50
2755
25723
2778
26374
2.56
19.68
42.4
28.1
132.06
134.55
g/l
13.29
2771
26074
419
2648
1.68
19.58
2.2
1.8
1.63
1.56
%
0.92
368
2258
717
5158
1.52
19.34
2.1
2.0
—
—
—
0
0
2623
24414
1.85
19.17
6.5
5.5
4.36
4.52
mmol/l
12.92
2515
22620
104
395
2.69
19.15
3.1
2.3
5.09
163.80
u/ml
0.88
104
387
349
2112
1.74
19.09
1.5
1.4
—
—
—
0
0
2609
24260
1.81
18.91
6.2
5.4
1.38
1.44
mmol/l
11.05
2495
22304
331
1978
1.76
18.91
4.4
3.1
124.32
128.11
g/l
2.13
325
1918
1025
7956
1.45
18.74
5.4
4.2
0.00
0.00
estimate
1.15
240
2714
163
777
2.16
18.15
1.9
1.6
—
—
—
0
0
1117
8865
1.43
17.85
3.8
3.3
37.01
39.61
u/l
0.19
1054
8363
323
1956
1.73
17.57
9.9
9.8
23.98
24.24
mmol/l
0.70
311
1924
1559
13170
1.40
17.12
2.7
2.5
—
—
—
0
0
198
1039
1.97
17.03
4.5
3.7
1.48
1.36
mmol/l
0.55
192
1022
219
1192
1.91
16.90
3.7
3.5
203.37
4275.91
u/ml
1.08
192
1038
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
202
1078
1.94
16.54
2.7
3.0
0.33
0.34
iu/ml
0.32
112
588
328
2036
1.69
16.25
4.8
3.8
5.17
5.15
kpa
0.13
311
1963
638
4635
1.48
15.98
2.2
2.1
29.88
29.75
s
0.19
622
4507
316
1959
1.69
15.72
8.5
6.7
24.29
24.48
mmol/l
0.40
307
1875
195
1055
1.91
15.32
4.8
4.0
24.67
24.85
mmol/l
0.32
178
979
283
1725
1.71
14.97
4.5
3.6
1.55
1.91
mmol/l
0.84
213
1276
205
1140
1.86
14.80
2.4
2.2
507.56
685.59
ug/l
0.38
194
1086
150
755
2.04
14.51
1.6
1.5
—
—
—
0
0
405
2733
1.56
14.21
2.4
2.9
65.71
66.32
g/l
0.87
365
2520
542
3900
1.48
14.04
1.9
1.9
—
—
—
0
0
181
985
1.89
13.98
1.4
1.3
—
—
—
0
0
586
4286
1.46
13.95
1.4
1.3
14.48
13.43
u/ml
0.10
215
1582
615
4541
1.45
13.93
1.4
1.3
28.95
35.84
iu/ml
0.64
186
1404
253
1530
1.72
13.75
1.5
1.5
—
—
—
0
0
212
1225
1.79
13.51
1.6
1.5
22.84
18.56
iu/ml
—
5
27
293
1866
1.63
13.07
11.3
10.0
15.92
15.96
%
0.11
284
1803
369
2486
1.56
12.99
2.6
2.5
0.29
0.48
e6/l
1.91
356
2388
189
1068
1.82
12.97
1.1
1.0
—
—
—
0
0
370
2508
1.55
12.66
2.8
2.4
377.07
376.65
nmol/l
0.01
339
2317
900
7204
1.36
12.52
4.0
3.1
0.09
0.05
0.18
23
193
474
3399
1.47
12.36
5.1
5.3
32.54
32.96
%
0.36
359
2171
138
721
1.96
12.06
3.6
3.4
63.22
740.58
u/ml
1.23
130
671
84
363
2.35
11.91
3.2
2.3
25.76
21.87
mg/l
0.34
35
129
1233
10399
1.33
11.90
5.6
4.0
2.57
0.29
estimate
0.43
197
2459
498
3649
1.44
11.54
2.0
1.9
—
—
—
0
0
297
1965
1.57
11.27
2.0
1.7
—
—
—
0
0
133
735
1.85
9.85
1.5
1.6
0.24
0.24
g/l
0.07
127
702
124
673
1.88
9.72
3.5
3.4
0.80
0.83
nmol/l
0.30
104
544
741
5950
1.33
9.62
1.8
1.8
45884585.72
25624664.80
pmol/l
0.45
656
4886
2140
19764
1.32
9.47
36.7
24.1
330.24
332.01
g/l
14.75
2131
19660
131
736
1.82
9.22
1.3
1.2
136.15
106.09
titre
0.28
13
64
184
1139
1.66
9.19
2.2
2.0
—
—
—
0
0
173
1054
1.68
9.18
2.1
1.9
—
—
—
0
0
125
695
1.83
9.11
3.6
2.4
60.15
60.97
%
0.15
125
690
719
5790
1.32
9.06
4.9
4.2
291.72
560.00
ng/l
0.83
596
4842
159
955
1.70
8.90
1.4
1.3
—
—
—
0
0
301
2103
1.48
8.84
2.6
2.9
10.40
10.66
g/l
0.52
288
1934
123
690
1.82
8.72
3.1
2.8
35.81
35.64
umol/l
0.02
106
616
237
1583
1.54
8.62
1.4
1.3
39.32
57.21
au/ml
1.03
17
118
255
1739
1.51
8.42
2.6
2.5
21.74
22.07
au/ml
0.02
20
143
1334
11713
1.26
8.32
13.9
12.4
0.00
0.00
e9/l
0.60
1108
9546
149
896
1.70
8.32
1.7
1.6
24.36
20.21
u/ml
0.31
27
168
137
806
1.73
8.28
1.4
1.3
—
—
—
0
0
113
640
1.80
7.80
1.5
1.7
—
—
—
0
0
204
1350
1.55
7.75
2.0
2.5
3.61
3.72
g/l
0.66
177
1244
204
1351
1.55
7.72
2.0
2.5
7.66
7.39
g/l
1.17
177
1244
204
1351
1.55
7.72
2.0
2.5
4.27
4.18
g/l
0.75
177
1246
175
1119
1.60
7.71
2.7
2.6
—
—
—
0
0
90
477
1.92
7.66
1.3
1.3
—
—
—
0
0
41
157
2.63
7.62
1.7
1.2
—
—
—
0
0
178
1151
1.58
7.48
2.6
3.7
56.57
58.29
mg/l
0.07
162
989
180
1168
1.58
7.46
2.0
2.6
9.69
10.38
g/l
1.59
150
1053
98
539
1.85
7.45
1.2
1.2
88.00
406.82
titre
—
5
44
41
159
2.60
7.44
1.7
1.2
—
—
—
0
0
1264
11138
1.24
7.30
6.2
5.8
2.70
3.31
ug/l
0.47
1161
10047
177
1151
1.57
7.27
2.6
3.7
38.31
68.52
mg/l
1.38
159
991
162
1033
1.60
7.23
2.6
3.6
3.12
2.94
ratio
0.04
106
607
51
224
2.30
7.11
1.3
1.1
—
—
—
0
0
202
1361
1.52
7.08
2.0
1.9
1.51
2.34
ug/l
0.89
185
1210
157
999
1.60
7.08
2.2
1.7
0.33
0.35
mg/l
0.15
74
463
36
136
2.67
6.90
2.3
2.5
671.92
1216.21
u/ml
1.65
36
136
238
1674
1.46
6.76
1.8
1.9
1.41
1.38
g/l
0.05
222
1532
206
1410
1.50
6.71
2.4
2.2
0.00
0.61
estimate
0.51
42
415
89
492
1.83
6.69
1.5
1.5
—
—
—
0
0
117
702
1.69
6.65
2.6
2.3
184.72
99.51
ug/min
1.02
71
425
74
386
1.94
6.64
1.3
1.1
1.55
1.55
g/l
0.04
68
347
30
105
2.88
6.63
2.5
2.6
0.61
0.61
mmol/l
0.05
30
105
160
1042
1.57
6.56
1.6
1.7
7.67
7.29
iu/ml
0.06
43
245
67
341
1.99
6.46
1.6
1.4
—
—
—
0
0
46
204
2.28
6.31
1.6
1.3
28.85
32.06
u/l
0.23
39
166
64
324
2.00
6.28
1.7
1.4
—
—
—
0
0
64
324
2.00
6.28
1.7
1.4
—
—
—
0
0
67
345
1.96
6.26
1.6
1.4
—
—
—
0
0
186
1268
1.50
6.20
2.0
2.6
2.98
2.93
g/l
0.22
159
1162
64
326
1.99
6.18
1.7
1.4
—
—
—
0
0
390
3028
1.33
6.16
1.4
1.4
—
—
—
0
0
111
674
1.67
6.06
1.3
1.2
—
10.98
—
0
5
63
322
1.98
6.03
3.1
2.5
1.19
1.19
mmol/l
0.12
63
316
66
343
1.95
6.02
1.9
1.4
—
—
—
0
0
38
159
2.41
5.95
1.9
1.8
328.76
294.16
mu/l
0.21
33
125
64
332
1.95
5.88
3.0
2.5
106.13
105.51
mmol/l
0.56
64
326
64
332
1.95
5.88
3.0
2.5
4.11
4.08
mmol/l
0.16
64
326
173
1180
1.50
5.77
2.0
2.6
0.47
1.13
g/l
2.92
144
1021
33
132
2.52
5.69
1.8
1.6
4.00
2.62
u/field
0.35
20
97
63
333
1.91
5.50
1.6
1.4
—
—
—
0
0
124
795
1.58
5.48
3.9
3.4
1.97
1.80
index
0.11
71
406
95
570
1.69
5.46
1.4
1.3
—
—
—
0
0
95
570
1.69
5.46
1.4
1.3
—
—
—
0
0
127
820
1.57
5.45
1.9
2.1
90.03
90.40
%
0.05
119
797
64
344
1.88
5.33
1.7
1.4
—
—
—
0
0
121
780
1.58
5.24
1.5
1.5
24.97
14.01
iu/ml
0.17
29
152
208
1500
1.42
5.21
1.3
1.3
110.08
216.59
u/ml
4.85
192
1386
126
825
1.55
5.11
2.2
2.4
3.73
3.62
g/l
0.32
121
787
92
561
1.66
5.01
2.6
1.4
0.87
0.84
nmol/l
0.15
73
465
88
533
1.67
4.92
1.1
1.1
0.93
4.91
eliau/ml
—
8
52
98
612
1.62
4.87
1.3
1.2
1.67
4.24
u/ml
—
7
36
103
652
1.60
4.84
1.6
1.3
—
—
—
0
0
66
370
1.80
4.84
1.2
1.3
335.72
294.02
pmol/l
0.31
57
317
93
577
1.63
4.75
7.5
5.4
155.71
620.04
iu/ml
1.28
17
84
111
719
1.57
4.74
1.4
1.2
1.46
3.11
u/ml
1.96
12
63
1220
11035
1.18
4.63
2.0
2.0
1.50
1.34
mmol/l
4.50
1075
9121
133
902
1.50
4.62
2.1
2.5
0.00
0.00
g/l
-0.00
118
856
1007
8971
1.19
4.54
5.0
4.8
22.14
22.06
%
0.06
557
4628
110
721
1.55
4.48
1.3
1.2
2.09
7.57
u/ml
1.71
17
107
138
952
1.47
4.42
1.3
1.2
1.13
0.79
u/ml
0.20
12
72
21
77
2.74
4.34
1.0
1.0
—
—
—
0
0
143
998
1.46
4.32
2.1
2.5
0.02
0.02
g/l
0.06
127
904
119
810
1.49
4.10
1.6
1.4
—
—
—
0
0
178
1306
1.39
4.09
7.2
5.2
0.92
0.86
%
1.19
170
1231
196
1463
1.36
4.05
3.5
3.5
4.32
4.42
pmol/l
0.62
183
1288
27
117
2.32
4.01
3.5
2.2
645.50
777.97
e6/l
0.19
18
87
41
212
1.95
3.91
1.2
1.2
134.00
115.83
titre
—
5
36
112
762
1.49
3.88
1.9
2.4
221.74
200.45
%
1.80
101
727
111
756
1.49
3.83
1.8
1.6
13156.49
13377.31
e6/l
0.02
77
521
14
44
3.19
3.77
1.0
1.6
—
9180.00
—
0
5
23
96
2.41
3.72
1.7
1.1
—
—
—
0
0
39
202
1.94
3.72
1.3
1.4
1.52
1.05
promille
1.15
33
160
136
970
1.42
3.70
2.1
2.5
0.00
0.00
g/l
-0.00
118
857
43
231
1.87
3.69
2.0
2.0
2.96
1.70
u/field
0.31
23
118
27
122
2.22
3.67
5.6
6.2
63.00
63.83
mg/l
0.02
19
88
45
246
1.84
3.66
1.1
1.2
—
—
—
0
0
44
244
1.82
3.44
1.8
1.6
—
—
—
0
0
44
244
1.82
3.44
1.8
1.6
—
—
—
0
0
44
244
1.82
3.44
1.8
1.6
—
—
—
0
0
188
1435
1.33
3.40
6.5
5.0
1.74
1.58
%
1.66
181
1354
42
232
1.82
3.34
1.4
1.4
12.02
13.31
u/l
0.83
42
221
23
102
2.27
3.29
3.5
2.0
857.00
21505.93
e6/l
0.59
12
57
68
432
1.59
3.26
1.8
1.4
151.38
157.18
au/ml
0.15
21
132
23
103
2.24
3.22
1.3
1.3
—
—
—
0
0
119
852
1.41
3.21
3.9
2.9
1.80
1.68
mg/l
0.79
105
771
91
620
1.48
3.19
5.6
3.3
7.66
7.52
mmol/l
0.21
91
601
22
97
2.28
3.19
1.5
1.4
3.98
3.37
mmol/l
0.19
22
87
46
266
1.74
3.16
4.3
3.5
14.25
11.05
index
0.81
28
151
305
2507
1.24
3.11
3.3
3.1
227.64
207.56
ng/l
0.41
285
2304
55
336
1.65
3.10
1.5
1.3
0.18
0.19
nmol/l
0.37
43
278
55
336
1.65
3.10
1.4
1.6
20.40
29.69
ng/l
1.57
55
336
26
125
2.09
3.08
1.5
1.4
8.55
12.97
umol/l
0.38
20
79
18
74
2.44
3.04
1.9
1.1
—
—
—
0
0
95
661
1.45
3.01
1.5
1.4
—
—
—
0
0
40
226
1.78
2.99
1.3
1.6
179.94
1955.24
u/l
—
10
77
52
317
1.65
2.97
2.4
1.6
—
—
—
0
0
153
1158
1.34
2.97
2.0
1.9
38.38
39.12
u/l
0.18
136
1011
21
94
2.24
2.96
3.0
1.4
12.04
12.76
g/l
0.12
14
72
148
1116
1.34
2.94
2.0
1.7
—
—
—
0
0
44
258
1.72
2.90
1.1
1.1
3.14
1.98
eliau/ml
0.45
14
95
48
289
1.67
2.88
2.8
2.6
—
—
—
0
0
46
274
1.69
2.87
1.9
1.4
15073.91
102846.70
e6/l
1.52
32
186
186
1462
1.29
2.77
5.2
3.4
1.02
1.02
ratio
0.25
169
1338
79
540
1.48
2.77
1.3
1.2
11.60
50.57
u/ml
—
7
57
65
429
1.53
2.70
1.3
1.2
302.74
285.67
u/ml
0.15
47
250
70
470
1.50
2.69
1.3
1.2
—
143.96
—
0
5
103
745
1.40
2.68
2.7
2.2
125.87
128.90
g/l
0.54
70
580
48
296
1.63
2.66
2.5
1.6
—
—
—
0
0
325
2737
1.21
2.64
1.4
1.4
—
—
—
0
0
104
757
1.39
2.61
1.9
1.9
45.06
43.09
nmol/l
0.32
96
724
179
1412
1.29
2.61
1.2
1.2
128.55
131.85
u/ml
0.04
71
496
23
113
2.04
2.61
1.3
1.5
—
—
—
0
0
104
758
1.39
2.60
5.2
3.1
1.65
1.58
mmol/l
0.29
104
736
52
330
1.59
2.57
1.7
1.6
57.29
61.03
%
0.26
35
204
133
1015
1.33
2.49
2.0
1.7
—
—
—
0
0
7
16
4.38
2.47
2.0
1.9
—
—
—
0
0
62
415
1.50
2.44
1.7
1.4
3469.15
3819.18
e6/l
0.05
46
291
68
467
1.47
2.37
3.1
2.5
—
1861.38
—
0
37
33
191
1.74
2.33
2.1
1.9
130.88
124.56
ng/l
0.14
33
191
38
229
1.67
2.33
2.3
2.3
16.09
42.47
iu/ml
—
8
36
149
1168
1.29
2.31
2.5
4.0
36.97
78.27
u/ml
2.30
142
1128
28
157
1.79
2.21
1.2
1.1
94.29
84.85
u/l
0.33
28
138
110
835
1.33
2.17
1.9
1.7
—
—
—
0
0
28
158
1.78
2.17
1.2
1.1
28.14
27.06
u/l
0.05
28
138
94
697
1.36
2.16
1.2
1.2
—
—
—
0
0
88
647
1.37
2.14
2.3
1.9
72.76
3.76
iu/l
0.50
34
247
71
504
1.42
2.12
1.5
1.3
13.20
10.21
u/l
0.67
56
407
193
2342
0.81
2.11
4.5
4.1
1.23
1.23
mmol/l
0.50
177
2050
74
530
1.41
2.10
3.3
3.7
1.35
1.49
%
0.10
68
474
8
25
3.21
2.09
2.0
2.6
1.13
0.56
u/field
—
8
25
8
25
3.21
2.09
1.1
1.2
—
—
—
0
0
38
587
0.64
2.00
6.2
3.7
25.44
28.42
mg/l
0.19
27
402
723
6630
1.12
1.91
3.6
3.4
0.80
0.78
ug/l
0.10
543
4558
53
364
1.46
1.91
1.8
1.4
30624.03
93257.09
e6/l
1.50
35
206
40
259
1.55
1.89
1.3
1.3
—
—
—
0
0
260
3030
0.84
1.87
3.6
3.7
—
—
—
0
0
77
568
1.37
1.87
1.4
1.4
—
—
—
0
0
86
648
1.34
1.83
9.9
6.8
104.66
105.19
mmol/l
0.43
79
575
67
485
1.39
1.83
1.3
1.4
—
—
—
0
0
49
336
1.47
1.79
1.1
1.2
120.00
112.94
%
0.57
43
309
55
387
1.43
1.77
2.7
1.7
—
—
—
0
0
101
784
1.30
1.76
1.8
1.6
—
—
—
0
0
19
102
1.87
1.76
1.1
1.1
—
—
—
0
0
27
162
1.67
1.74
1.3
1.4
1.31
1.15
nmol/l
0.25
20
112
76
571
1.34
1.67
1.5
1.4
—
—
—
0
0
16
83
1.93
1.64
1.4
1.3
24.41
24.63
g/l
0.01
11
68
51
361
1.42
1.61
1.1
1.2
2.37
5.82
u/ml
1.64
19
165
29
182
1.60
1.60
1.1
1.3
0.25
1.47
u/ml
0.92
16
101
22
128
1.72
1.60
1.7
1.4
—
—
—
0
0
22
128
1.72
1.60
1.7
1.4
—
—
—
0
0
33
497
0.66
1.60
1.2
1.2
0.87
0.64
ratio
—
7
87
2060
20026
1.10
1.56
32.4
22.8
14.13
13.78
%
20.33
2045
19747
23
137
1.68
1.55
1.1
1.0
—
—
—
0
0
107
1330
0.80
1.53
1.9
1.9
3.38
3.46
mmol/l
0.26
74
976
5
15
3.34
1.52
2.2
1.4
—
—
—
0
0
22
131
1.68
1.49
1.2
1.1
1.27
1.21
u/l
0.09
12
63
66
498
1.33
1.45
1.8
1.9
4.94
4.70
mmol/24h
0.25
58
432
18
102
1.77
1.44
2.4
1.8
—
—
—
0
0
18
102
1.77
1.44
2.4
1.8
—
—
—
0
0
26
164
1.59
1.43
2.3
1.9
—
—
—
0
0
62
465
1.34
1.42
2.9
1.8
—
—
—
0
0
20
118
1.70
1.41
1.3
1.1
0.58
0.52
ratio
0.26
13
71
7
29
2.42
1.39
1.3
1.6
—
—
—
0
0
9
41
2.20
1.37
1.0
1.4
—
17.83
—
0
7
18
104
1.74
1.37
2.4
1.8
—
—
—
0
0
47
341
1.38
1.34
1.1
1.1
—
—
—
0
0
26
168
1.55
1.31
1.3
1.8
—
—
—
0
0
6
24
2.50
1.30
1.2
1.5
—
—
—
0
0
28
185
1.52
1.29
1.6
1.3
—
—
—
0
0
8
36
2.23
1.24
1.4
1.6
44.38
49.28
umol/l
—
8
36
28
187
1.50
1.23
1.6
1.3
—
—
—
0
0
9
45
2.00
1.23
16.2
16.1
4.54
5.36
mmol/l
—
9
45
69
540
1.28
1.21
1.8
1.6
—
—
—
0
0
8
37
2.17
1.21
1.4
1.1
—
—
—
0
0
85
683
1.25
1.21
1.6
1.5
—
—
—
0
0
34
238
1.43
1.20
1.4
1.5
34.40
25.20
u/ml
—
5
40
45
332
1.36
1.19
2.8
3.8
—
—
—
0
0
31
215
1.45
1.15
1.0
1.1
—
—
—
0
0
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
24
158
1.52
1.14
2.2
2.0
289.50
284.35
ug/min
—
6
37
20
126
1.59
1.14
1.4
1.1
—
—
—
0
0
23
150
1.54
1.14
1.1
1.0
—
—
—
0
0
10
51
1.96
1.11
1.9
2.2
—
—
—
0
0
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
16
97
1.65
1.06
6.9
2.7
4.85
4.83
kpa
0.01
16
97
16
97
1.65
1.06
6.9
2.7
10.49
10.05
kpa
0.25
16
97
10
52
1.93
1.06
2.8
2.8
30.68
71.45
au/ml
—
5
10
7
34
2.06
1.03
1.9
1.9
—
—
—
0
0
10
53
1.89
1.01
1.9
2.2
—
—
—
0
0
7
35
2.00
1.00
1.3
2.1
18.51
18.02
umol/l
—
7
35
42
550
0.76
0.99
1.3
1.2
1.49
1.54
g/l
0.43
42
550
33
240
1.38
0.98
1.2
1.1
—
—
—
0
0
25
173
1.45
0.97
2.4
2.0
—
—
—
0
0
48
371
1.30
0.97
1.1
1.2
1.36
2.94
u/ml
1.55
14
128
74
604
1.23
0.96
1.2
1.4
6.15
37.50
e6/l
1.46
60
441
17
108
1.58
0.96
1.4
1.4
—
—
—
0
0
12
69
1.74
0.96
1.2
1.1
—
—
—
0
0
53
416
1.28
0.96
1.0
1.1
40.57
63.57
iu/ml
—
7
72
22
149
1.48
0.95
1.1
1.2
—
—
—
0
0
169
1916
0.87
0.94
2.0
2.1
3.58
3.47
ratio
0.43
134
1564
29
208
1.40
0.94
1.1
1.4
—
521.00
—
0
20
57
454
1.26
0.92
1.3
1.3
93.93
212.13
miu/ml
3.12
20
177
91
764
1.20
0.91
1.7
1.6
—
—
—
0
0
40
305
1.32
0.90
1.5
1.2
158.60
71.16
u/ml
—
5
15
21
143
1.47
0.89
2.2
1.7
—
—
—
0
0
21
143
1.47
0.89
2.2
1.7
—
—
—
0
0
21
143
1.47
0.89
2.2
1.7
—
—
—
0
0
21
143
1.47
0.89
2.2
1.7
—
—
—
0
0
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
36
271
1.33
0.89
1.1
1.2
96.55
95.81
%
0.04
31
255
74
611
1.22
0.88
1.3
1.4
414.16
953.21
e6/l
0.95
61
473
22
152
1.45
0.88
1.3
1.2
132.64
140.53
nmol/l
0.33
22
152
8
46
1.74
0.82
1.1
1.2
—
—
—
0
0
19
130
1.46
0.80
1.4
1.6
41.12
39.98
g/l
0.38
19
130
84
710
1.19
0.80
1.2
1.3
629.48
593.66
mg/l
0.16
84
672
17
114
1.49
0.79
1.4
1.3
143.18
170.10
mmol/24h
0.80
17
114
10
163
0.61
0.78
1.1
1.5
154.93
213.02
pmol/l
—
10
163
34
260
1.31
0.78
1.7
1.5
31.61
29.27
%
0.11
18
156
21
148
1.42
0.77
2.6
2.3
—
—
—
0
0
18
125
1.44
0.72
1.1
1.1
—
—
—
0
0
18
253
0.71
0.71
1.2
1.5
—
—
—
0
0
11
68
1.62
0.71
3.3
2.5
4.64
506.94
ug/l
0.63
11
68
11
68
1.62
0.71
4.7
8.2
5.28
5.49
kpa
0.19
11
68
73
618
1.19
0.71
1.5
1.3
—
—
—
0
0
12
182
0.66
0.70
1.1
1.0
0.13
0.33
u/ml
—
7
67
14
93
1.51
0.69
1.3
1.3
247.93
154.55
ug/l
—
9
40
20
145
1.38
0.65
3.9
3.7
1.75
1.12
%
0.47
20
145
68
578
1.18
0.65
1.3
1.4
—
—
—
0
0
26
198
1.32
0.64
1.2
1.2
—
—
—
0
0
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
8
52
1.54
0.59
5.1
7.6
10.07
10.30
%
—
8
52
23
175
1.32
0.58
2.0
2.1
16.52
15.96
%
0.08
23
167
12
81
1.48
0.57
1.0
1.1
5.74
9.90
pmol/l
—
5
30
11
73
1.51
0.56
1.3
1.3
110.55
106.98
%
0.10
11
63
260
2424
1.08
0.56
2.7
2.3
12.01
13.19
nmol/l
1.61
223
2151
5
89
0.56
0.56
1.8
1.6
67.08
61.71
ug/l
—
5
72
51
433
1.18
0.52
2.0
1.9
17.92
25.87
ug/l
1.07
51
425
32
260
1.23
0.51
1.9
1.5
—
—
—
0
0
20
153
1.31
0.50
1.4
1.4
—
—
—
0
0
20
153
1.31
0.50
1.4
1.4
—
—
—
0
0
6
41
1.46
0.50
1.5
3.3
35.00
43.62
umol/l
—
6
33
10
67
1.49
0.49
2.5
1.3
8.59
9.14
ug/l
—
10
67
40
335
1.20
0.48
1.3
1.3
276.90
275.06
mosm/kgh2o
0.15
29
250
32
388
0.82
0.48
1.6
1.5
—
—
—
0
0
30
244
1.23
0.48
1.2
1.1
—
—
—
0
0
83
738
1.13
0.48
1.8
1.8
3.82
4.70
mg/l
0.20
67
561
48
410
1.17
0.47
1.2
1.1
—
—
—
0
0
7
50
1.40
0.45
1.0
1.1
—
—
—
0
0
31
257
1.21
0.43
1.1
1.1
0.71
1.38
u/ml
0.55
14
104
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
11
79
1.39
0.40
2.4
2.3
1.92
2.37
ratio
0.37
11
74
15
114
1.32
0.40
1.8
2.4
128.62
108.52
umol/l
—
8
77
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
8
60
1.33
0.40
1.0
1.4
1.24
1.18
mmol/l
—
8
60
0
19
0.00
0.39
0.0
6.2
—
—
—
0
0
28
233
1.20
0.38
2.9
2.2
813.32
641.18
ml
1.05
19
147
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
5
37
1.35
0.37
1.2
1.4
8.82
8.86
mmol/l
—
5
37
17
134
1.27
0.37
9.8
6.1
124.57
59.21
u/ml
—
7
29
24
198
1.21
0.36
1.3
1.1
—
—
—
0
0
37
319
1.16
0.35
1.1
1.1
2.94
1.52
u/ml
0.25
21
174
24
288
0.83
0.35
1.3
1.4
—
—
—
0
0
13
99
1.31
0.35
1.2
1.4
—
1136639.80
—
0
5
9
126
0.71
0.35
1.1
1.1
—
—
—
0
0
31
264
1.18
0.34
1.1
1.0
2.83
3.35
u/ml
0.09
16
124
12
156
0.77
0.34
4.7
3.7
—
—
—
0
0
26
218
1.19
0.34
1.3
1.1
—
—
—
0
0
32
370
0.86
0.32
1.1
1.1
—
—
—
0
0
40
351
1.14
0.32
1.6
6.2
7.20
7.40
mmol/l
0.13
29
301
24
203
1.18
0.30
1.3
1.1
—
—
—
0
0
8
62
1.29
0.28
1.5
1.6
—
—
—
0
0
24
205
1.17
0.27
2.5
2.9
26.76
31.27
mg/l
0.21
16
149
8
65
1.23
0.27
1.0
1.3
—
—
—
0
0
16
133
1.20
0.24
1.9
1.3
—
—
—
0
0
24
208
1.16
0.24
1.3
1.1
—
—
—
0
0
24
208
1.16
0.24
1.3
1.1
—
—
—
0
0
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
7
91
0.77
0.22
1.3
1.1
—
13.20
—
0
10
5
40
1.25
0.22
1.6
1.4
70.20
52.43
ug/l
—
5
40
16
189
0.85
0.22
1.1
1.4
—
—
—
0
0
24
210
1.14
0.21
4.0
5.4
20.16
52.98
u/ml
—
9
58
44
401
1.10
0.21
1.4
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
0.01
—
0
5
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
22
192
1.15
0.20
1.6
2.1
8.24
8.12
mmol/l
0.06
22
192
10
80
1.25
0.20
1.1
1.1
—
—
—
0
0
10
123
0.81
0.20
1.3
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
0.01
—
0
9
17
197
0.86
0.19
1.1
1.4
—
—
—
0
0
11
90
1.22
0.19
1.0
1.2
—
—
—
0
0
21
184
1.14
0.19
1.0
1.1
0.20
6.55
nmol/l
—
7
38
22
194
1.14
0.18
1.1
1.1
1.26
2.43
u/ml
0.63
14
89
7
59
1.19
0.18
2.1
1.4
—
—
—
0
0
7
62
1.13
0.17
1.3
1.2
—
—
—
0
0
5
70
0.71
0.16
1.6
1.1
—
—
—
0
0
711
7210
0.98
0.16
4.5
3.6
0.28
0.14
estimate
0.20
187
2321
6
77
0.78
0.15
1.3
1.1
—
—
—
0
0
6
78
0.77
0.15
1.3
1.1
—
—
—
0
0
10
119
0.84
0.15
1.0
1.2
—
73.06
—
0
16
9
81
1.11
0.15
3.7
2.5
227.78
143.11
nmol/l
—
9
73
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
138
0.87
0.13
1.2
1.1
—
—
—
0
0
26
239
1.09
0.12
1.2
1.1
2.35
1.08
u/ml
0.36
17
123
18
199
0.90
0.11
1.3
1.5
0.20
0.24
nmol/l
0.51
12
145
5
45
1.11
0.09
1.0
1.3
—
—
—
0
0
11
97
1.13
0.09
1.1
1.1
1333.36
1657.63
miu/ml
0.60
11
97
6
54
1.11
0.09
1.2
1.5
—
—
—
0
0
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
38
362
1.05
0.07
1.2
1.1
58.15
19.02
au/ml
—
8
68
7
84
0.83
0.07
1.4
1.1
—
—
—
0
0
9
86
1.05
0.07
1.1
1.6
24.22
482.49
nmol/24h
—
9
86
13
140
0.93
0.04
1.6
1.6
—
—
—
0
0
15
160
0.94
0.04
1.2
1.1
—
—
—
0
0
21
220
0.95
0.03
1.2
1.2
92.81
104.97
pmol/l
0.51
21
220
10
92
1.09
0.03
1.3
1.2
7.90
10.39
mm/h
—
10
92
21
217
0.97
0.01
1.2
1.2
2.06
2.27
mmol/l
0.48
21
203
18
174
1.03
0.00
2.1
1.6
90.11
86.87
umol/l
0.21
18
174
10
95
1.05
0.00
1.0
1.3
—
—
—
0
0
13
125
1.04
0.00
1.2
1.2
5.95
6.22
mmol/l
0.37
13
117
10
101
0.99
0.00
1.1
1.0
—
—
—
0
0
21
215
0.98
0.00
1.2
1.4
—
—
—
0
0
21
212
0.99
0.00
1.1
1.1
0.28
2.32
u/ml
4.29
11
108
59
587
1.01
0.00
1.4
1.3
37.31
32.47
iu/l
0.43
50
497
11
107
1.03
0.00
1.2
1.2
214.91
198.11
iu/ml
0.08
11
107
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
312.40
—
0
5
8
82
0.98
-0.00
1.1
1.1
—
—
—
0
0
7
77
0.91
-0.00
1.4
1.1
—
—
—
0
0
25
250
1.00
-0.00
1.0
1.0
71.21
43.40
ng/l
0.65
18
169
0
9
0.00
-0.00
0.0
1.0
—
0.01
—
0
9
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
25
250
1.00
-0.00
1.0
1.0
696.90
706.54
ng/l
0.03
20
168
5
53
0.94
-0.00
1.0
1.3
—
—
—
0
0
25
250
1.00
-0.00
1.0
1.0
315.95
318.29
ng/l
0.02
20
172
0
7
0.00
-0.00
0.0
1.1
—
1.26
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_DESCENDING_COLON and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_DESCENDING_COLON | 1.226 [1.09, 1.38] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.251 |
During the follow-up period (1.1.1998 — 31.12.2019), 872 out of 4109 females with CD2_BENIGN_DESCENDING_COLON died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_DESCENDING_COLON | 1.327 [1.18, 1.5] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1413 out of 5120 males with CD2_BENIGN_DESCENDING_COLON died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_DESCENDING_COLON.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.109% | 0.179% |
| 5 | 0.695% | 1.384% |
| 10 | 2.046% | 3.572% |
| 15 | 3.64% | 6.784% |
| 20 | 6.548% | 11.258% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_DESCENDING_COLON – Benign neoplasm: Descending colon
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data